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Abstract 
This thesis focuses on our progress towards the total synthesis of N-methylwelwitindolinone 
C isothiocyanate 7, commonly called welwistatin. This major alkaloid of the 
welwitindolinone family, which was isolated from Hapalosiphon welwitschii in 1994, 
represents a particularly attractive target due to both its interesting biological activities (MDR 
reversing agent) and its challenging structure. Welwistatin possesses a complex 
bicyclo[4.3.1]decane ring system consisting of four stereogenic centres, three quaternary 
carbons and two unusual reactive functionalities: the isothiocyanate bridgehead and a vinyl 
chloride group. 
 
 
 
 
Inspired by the synthetic challenge of this complex architecture, the Simpkins group reported 
an expedient four-step synthesis of the core structure of welwistatin 7 in 2005. Three years 
later, our group had also investigated the reactivity at the bridgehead enolate positions. After 
synthesising skeleton 88, we successfully functionalised the bridgehead positions using the 
bridgehead enolate chemistry developed by our group to access bridgehead alkene 126. With 
bridgehead alkene 126 in hand, we turned our attention towards the other features present on 
welwistatin and successive oxidations led to the formation of enone 198.  
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At this stage, the tetracyclic model system 88 presented certain difficulties. Based on 
preliminary studies carried out in our group, these issues would be avoided by the preparation 
of skeleton 170, which possesses the gem-dimethyl moiety already present at position C16. We 
turned our attention to the synthesis of tetracycle 170 and its subsequent functionalisation. 
Preliminary studies to enone 227 had also been carried out in our group which demonstrated 
the lability of the azide functionality at the bridgehead position. 
 
In this present work, which builds on the past efforts of the Simpkins group, we optimised the 
synthetic route to azide 217 as well as pursuing the previous studies of our group towards the 
functionalisation of position C12. The vinyl fragment would be introduced via a regioselective 
aldol reaction followed by dehydration, whilst the methyl group could be introduced by 
quenching a regioselectively introduced enolate with excess methyl iodide. We studied 
various methods for installing the desired quaternary centre at position C12 of the tetracyclic 
structure. Unfortunately, despite the formation of advanced intermediates, we were unable to 
introduce the required methyl group at position C12. 
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An unexpected product was obtained while attempting to reduce and protect azide 227. The 
initial analysis of the spectral data suggested the formation of highly strained cyclophane 285. 
However, this highly provocative structure was eventually discarded, as subjecting enone 214 
to similar conditions did not afford the analogous cyclophane 286. Under these conditions, the 
bis-phenol products 291 and 292 were obtained. 
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CHAPTER ONE 
WELWITINDOLINONES: ISOLATION, STRUCTURES, 
BIOLOGICAL ACTIVITIES AND SYNTHETIC WORK 
  
2 
 
1.1 ISOLATION AND CHARACTERISATION OF THE WELWITINDOLINONE 
FAMILY 
In 1994, Moore and co-workers reported the isolation of fifteen novel alkaloids as part of their 
research towards new useful natural products.
1
 The fifteen structures were isolated from the 
lipophilic extracts of Australian cyanobacteria, two blue-green algae named Hapalosiphon 
welwitschii W. & G. S. West (UH strain IC-52-3) and Westiella intricata Borzi (UH strain 
HT-29-1). Hapalosiphon welwitschii and Westiella intricata were found to display potent 
biological activities such as antifungal, larvacidal and insecticidal activities. The major 
component of these blue-green algae, N-methylwelwitindolinone C isothiocyanate 7, was also 
shown to reverse multidrug resistance in chemotherapeutic cancer treatment.
2
 Along with 
N-methylwelwitindolinone C isothiocyanate 7, fourteen alkaloids were isolated as minor 
constituents: a unique spiro-cyclobutane named welwitindolinone A isonitrile 1, five compact 
tetracyclic oxindoles (2-6) related to 7 and eight biogenetically related structures including 
four fischerindoles (8-11) and four hapalindoles (12-15) (Figure 1.1). The structure and 
absolute stereochemistry of N-methylwelwitindolinone C isothiocyanate 7 was determined by 
X-ray crystallography.
1
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Figure 1.1 
 
In 1999, Moore and co-workers reported the isolation and characterisation of several oxidised 
welwitindolinones from the strains of terrestrial Fischerella muscicola Gomont (HG-39-5) 
and Fischerella major Gomont (HX-7-4).
3
 Eight alkaloids were isolated from these strains 
including four previously identified compounds, welwitindolinone A isonitrile 1, 
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N-methylwelwitindolinone C isonitrile 6, N-methylwelwitindolinone C isothiocyanate 7 and 
12-epi-fischerindole I isonitrile 11, and four novel oxidised welwitindolinones, 
3-hydroxy-N-methylwelwitindolinone C isonitrile 16, 3-hydroxy-N-methylwelwitindolinone 
C isothiocyanate 17, N-methylwelwitindolinone D isonitrile 18 and welwitindolinone 19 
(Figure 1.2). While welwitindolinones 16 and 17 were simply the result of an oxidation of 
their respective analogues 6 and 7 at the C3 position, N-methylwelwitindolinone D isonitrile 
18 contains a bridging spiro-ether functionality that was believed to arise from a 
photo-oxidation-cyclisation of N-methylwelwitindolinone C isonitrile 6. Finally, 
welwitindolinone 19, possessing a formamide functionality at the benzylic bridgehead 
position C11, was described as an artifact obtained during the isolation process of 
3-hydroxy-N-methylwelwitindolinone C isonitrile 16 (Figure 1.2). 
 
Figure 1.2 
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1.2 BIOSYNTHETIC ROUTE 
1.2.1 A common intermediate for the 15 alkaloids of Hapalosiphon welwitchii 
In addition to the isolation and characterisation studies carried out on the fifteen alkaloids 
isolated from Hapalosiphon welwitschii, Moore proposed a biogenesis of the 
welwitindolinones, fischerindoles and hapalindoles.
1
 Moore noticed that the relative 
stereochemistry of the welwitindolinones, fischerindoles and hapalindoles matched that of 
12-epi-hapalindole E isonitrile 12 or its isothiocyanate analogue 14. He therefore proposed 
these two entities (12 and 14) as common precursors of the biogenesis of the diverse 
chlorine-containing alkaloids isolated from the blue-green algae.  
First isolated by Schwartz and co-workers in 1987, 12-epi-hapalindole E isonitrile 12 was 
found to be the second most abundant component in Hapalosiphon welwitschii.
4
 Hapalindole 
12 could be generated from the chloronium ion-induced cyclisation of a geranyl 
pyrophosphate derivative, (Z)-3,7-dimethyl-1,3,6-octatriene 20 and a L-tryptophan derivative, 
3-((Z)-2’-isocyanoethenyl)indole 21 (Scheme 1.1). 
 
Scheme 1.1 
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From 12-epi-hapalindole 12, an enzyme-controlled or an acid-catalysed condensation of the 
isopropenyl group onto the C2 or C4 position of the indole motif would respectively lead to 
the formation of the tetracyclic fischerindole 8 or hapalindole 22.
1
 Further modifications of 8 
or 22 would lead to the biogenesis of their whole families (Scheme 1.2). 
 
Scheme 1.2 
 
1.2.2 Biogenesis of the welwitindolinones 
An oxidation of the indole of 12-epi-hapalindole E isonitrile 12 was envisaged in the early 
stages of the biogenesis of the welwitindolinone family.
1
 Indeed, the absence of an indole 
possessing the characteristic skeleton of the welwitindolinone family shows the crucial role of 
the oxidation step in the formation of this unusual compact structure. Welwitindolinone A 
isonitrile 1 could then be obtained via an acid-catalysed cyclisation performed on oxindole 23. 
Oxidation of spiro-oxindole 1 could generate the isocyano-epoxide intermediate 24 which 
could undergo skeletal rearrangement via a tandem retro-aldol 
type-fragmentation/Friedel-Crafts alkylation sequence to afford, after tautomerisation, 
welwitindolinone B isonitrile 25 (Scheme 1.3). 
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Scheme 1.3 
 
Even though welwitindolinone B isonitrile 25 was not present in the extracts of Hapalosiphon 
welwitschii, Moore considered welwitindolinone 25 as a potential common precursor of the 
remaining members of the family.
1
 N-Methylwelwitindolinone B isonitrile 26 would arise 
from the methylation of welwitindolinone 25. At this stage, Moore described the origin of the 
isothiocyanate functionality as unclear; however, along with the hypothesis of the presence of 
a thiocyanate inorganic fragment in the early stages of the biogenesis, he postulated that sulfur 
could be introduced at a late stage of the biogenesis on the isonitrile intermediate. Based on 
this assumption, introduction of a sulfur would lead to isothiocyanate analogue, 
N-methylwelwitindolinone B isothiocyanate 3. Finally, appropriate oxidations, likely to be 
facilitated enzymatically, are required to lead to the other members of the family, 
N-methylwelwitindolinone C isonitrile 6 and N-methylwelwitindolinone C isothiocyanate 7 
(Scheme 1.4). 
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Scheme 1.4 
 
A photo-catalytic oxidation performed on N-methylwelwitindolinone C isonitrile 6, or its 
isothiocyanate analogue 7, could provide the hydroperoxy intermediates 27 or 28 that, under 
subsequent reduction, would afford 3-hydroxy-N-methylwelwitindolinone C isonitrile 16 and 
isothiocyanate 17.
3
 Alternatively, intramolecular epoxidation of the vinyl chloride present on 
27 followed by cyclisation and ring-opening of the epoxide by the hydroxy group in position 
C3 would give N-methylwelwitindolinone D isonitrile 18. This oxidative pathway hypothesis 
was reinforced as exposure of welwitindolinone 6 in methanol to singlet oxygen for four days 
gave the oxidised welwitindolinones 16 and 18 (respective yields of 4.9% and 3.2%) 
(Scheme 1.5). 
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Scheme 1.5 
 
In 2005, Baran underlined the unlikely architecture of intermediate 23, highlighting the fact 
that Moore’s pathway would require an unusual cationic cyclisation to afford 
welwitindolinone A isonitrile 1.
1,5
 He proposed an alternative biogenesis of welwitindolinone 
A isonitrile 1, involving a benzylic oxidation of 12-epi-fischerindole G isonitrile 8 followed 
by an oxidative ring contraction of 12-epi-fischerindole I isonitrile 11 (Scheme 1.6). This 
hypothetical biogenesis is reinforced by the fact that the two fischerindoles 8 and 11 involved 
in this process were initially co-isolated from the Hapalosiphon welwitchii algae.  
 
10 
 
 
Scheme 1.6 
 
In 2009, our group supported the proposal of Baran and Richter regarding the unlikely 
architecture of intermediate 23, presented in the initial biogenesis proposed by Moore and 
co-workers. Experimental procedures involving a singlet oxygen transfer on members of the 
hapalindole family (such as hapalindole A) did not yield the desired oxindole motif.
6
 
 
Scheme 1.7 
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Our group presented an acid-mediated oxidation of a large range of tetracyclic indoles into the 
corresponding -unsaturated oxindoles (such as oxindoles 32 and 33) as well as a potential 
mechanism for the transformation (Scheme 1.7). The strained welwitindolinone scaffold was 
presented as a key feature of this intriguing equilibration, thus reinforcing the improbable 
character of biosynthetic intermediate 23.
6
 
 
 
1.3 BIOLOGICAL PROPERTIES OF THE WELWITINDOLINONES 
As photosynthetic organisms which produce biologically active metabolites, cyanobacteria 
represent an attractive source of pharmaceutical leads. In 1984, Moore and co-workers 
reported the isolation and characterisation of several alkaloids from Hapalosiphon intricatus 
and Hapalosiphon fontinalis.
7
 Most of these novel natural products displayed antifungal 
and/or antibacterial activities. Therefore, ten years later, as part of their effort to identify new 
biologically active natural products, Moore and colleagues re-investigated the blue-green 
algae. While the isonitrile functionality was known to be responsible for antifungal activities 
(e.g. expressed in welwitindolinone A isonitrile 1, welwitindolinone D isonitrile 18), 
N-methylwelwitindolinone C isothiocyanate 7 demonstrated both multidrug resistance (MDR) 
reversing activity and larvicidal properties.
1,2 
 
1.3.1 Definition of MDR and how to overcome the MDR process 
Cancer consists of a large group of almost 100 diseases that is defined by an uncontrolled 
growth of malignant cells and their ability to multiply and spread inside the human body. One 
of the many treatments of cancer is known as chemotherapy and involves the selective 
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destruction of malignant cells by use of chemical substances (e.g. taxol 37, vinblastine 38, 
colchicine 39, see Figure 1.3). This technique has shown an impressive success in many 
cancer therapies (e.g. lung or breast cancers) reducing considerably the number of infected 
cells over the first weeks of medication. However, over time, the tumour cells seem to 
develop an ability to resist the cytotoxic agent, which represents a significant obstacle to 
providing effective and sustainable treatments against cancer. Formally known as multidrug 
resistance, this phenomenon enables a disease-causing organism, or cancerous cell, that has 
been exposed to one chemotherapeutic agent to develop cross-resistance towards distinct 
drugs of a wide variety of structures and functions targeted at eradicating the organism or 
cancerous cell. 
 
Figure 1.3 
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Diverse mechanisms have been invoked to explain the MDR process including a decrease in 
the permeability of the cell (also compromising accessibility of the active substances in the 
tumour cell), alteration of the binding sites and an increase in the efflux of chemotherapeutic 
drugs. After extensive research over the past few decades, a correlation has been established 
between the MDR phenomenon and the over-expression of plasma membrane proteins such 
as P-glycoprotein (P-gp).
8
 P-Gp has been identified on the surface of cancer cells of the liver, 
kidneys, intestine and ovaries. It is responsible for the efflux migration of diverse cytotoxic 
agents from the intracellular milieu, which serves to reduce the presence of the active 
substance in the tumour cells. 
As illustrated on the left-hand side of Figure 1.4, the chemotherapeutic drugs were able to 
penetrate the affected cells but were later pumped out by the MDR efflux pump mechanism of 
the P-gp.
9
 In order to overcome the MDR phenomenon, a chemical substance would need to 
inhibit the action of the P-gp and thereby allow the accumulation of chemotherapeutic 
substances in the infected cells. 
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Figure 1.4 
 
Extensive studies have already been carried out to identify chemical substances that are able 
to antagonise the P-gp pump effect (illustrated on the right side of Figure 1.4).
9
 Several 
blocking agents (e.g. verapamil 40, see Figure 1.5), commonly called MDR reversing agents, 
MDR modulators or MDR chemosensitisers, have already proved their efficiency in reducing 
the resistance of the cancer cells in vitro, however, none of these chemosensitisers has been 
clinically tested due to their high cytotoxicity. 
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Figure 1.5 
 
Research to identify non-cytotoxic MDR reversing agents that inhibit the P-gp pump effects is 
still an important area in cancer chemotherapy.   
 
 
1.3.2 Welwitindolinones as MDR reversing agents 
Measurement of the ability of a chemical substance to reverse MDR activity in vitro can be 
carried out by treating an infected cell with a combination of several doses of anticancer drugs 
(such as taxol 37 or vinblastine 38, see Figure 1.3) as well as the agent in question. Analyses 
of the percentage of cancer cells killed versus a control would then determine the capacity of 
the agent to antagonise the MDR agent. 
In their effort to identify novel MDR inhibitors, Moore and colleagues screened an extensive 
collection of extracts from Hapalosiphon welwitschii to define their ability to antagonise 
P-gp.
1,2
 Tested in vitro on MCF-7/ADR (infected cells from breast cancer cell line) and 
SK-VLB-1 (infected cells from ovarian cancer cell line selected for their resistance to 
vinblastine 38 due to the presence of over-expressed P-gp), the extracts were identified as 
possessing MDR reversing agents that were able to promote the accumulation of the 
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chemotherapeutic drug, [
3
H]-vinblastine, in the infected cells. Components of these extracts, 
specifically three members of the family were studied: N-methylwelwitindolinone C 
isothiocyanate 7 and welwitindolinone C isothiocyanate 5 were chosen for their ability to 
reduce considerably the resistance of the infected cells to the anticancer drugs (Figure 1.3), 
N-methylwelwitindolinone C isonitrile 6 was investigated due to its chromatographic 
similarity with 7. 
In SK-VLB-7 cells, Moore and colleagues studied the accumulation of actinomycin D and 
daunomycin. N-Methylwelwitindolinone C isothiocyanate 7 was identified as being as potent 
as verapamil 40 (the best characterised MDR chemosensitiser to date) at lower doses (20 µM 
of 40 against 5 µM of welwitindolinone 7). Welwitindolinone C isothiocyanate 5 was able to 
promote the accumulation of actinomycin D at similar doses and efficiency to 
welwitindolinone 7 but was not able to accumulate the anti-cancer agent daunomycin. Finally, 
N-methylwelwitindolinone C isonitrile 6 was considered inactive as similar results were 
obtained in the absence of MDR reversing agent. 
In moderately resistant MCF-7/ADR cells, the activity of N-methylwelwitindolinone C 
isothiocyanate 7 was investigated in the presence of diverse chemotherapeutic drugs, 
including taxol 37, colchicine 39 and actinomycin. Natural product 7 demonstrated 
modulation of MDR activity 20 to 100 times greater than verapamil 40 at non-cytotoxic doses 
(0.1 µM). Welwitindolinone C isothiocyanate 5 was shown to be less active than 7, whilst 
N-methylwelwitindolinone C isonitrile 6 was totally inactive towards the MCF-7/ADR cells. 
 
It is interesting to observe that the inactivity of N-methylwelwitindolinone C isonitrile 7 as a 
modulator suggests that the isothiocyanate functionality plays an important role in the binding 
with the P-gp. 
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A combination of low cytotoxicity and an excellent efficacy in chemosensitisation could 
promote N-methylwelwitindolinone C isothiocyanate 7 as a promising candidate for medical 
testing as a MDR reversing agent. 
 
1.3.3 Microtubule definition 
Tubulin molecules present in the cytoplasm are known as microtubules.
10
 These long hollow 
cylindrical structures are found in almost all eukaryotic cells and play a critical role in the 
cytoplasmic skeleton, the formation of the mitotic spindle and the transport of organelles such 
as mitochondria or chromosomes. The assembly and disassembly of tubulins is crucial to 
promoting the development and dynamic equilibrium of cells. Alteration of microtubules 
could disturb the cell cycle in the mitotic phase. This principle has been envisaged in the 
treatment of cancer to perturb the multiplication of infected cells. Drugs able to damage the 
microtubule process are known as anti-microtubules. Taxol 37, vinblastine 38 and 
colchicine 39 are the most common anti-microtubule agents (see: Figure 1.3). They are often 
used as anticancer drugs due to their ability to block cell growth by interference with 
microtubules.  
 
1.3.4 Welwitindolinones as anti-microtubule agents 
In 1995, Smith and co-workers reported the screening of the welwitindolinones as 
anti-microtubule agents. Incubations of the mutant cells were carried out with three members 
of the family, welwitindolinone C isothiocyanate 5, N-methylwelwitindolinone C 
isothiocyanate 7 and its isonitrile analogue 6.
11
 A dose-dependent disruption of the 
microtubule activity was observed when the mutant cells were incubated with 
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welwitindolinone C isothiocyanate 5. Welwitindolinone 5 could considerably reduce the 
polymerisation of microtubules without suffering from the P-gp pump effect. 
 N-Methylwelwitindolinone C isothiocyanate 7 was shown to be a less potent 
anti-microtubule agent than 5. Finally, despite a limited amount of its isonitrile analogue 6 
tested, the latter appeared to display similar activity to 5. 
 
 
1.4 WELWITINDOLINONE, SYNTHETIC INTEREST FROM 1994 TO 2010 
Since their isolation in 1994, the members of the welwitindolinone family have represented 
fascinating synthetic targets due to both their unique architecture and their impressive 
biological activities.
1
 Two welwitindolinones have been particularly targeted by the synthetic 
community: welwitindolinone A isonitrile 1, due to its unusual tetracyclic structure which 
links an oxindole to a cyclohexene via a spirocyclic, four-membered ring system, and 
welwitindolinone C isothiocyanate 7 (Figure 1.6).  
 
Figure 1.6 
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1.4.1 Syntheses of welwitindolinone A isonitrile 1 
Despite its challenging structure, welwitindolinone A isonitrile 1 was the first 
welwitindolinone to be synthesised. In 2005, the first total synthesis of enantiomerically pure 
(+)-welwitindolinone A isonitrile 1 was published by the research group of Baran.
5
 A few 
months later, Wood and co-workers reported an alternative approach to the spiro-oxindole.
12
 
 
In 2004, Baran and Richter developed a direct coupling of indoles with carbonyl compounds, 
allowing access to the hapalindole and fischerindole alkaloid families.
13
 A year later, the same 
authors reported the first enantioselective syntheses of three natural products isolated from the 
blue-green algae, welwitindolinone 1, fischerindole I isonitrile 11 and fischerindole G 
isonitrile 8.
5
  
Their approach consists of a very efficient protecting-group-free sequence, based on their 
proposed biogenesis of the alkaloids of the cyanobacteria (see: Scheme 1.6).
5
 A novel 
sequence of enolisation of (S)-carvone oxide 41 followed by regioselective Grignard opening 
of the epoxide afforded alcohol 42. At this stage, chlorination using N-chlorosuccinimide 
(NCS) in the presence of PPh3 was performed to introduce the required chlorine atom at 
position C13 with the required relative stereochemistry. Direct coupling of chloroketone 43 
with indole was completed using the conditions developed in 2004. Montmorillonite K-10 
was used as the acid catalyst for the intramolecular Friedel-Crafts cyclisation that generated 
tetracyclic 45 as a single diastereoisomer. Transformation of the ketone to the vinyl isonitrile 
afforded the key intermediate 11 in six steps. After chlorination at low temperature, 46 was 
subjected to acidic conditions at higher temperatures to provide welwitindolinone A isonitrile 
1 in 28% yield (Scheme 1.8).  
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Scheme 1.8 
 
In 2006, Wood and colleagues reported an alternative total synthesis of (±)-welwitindolinone 
A isonitrile 1 with an overall yield of 2.5%.
12,14
 Wood based his strategy on previous work 
regarding the formation of a spiro-oxindole via a mild SmI2-mediated approach and an 
unusual synthesis of an -chloro-quaternary centre.15  
A regio- and stereoselective [2+2] cycloaddition using isobutyryl chloride was performed on 
acetal 47 to afford tricyclic ketone 48 in 85% yield. Addition of the unusual triazene Grignard 
reagent 49 gave access to the required alcohol 50 in high yield. A four-step sequence 
involving chemoselective reduction of the triazene motif, protection of the resultant amino 
alcohol, acetonide removal and selective oxidation of the allylic alcohol was carried out on 50 
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to give tetracycle 51. Tertiary allylic alcohol 52 was prepared from keto-alcohol 51 in four 
steps (Scheme 1.9). 
 
Scheme 1.9 
 
At this stage, the unusual chloronium-ion mediated semi-pinacol rearrangement successfully 
generated intermediate 53 with a chlorine atom next to the quaternary centre. Rearrangement 
proceeded smoothly and chloroketone 53 was obtained with an excellent control of the 
relative stereochemistry as a single diastereoisomer in 78% yield. After desilylation and 
stereoselective reduction of the ketone, the diol was subjected to a highly regioselective 
dehydration process before oxidation of the remaining alcohol, urethane 54 was obtained in 
61% yield over four steps (Scheme 1.10). Urethane 54 was then converted into the 
corresponding N-formamide 55 in 40% overall yield following six further steps. 
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Scheme 1.10 
 
Exposure of deprotected amine 55 to phosgene in the presence of Et3N furnished the required 
isocyanate 56 which, after deprotonation using LHMDS at low temperature, provided the 
desired welwitindolinone A isonitrile 1 as a single diastereoisomer (Scheme 1.11). 
 
Scheme 1.11 
 
Finally, a few years after reporting the first example of the direct formation of a 
spirocyclic-four-membered ring system from an annulated five-membered ring, Baran 
published a new sequence that involves both fischerindoles G 8 and I 11 as intermediates in 
the synthesis of spiro-oxindole 1, thus reinforcing his proposed biogenesis.
16
 Carried out on a 
gramme scale, the sequence starts by the preparation of ketone 44 from carvone oxide 41 as 
previously described.
5
 Fischerindole G isonitrile 8 was obtained in 95% yield upon 
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formylation and dehydration of single diastereoisomer 57. Oxidation of 8 by DDQ in presence 
of water afforded fischerindole I isonitrile 11 in excellent yield (Scheme 1.12). 
 
Scheme 1.12 
 
Motivated by the intention to improve their previous sequence, Baran and Richter developed 
an alternative route to synthesise welwitindolinone A 1 (Scheme 1.13). Xenon difluoride was 
added to fischerindole I isonitrile 11 in the presence of water to form intermediate 60, which, 
after expulsion of fluoride, was converted into welwitindolinone A isonitrile 1 via a [1,5] 
sigmatropic shift. 
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Scheme 1.13 
 
Despite its challenging and unique structure, welwitindolinone A isonitrile 1 was successfully 
synthesised by Baran and Wood. While Baran described a very rapid access to the 
enantiomerically pure (+)-welwitindolinone A isonitrile 1 based on the biogenesis,  Wood 
proposed an approach involving a samarium-mediated closure of the spiro-oxindole as well as 
an intriguing semi-pinacol rearrangement. 
 
1.4 .2 Syntheses towards N-methylwelwitindolinone C isothiocyanate 7 
Since its isolation in 1994, N-methylwelwitindolinone C isothiocyanate 7, commonly called 
welwistatin, has attracted the attention of many synthetic chemists. A combination of 
remarkable biological activities and a fascinating structure has made welwistatin 7 an 
intriguing target over the past two decades. As previously reported, its ability to reverse MDR 
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action and its low cytotoxicity make it potentially interesting in cancer therapies.
2
 This 
synthetically challenging natural product consists of a tetracyclic compact structure, which 
links an oxindole to a cyclohexenone via a seven-membered ring system. Moreover, 
welwistatin 7 displays a number of characteristic features on its highly functionalised core 
structure, including four stereogenic centres, three sp
3
 quaternary centres, a gem-dimethyl 
group, a vinyl chloride and an unusual isothiocyanate functionality in a bridgehead position 
(Figure 1.7).  
 
Figure 1.7 
 
Five years after its isolation, Wood and co-workers presented the first work towards the 
synthesis of a member of the welwitindolinone family.
17
 They reported a fifteen-step 
stereoselective synthesis based on two key features: a catalytic C-H insertion and a 
ring-closing metathesis. Reaction of commercially available isatin 62 with two phosphorus 
ylides  was followed by exposure to iodomethane to furnish ester 63. After saponification of 
ester 63, the carboxylic acid was converted into its corresponding acid chloride. Treatment 
with diazomethane gave the required -diazoketone 64 that participated in a 
rhodium-catalysed aryl C-H insertion reaction performed in the presence of montmorillonite 
K-10. At this stage, ketone 65 was oxidised to the corresponding diketone using PCC. 
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Regioselective diazotisation of this diketone using hydrazine 66 followed by treatment with 
basic alumina provided -diazoketone 67. Interestingly, coupling of diazo 67 with an allylic 
alcohol framework under rhodium catalysis was accompanied by the opening of the 
cyclopropane motif and generation of the desired seven-membered ring system to give 68. 
Grignard addition to ketone 68 followed by a [3,3] sigmatropic rearrangement led to tertiary 
alcohol 69. Treatment of terminal alkyne 69 with H2 and Lindlar catalyst, followed by 
ring-closing metathesis in the presence of Grubbs’ first-generation catalyst, yielded tetracyclic 
compound 70, possessing the core structure of the welwitindolinone family (Scheme 1.14) 
 
Scheme 1.14 
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In 2001, Konopelski and Deng envisaged a coupling between an organolead indole and a 
suitably functionalised cyclohexanone and an aldol-type condensation as the key features of 
their approach to the core structure of the welwitindolinones.
18
 Unable to perform a direct 
plumbation, lead(IV) 4-indolyl triacetate 73 was built from commercially available 
4-bromoindole 71 via a stannane-indole intermediate 72. Treatment with KH to deprotonate 
the nitrogen of the indole was necessary to avoid side reactions on position C2 or C3 during 
the halogen-lithium exchange. Tri-n-butyltin chloride was chosen for the quench of the 
dianion. After protection of the indole nitrogen, organolead 73 was easily prepared by metal 
exchange in the presence of a mercury(II) catalyst (Scheme 1.15). 
 
Scheme 1.15 
 
With lead(IV) 4-indolyl triacetate 73 in hand, the coupling with two different -ketoesters 
was investigated. Although coupling with cyclohexanone 74 in the presence of pyridine gave 
the desired adduct 75 in excellent yield, coupling with cyclohexanone 76 did not occur. 
Substitution of the position C12 of the cyclohexanone partner seemed to have a dramatic effect 
on the formation of the C4-C11 bond (Scheme 1.16). 
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Scheme 1.16 
 
Moreover, attempts to cyclise intermediate 79 (and its unprotected analogue) via an aldol-type 
reaction remained unsuccessful (Scheme 1.17). 
 
Scheme 1.17 
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In 2005, Rawal and co-workers reported a ten-step sequence to the skeleton of the 
welwitindolinone alkaloids based on the late-stage construction of the seven-membered ring 
by formation of the C4-C11 bond.
19
 Their strategy involves an intramolecular Pd-catalysed 
enolate arylation to build the bicyclo[4.3.1]decane core of the molecule, followed by a Curtius 
rearrangement to functionalise the bridgehead position. 
Seven steps were required to prepare advanced intermediate 81 from 4-bromoindole 71 in 
56% yield. A vast range of experimental conditions, such as the source of palladium and the 
influence of the ligands, base and solvent, were tested to define the optimum conditions of the 
formation of the C4-C11 bond. -Ketoester 81 was treated accordingly using palladium(II) 
acetate, tri-tert-butylphosphine and potassium tert-butoxide in toluene at 70 °C to afford 
desired skeleton 82 in good yield. 
Although the ester motif favoured the arylation, its main purpose was to introduce the 
isothiocyanate bridgehead functionality. Surprisingly, Rawal’s group reported their incapacity 
to perform a basic hydrolysis (60 eq. of LiOH in a mixture H2O/MeOH at reflux) on ester 82, 
reinforcing the hypothesis of a highly encumbered stereocentre in the position C11. 
Nonetheless, ester cleavage of 82 was achieved using excess lithium iodide in refluxing 
pyridine to afford carboxylic acid 83 in excellent yield. The required nitrogen at the 
bridgehead position was introduced by a Curtius rearrangement. Thus, treatment of acid 83 
with diphenylphosphoryl azide in the presence of triethylamine furnished isocyanate 84. 
Further manipulations towards the isothiocyanate analogue were unsuccessful (Scheme 1.18). 
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Scheme 1.18 
 
In the same year, our group established a concise access to the tetracyclic skeleton via an 
acid-mediated ring closure of a suitable indole fragment.
20
 This expedient three-step synthesis 
of the bridged structure consists of a Buchwald-type coupling on position C4 of N-methylated 
indole 85 followed by formylation of position C3 via a Vilsmeier-Haack reaction. Exposure of 
aldehyde 87 to p-toluenesulfonic acid in THF at 50 °C led to a 1:1 mixture of two bridged 
ketones 88 and 89 (Scheme 1.19). 
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Scheme 1.19 
 
The mixture of ketones 88 and 89 was rationalised with a two-step sequence involving an 
initial aldol condensation to afford secondary alcohol 90 which could then form iminium 91 
by dehydration. An intermolecular hydride transfer could then occur from alcohol 90 to 
iminium 91 to generate the two ketones 88 and 89 (Scheme 1.20). 
 
Scheme 1.20 
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Although it was possible to separate ketones 88 and 89 via column chromatography, diverse 
experimental conditions were screened to access each product separately. Using Et3SiH a 
source of hydride in the presence of 87, it was possible to obtain ketone 88. Treatment of 
aldehyde 87 with pTSA in the presence of triethylsilane exclusively resulted in ketone 88 in 
excellent yield. On the other hand, utilisation of a hydride acceptor such as 
2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) allowed the formation of only ketone 89 
(Scheme 1.21).  
 
Scheme 1.21 
 
Further manipulations showed that it was possible to convert indole 88 to oxindole 92 using 
N-bromosuccinimide (NBS) in tert-butanol. Unfortunately, NMR spectroscopic studies and 
X-ray analysis confirmed that the stereochemistry of the new stereogenic centre formed in 
position C3 corresponds to that of epi-welwistatin (Scheme 1.22). 
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Scheme 1.22 
 
One year later, in 2006, two groups published advanced syntheses of welwitindolinone 7.  
Based on a conceptually different strategy, Funk and Greshock reported the preparation of an 
advanced intermediate 103 based on the elaboration of a bicyclo[4.3.1]decanone followed by 
the annulation of the indole/oxindole around the seven-membered ring system.
21
 Starting 
ketone 93 was easily prepared from commercially available 3-methyl-3-cyclohexenone. After 
alkylation and cyanation using enolate chemistry on ketone 93, a retrocycloaddition 
performed under high temperatures gave enone 95. A key 7-endo intramolecular conjugate 
addition was realised in the presence of triethylamine to give bicyclo[4.3.1]decanone 96. 
Further manipulations were carried out on bicyclic compound 96 to obtain -bromoenone 97 
in five steps and 39% yield (Scheme 1.23). 
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Scheme 1.23 
 
After two successive enolate methylations to generate the gem-dimethyl at position C16, a 
Stille coupling with stannane 99 provided amidotriene 100 in 75% yield. After the 6 
electrocyclisation on amidotriene 100, tetracyclic 102 was formed by closure of the indole. 
Finally, Funk described the possibility of introducing an isocyanate functionality at the 
bridgehead position via a Hofmann rearrangement (Scheme 1.24). 
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Scheme 1.24 
 
Shortly afterwards, Shea and Lauchli published a synthesis of the core structure of the 
welwitindolinone alkaloids.
22
 Their approach consists of the annulation of 
bicyclo[4.3.1]decane using a type 2 intramolecular Diels-Alder reaction, where the diene and 
dienophile are linked by an indole tether. After formylation of 4-bromoindole 71, a Suzuki 
coupling was performed in position C4 of aldehyde 104 using 3-furan boronic acid 106 in the 
presence of tetrakis(triphenylphosphine)palladium. After N-tosylation of the indole, addition 
of vinyl Grignard converted aldehyde 106 into allylic alcohol 107. Oxidation of alcohol 107 
using manganese dioxide led to the cyclisation precursor 108, which, upon heating, yielded 
cycloadduct 109 (Scheme 1.25). 
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Scheme 1.25 
 
In 2007, Menéndez reviewed the different approaches to the tetracyclic core structure of 
welwistatin 7.
23
 After methodically organising his report between the failed attempts to the 
tetracyclic framework and the more successful strategies, Menéndez reported some previously 
unpublished work from his own group. He presented a four-step sequence starting with the 
ring expansion of ketone 110 (known as Kornfeld’s ketone).24 The key step consists of a 
high-yielding anionic domino process, involving a Michael addition followed by an 
intramolecular aldol reaction, which was accompanied by the hydrolysis of the pivaloyl 
protection by the use of DBU. A simple methylation of the nitrogen and oxidation of the 
alcohol gave compact tetracyclic structure 113 (Scheme 1.26). 
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Scheme 1.26 
 
In early 2009, our group published their second paper towards this challenging molecule 
based on the functionalisation of the bridgehead positions.
25
 Simpkins reported the first 
synthesis towards welwistatin 7 that exhibits the unusual isothiocyanate functionality at the 
bridgehead position. Starting from tetracyclic ketone 88, two successive regiocontrolled 
bridgehead substitutions were carried out in the presence of LTMP to afford ketoester 115. 
Removal of the blocking silyl group was achieved by addition of TBAF before hydrolysis of 
the ester. Surprisingly, treating carboxylic acid 116 with DPPA did not produce the expected 
isocyanate analogue but the azido oxazolidinone 117 (as determined by X-ray crystallography 
and NMR spectroscopy studies). Exposure of this oxazolidinone 117 to sodium methoxide led 
to the corresponding carbamate which was smoothly removed using iodotrimethylsilane under 
basic conditions. Bridgehead amine 118 was efficiently converted to isothiocyanate analogue 
120 using thiocarbonyl reagent 119 (Scheme 1.27). 
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Scheme 1.27 
 
Simpkins also established a strategy to access noteworthy bridgehead alkenes. Selenides 121, 
124 and 125, obtained using the bridgehead enolate chemistry previously described, were 
treated with oxidising agent mCPBA to give bridgehead enones 122, 126 and 127.
19
 Further 
manipulations on alkene 122 showed the feasibility of an isomerisation of the double bond 
using rhodium(III) chloride in refluxing ethanol. Ketone 123 was presented as a potential 
precursor for the installation of the vinyl chloride functionality in position C13 (Scheme 1.28). 
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Scheme 1.28 
 
In a separate communication, Simpkins also reported the formation of ,-unsaturated 
oxindoles from the corresponding indoles via a singlet oxygen transfer.
6
 Delighted by the 
obtention of oxindole 129 via an autoxidation process under air conditions, our group decided 
to investigate the feasibility of the reaction with a large range of bridgehead substituted core 
structures. However, bridgehead substituents seem to have a dramatic effect on the oxidation 
process (such as a methyl group in the oxidation of 128), reducing the yield considerably 
(Scheme 1.29). 
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Scheme 1.29 
 
Further investigations led our group to study photo-oxygenation conditions. 
Tetraphenylporphyrin was used as a sensitiser and the transformation of methylated ketone 
128 proceeded smoothly to give oxindole 130 in 83% yield. A high-yielding conversion was 
observed for the majority of substrates; however the presence of other oxidisable sites on the 
starting indole compromised the formation of the-unsaturated oxindoles. Finally, 
hydrogenation of oxindole 129 gave a mixture of oxindoles 131 and 132 (ratios between 1:1 
and 1:2) (Scheme 1.30). 
 
Scheme 1.30 
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In 2009, Garg and colleagues published a four-step sequence of the welwitindolinone 
skeleton, involving an indolyne cyclisation.
26
 Coupling of commercially available 
5-bromoindole 133 with enone 134 occurred in high yield in the presence of a catalytic 
amount of iodine.
27
 Treatment of 135 with NaNH2/tBuOH formed the corresponding aryne 
136, which, upon reaction with the enolate, afforded bicyclo[4.3.1]decane 137. Interestingly, 
Garg reported tetracycle 137 as being the first molecule obtained by formation of the C4-C11 
bond adjacent to a quaternary centre at the C12 position. Finally, bromination of the C2 
position of indole 137 followed by HCl hydrolysis gave the desired oxindole 138 as a single 
diastereoisomer in good yield (Scheme 1.31). 
 
Scheme 1.31 
 
Also in 2009, Trost and McDougall disclosed the synthesis of -unsaturated oxindole 145 
in ten steps from commercially available anisole.
28
 Their strategy to build the tetracyclic core 
is based on sequential cycloadditions. Enantioselective formation of bicyclo[4.3.1]decadiene 
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142 was achieved by a powerful Pd-catalysed [6+3] cycloaddition of 
cyano-trimethylenemethane 140 onto tropone 139. Obtained as a single regio- and 
diastereoisomer, 142 was transformed into imidofuran 143 in 63% yield over three steps. An 
intramolecular Diels-Alder reaction was performed in refluxing toluene to afford oxabicycle 
144 as a single diastereoisomer. Due to the electron-withdrawing effect of the Boc protecting 
group, ring-opening of oxabicycle 144 followed by dehydration did not occur. However, 
exposure of 144 to a catalytic amount of ytterbium(III) triflate gave unprotected oxindole 145 
in 50% yield (Scheme 1.32). 
 
Scheme 1.32 
 
Three years after the preparation of the tetracyclic structure via an intramolecular Diels-Alder 
process, Shea and colleagues revealed their strategy towards advanced intermediate 151.
29
 
Prepared from 4-bromoindole 71, oxindole 146 was coupled with diethyl fumarate via a Heck 
reaction. The resulting mixture of isomers was treated with TBSOTf and silylketene aminal 
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147 was obtained. An alkylation of aminal 147 was carried out with furan 148 in the presence 
of Lewis acid (ZnI2) to afford the required Diels-Alder precursor 149. Spontaneous 
cyclisation of 149 resulted in pentacyclic 150, which, upon desilylation, yielded advanced 
oxindole 151 (Scheme 1.33). 
 
Scheme 1.33 
 
In 2010, Wood and co-workers described their investigations towards this challenging 
target.
30
 Their synthesis features the insertion of an allylic alcohol fragment into an 
-diazoketone in the presence of a rhodium catalyst, followed by a Claisen rearrangement and 
a transannular nitrone cycloaddition. Cyclopropane 67, synthesised from isatin as reported in 
1999, was coupled to allylic alcohol 152 with opening of the cyclopropane moiety in the 
presence of the rhodium catalyst. Claisen rearrangement and Pd-catalysed allylic migration 
were required to convert enol ether 153 into diketone 154. The last ring of the 
welwitindolinone core was obtained by treatment of terminal alkene 154 with 
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N-methylhydroxylamine in refluxing ethanol. Further manipulations were carried out on 
intermediate 155 before the chloronium ion-induced semi-pinacol rearrangement afforded 
over-chlorinated tetracycle 157 (Scheme 1.34). 
 
Scheme 1.34 
 
Also in 2010, Martin and colleagues reported a synthesis of the scaffold of the 
welwitindolinone family.
31
 Their strategy focused on three key steps, involving (i) the 
coupling of a substituted indole, (ii) a silyl ketene acetal, a palladium-catalysed enolate 
arylation and (iii) an allylic arylation to generate the tetracyclic structure. Vinylogous silyl 
enol ether 159 was coupled to tertiary alcohol 158, obtained in three steps from 
4-bromoindole 71. Acetal removal occurred at high temperature in the presence of methanol 
to afford the corresponding masked ketoester. The synthesis of tricyclic 161 was achieved by 
palladium-catalysed intramolecular cyclisation of ketoester in the presence of sodium 
tert-butoxide. Allylic alcohol 162, accessed via a deprotection-protection sequence from 161, 
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underwent a second Pd-catalysed cyclisation to form the core structure of welwistatin 7. An 
oxidative cleavage performed in the presence of osmium tetroxide and sodium periodate 
converted the terminal alkene 163 into diketone 164 (Scheme 1.35).
 
 
Scheme 1.35 
 
The structural complexity of the welwitindolinone family has made their synthesis exciting as 
well as ambitious. Up to 2010, sixteen years after their isolation, welwitindolinone A 
isonitrile 1 was the only welwitindolinone that had been synthesised. Despite an increasing 
interest and a strong contribution from the synthetic community, by 2010, welwistatin 7 had 
not been successfully prepared. 
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1.5 AIMS AND OBJECTIVES 
At the start of this project, we speculated that highly functionalised intermediate 165 could be 
a key target in the synthesis of N-methylwelwitindolinone C isothiocyanate 7 (Figure 1.8).  
 
Figure 1.8 
 
We believed that (i) the vinyl chloride moiety could arise from modification of the ketone 
adjacent to quaternary centre C12, (ii) amine derivative 165 would be converted into the 
desired isothiocyanate bridgehead using conditions previously described by our group on 
similar framework 166 (Scheme 1.36) and (iii) the oxindole would be obtained via an 
oxidation process on the corresponding indole motif following an established procedure from 
the Simpkins laboratory.
25, 26, 32,
  
 
Scheme 1.36 
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For the purpose of synthesising welwitindolinone 7, we turned our attention towards key 
intermediate 165. Advanced scaffold 165 presents many challenging features of welwistatin 
7; along with this tetracyclic compact structure it also possesses the required gem-dimethyl in 
position C16, a nitrogen group in the bridgehead position C11 and the desired stereochemistry 
for the quaternary centre C12 (see Figure 1.8).  
Our aim was to develop some synthetic strategies to functionalise the cyclohexanone motif of 
the tetracyclic core structure. A few years earlier, the Simpkins group had synthesised 
compact tetracycle 88 in four steps from commercially available materials. After extensive 
studies, our group developed an interesting strategy to functionalise the C11 position of 
tetracycle 88. Successive metallations and substitutions were involved to block the most 
reactive bridgehead position C15 using a trimethylsilyl group (Scheme 1.37). 
 
Scheme 1.37 
 
A large range of electrophiles were successfully substituted at the C11 position (Scheme 1.37). 
An appropriate choice of electrophiles gave access to the synthesis of the first isothiocyanate 
bridgehead analogue 120 as well as a fascinating bridgehead alkene 126 (Figure 1.9). 
48 
 
 
Figure 1.9 
 
Inspired by this concise and efficient synthetic route, we decided to undertake the synthesis of 
alkene 126 via tetracycle 88. Alkene 126 was considered as a key intermediate for accessing 
advanced intermediate 168 (Scheme 1.38). 
 
Scheme 1.38 
 
While we were studying the access to more complex tetracyclic structures such as 165, 
preliminary studies were carried out within our group on tetracycle 170 possessing the 
required gem-dimethyl in position C16.
33
 Facing some difficulties to introduce the 
gem-dimethyl motif on tetracycle 88, our group decided to include this functionality in the 
early stage of the synthesis. After deciding to adopt Rawal’s strategy to synthesise 
intermediate 169, the seven-membered ring system was built via a palladium-catalysed 
arylation.
33
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Direct functionalisation of the C11 bridgehead position was achieved on tetracycle 170 with 
the gem-dimethyl and corresponding alkene 171 was successfully synthesised using the 
oxidative method previously developed. Successive oxidations were performed on alkene 171 
to afford diketone 172. Preliminary studies involving regioselective enolisation of diketone 
172 were investigated to build the desired motif on carbon C12 (Scheme 1.39).
33
 
 
Scheme 1.39 
 
The difficulties introducing the gem-dimethyl portion, combined with the necessity of a 
blocking group at the C15 position for the functionalisation of the C11 position, led us to turn 
our attention to pursue the synthesis on advanced tetracycle 170. We decided to synthesise 
tetracycle 170 to develop the route towards welwistatin 7. After carefully investigating the 
route to diketone 172 to ensure its reproducibility, we will study the functionalisation of 
carbon C12 (Scheme 1.39).  
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CHAPTER TWO 
FUNCTIONALISATION OF THE TETRACYCLIC INDOLE 
MODEL SYSTEM USING BRIDGEHEAD ENOLATE 
CHEMISTRY 
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2.1 AIMS AND OBJECTIVES  
In their isolation paper, Moore and co-workers described the isothiocyanate functionality 
present in welwistatin 7 as being responsible for the multiple-drug resistance-reversing 
activity.
1,2
 Our group decided to explore how this unusual feature at the C11 position 
influences the biological properties of the molecule. As part of this study, our group 
synthesised the first isothiocyanate analogues of welwistatin 120 and 174, built on previous 
work related to the expedient access to the welwitindolinone scaffold 88 (Figure 2.1).
3,4
 
 
Figure 2.1 
 
Targeting the total synthesis of welwistatin 7, we judged that it was important to investigate 
the other functionalities present on its scaffold. The characteristic architecture still remained 
challenging, particularly due to the presence of a vinyl chloride functionality as well as the 
two quaternary centres (gem-dimethyl at the C16 position and the highly substituted C12, 
adjacent to the vinyl chloride). As a result, we decided to undertake the established route to 
the bicyclo[4.3.1]decane 88 in order to investigate the functionalisation of the cyclohexanone 
framework of this model system. Further chemistry would therefore entail reactions being 
carried out at the bridgehead positions of tetracycle 88 and these are the subject of discussion 
in this chapter. 
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2.2 BRIDGEHEAD ALKENES, BRIDGEHEAD ENOLATES, AN ATTRACTIVE 
METHOD TO FUNCTIONALISE THE WELWISTATIN SCAFFOLD 
2.2.1 Bridgehead enolates and bridgehead alkenes, two unusual strained motifs 
In 1924, despite a number of attempts to form bicyclic bridgehead alkene 176, including 
elimination of HBr from 175 or dehydration of the corresponding diacid 177, Bredt reported 
difficulties in generating such strained structures (Scheme 2.1).
5
 Bredt postulated that the 
existence of bridgehead alkenes is unlikely, particularly due to the orthogonal orientation of 
the distorted p orbitals creating an inefficient overlap for the formation of a -bond. This 
postulate is nowadays known as Bredt’s rule. 
 
Scheme 2.1 
 
However, a number of chemists have tried to investigate the possibility of generating 
bridgehead alkenes. In 1949, Prelog provided evidence for the limits of Bredt’s rule.6 The 
preparation of a large range of bridged enones such as 179 achieved by Robinson annulations 
of the corresponding -ketoesters 178 under acidic conditions was described (Scheme 2.2). 
The size of the combined rings was considered to be an important factor as bridgehead 
enolates were more stable in a larger ring system. 
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Scheme 2.2 
 
In 1950, Fawcett developed the concept of anti-Bredt alkenes and reviewed a large number of 
these bridgehead entities possessing a double bond at the bridgehead position.
7
 Fawcett 
introduced the sum (S) of the atoms on a bicyclic motif. He connected the postulate of Bredt 
to this number (S), demonstrating that bicyclic systems that possess (S) > 8 could display a 
double bond at the bridgehead position. So for the above example (Scheme 2.2), the sum was 
(S) = 5 + 3 + 1 = 9. 
In the same fashion, bridgehead metallation of small carbonyl systems (fewer than eight 
atoms) was expected to be very difficult as it would require an enolate intermediate that 
would violate Bredt’s rule. 
Interestingly, deprotonation of bridgehead ketones can successfully afford the corresponding 
-keto carbanions. However, their high reactivity compromises their use for reactions with 
external trapping reagents and aldol dimers are mainly obtained as illustrated in Scheme 2.3.
8 
 
Scheme 2.3 
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Alternative methods have been developed to circumvent the formation of aldol dimers. In 
1984, Corey reported a new strategy, known as in situ quenching (ISQ), which enabled the 
isolation of silylated bridgehead structures.
9
 An excess of the silyl trapping agent, present in 
the reaction mixture prior to the deprotonation, was able to intercept the bridgehead enolate 
before dimerisation could occur. Two techniques commonly used are: (i) a solution of 
substrate and TMSCl is added to the solution of base pre-cooled to -78 °C or (ii) a solution of 
substrate is added dropwise to a mixture of the base and TMSCl at -78 °C. 
 
2.2.2 Previous work on bridgehead enolates in our group 
While their high reactivity represents a great challenge for accessing bridgehead-substituted 
compounds, our group developed unprecedented strategies using chiral lithium amide bases. 
Silylation of bicycle 183 was achieved in 76% yield at low temperature in the presence of 
chiral base 184 (Scheme 2.4).
10
 A wide range of bridgehead substitutions were successfully 
undertaken and this methodology was applied in total syntheses.
10
 
 
Scheme 2.4 
 
More recently, the Simpkins group reported the synthesis of clusianone 188, another complex 
bridged bicyclic natural product.
11
 Clusianone 188 was successfully synthesised using a 
bridgehead substitution. Deprotonation of the C5 position of bicyclic compound 186 was 
58 
 
achieved using an excess of LDA at low temperature. Subsequent alkylation using prenyl 
bromide afforded ketone 187 in 91% yield (Scheme 2.5).
11 
 
Scheme 2.5 
 
Drawing inspiration from these results, our group decided to apply this strategy to the 
synthesis of welwistatin 7. Preliminary computational studies (in collaboration with 
Prof. Chris Hayes at the University of Nottingham) on the tetracyclic core structure 88 were 
carried out to determine the required energy of deprotonation of each bridged position.
12
 
Metallation of bridged positions appeared to be an exothermic process with a slight tendency 
to occur preferentially in the desired C11 position (Figure 2.2). 
 
Figure 2.2 
Functionalisations at the bridgehead positions of the tetracyclic structure 88 have been 
extensively investigated in our group and these will be the focus after preparation of the 
required scaffold 88. 
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2.3 PREPARATION OF THE WELWISTATIN SCAFFOLD WITHOUT 
GEM-DIMETHYL VIA AN EXPEDIENT FOUR-STEP SYNTHESIS 
A reproducible four-step sequence to the tetracyclic skeleton 88 had been investigated by 
previous members of the Simpkins group.
12,3
 The high efficiency of this strategy led us to 
undertake the proposed route to the core structure of welwistatin 88.
3
 
After N-methylation of commercially available 4-bromoindole (71), keto-indole 86 was 
isolated in reasonable yield via a Buchwald-type reaction using cyclohexanone as a coupling 
partner (Scheme 2.6). Optimisation of the coupling showed that using a chiral ligand such as 
(S)-Tol-BINAP (189) rather than the corresponding racemic ligand dramatically increased the 
yield of the reaction (from an average of 60% to a reproducible 78% yield). This result was in 
agreement with previous observations from Buchwald; the higher solubility of 
(S)-Tol-BINAP (189) compared to its corresponding racemic analogue seems to be 
responsible for this increased yield.
3,13
  
 
Scheme 2.6 
 
The following steps consist of formylation of the C3 position of indole 86 under standard 
Vilsmeier-Haack conditions to afford aldehyde 87 in 75% yield. Cyclisation of aldehyde 87 
followed by dehydration resulted in tetracycle 88 (Scheme 2.7).
3
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Scheme 2.7 
 
In our hands, gramme quantities of tetracycle 88 were obtained following this robust and 
scalable sequence. It was observed that performing the Buchwald-type coupling on larger 
scale (5 mmol) considerably increased the yield of the reaction from 78% to a reproducible 
90% yield (Scheme 2.8).  
 
Scheme 2.8 
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2.4 BRIDGEHEAD ENOLATE CHEMISTRY ON THE MODEL SYSTEM: 
PREVIOUS WORK IN OUR GROUP 
2.4.1 Choice of the base 
In preliminary studies, the importance of the base had been a key factor. It was demonstrated 
that treatment of bridged ketone 88 with a solution of lithium diisopropylamide (LDA) and 
TMSCl at low temperature afforded exclusively silyl ether 190 in 64% yield (Scheme 2.9).
12
 
 
Scheme 2.9 
 
However, metallation of the bridgehead positions was successfully achieved by addition of a 
solution of lithium 2,2,6,6-tetramethylpiperidide (LTMP) to a solution of substrate 88 with an 
excess of TMSCl at low temperature (Scheme 2.10). Despite our promising computational 
calculations, the addition did not occur at the desired position, C11, and silyl ketone 114 was 
formed as a single regioisomer in 54% yield.
4
 
 
Scheme 2.10 
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Even though the regioselectivity of the addition did not match our expectations, we were 
pleased to be able to metallate and substitute the bridgehead C15 position using LTMP as the 
base. Our group decided to examine the addition of a large range of electrophiles (including 
alkyl, acyl and selenyl groups) to define the scope of this reaction (Scheme 2.11).
4
 Many 
electrophiles were successfully added at the bridgehead position in good to excellent yields. 
 
Scheme 2.11 
 
To our delight, our group noticed that the stoichiometry of base used was playing an 
important role in the reaction. Increasing the number of equivalents of LTMP from one to 
three would lead solely to the bis-silylated adduct 196 in 68% yield (Scheme 2.12).
4
  
 
Scheme 2.12 
Obtaining this bis-silylated product 196 via a bridgehead strategy showed that it was possible 
to substitute at the C11 position. 
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2.4.2 Synthesis of isothiocyanate analogue and other advanced structures 
Even though a direct substitution of the C11 position was not possible, the bridgehead 
metallation was still considered as a powerful technique to functionalise the welwitindolinone 
skeleton.  
An alternative method involving successive substitutions was envisaged. A first substitution 
was performed on the C15 position of tetracycle 88. Slow addition of a solution of bridged 
ketone 88 and TMSCl to a solution of lithium tetramethylpiperidide (LTMP) pre-cooled to 
-78 °C afforded mono-silylated product 114 (see: Scheme 2.10). The TMS group acted as a 
temporary blocking agent to allow further substitution to occur in position C11.
4
 
 
With the kinetic position blocked with a temporary silyl group, a second metallation of the 
bridgehead was used to functionalise the C11 position.  
 
Scheme 2.13 
 
Treatment of mono-silylated bridged ketone 114 with one equivalent of LTMP at low 
temperature was followed by addition of an electrophile to give the corresponding bridged 
ketoester 115 or selenide 125 (Scheme 2.13).
4 
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Further manipulations were carried out on ketoester 115 in our group to introduce the 
isothiocyanate functionality. After desilylation, a Curtius rearrangement was performed to 
produce isothiocyanate analogue 120 (Scheme 2.14).
4
 
However, reaction of diphenylphosphoryl azide (DPPA) with carboxylic acid 116 afforded 
azido oxazolidinone 117 without any trace of the desired compound possessing the isocyanate 
functionality at the bridgehead position. Oxazolidinone ring opening was performed upon 
treatment with sodium methoxide in methanol. After removal of the carbamate protecting 
group, amine 118 was subjected to thiocarbonyldipyridinone (119) to give bridgehead 
isothiocyanate 120 in good yield (see Scheme 2.14).
4
 
 
Scheme 2.14 
 
Our group has also developed a strategy to access unusual bridgehead alkenes from the 
selenide compounds (Scheme 2.15).
4,12
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Scheme 2.15 
After desilylation of ketone 125, selenide 124 was converted into a remarkable bridgehead 
alkene 126 via an oxidation and syn elimination process (Scheme 2.15).
4,12
 
 
 
2.5 OUR PROGRESS TOWARDS THE FUNCTIONALISATION OF THE 
CYCLOHEXANONE MOTIF 
Inspired by the work developed within our group, we decided to undertake the same synthetic 
route to bridgehead alkene 126. Our objective was to further functionalise the cyclohexanone 
motif of the welwitindolinone scaffold towards the synthesis of advanced intermediate 168. 
 
Scheme 2.16 
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At this stage, tetracycle 88 was considered as a potential intermediate in the synthesis of 
framework 168 using strategies previously developed in our laboratory. Target 168 would 
arise from protected amine 197 after successive regioselective additions on carbon C12. A 
Michael-type addition on enone 198 would introduce the nitrogen at the bridgehead position 
C11. Diketone 198 could be introduced through successive oxidations on bridgehead alkene 
126, which in turn could be obtained by successive bridgehead substitution on tetracycle 88 
following the method developed by our group (Scheme 2.16).  
 
2.5.1 Bridgehead functionalisation  
With tetracycle 88 in hand, we confirmed the importance of the choice and preparation of the 
base for the bridgehead metallation. Utilisation of excess nBuLi on tetracycles 88 and 114 
resulted in the corresponding alcohols 199 and 200 (due to the presence of a large excess of 
nBu
-
) along with the desired adducts 114 and 125 (Scheme 2.17).  
 
Scheme 2.17 
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Functionalisation of both bridgehead positions was then achieved using the chemistry 
developed by our group. Insertion of the silyl temporary blocking agent in position C15 was 
completed in similar yield to the one previously described. However, using the optimum 
conditions reported by previous members of our group, we were only able to access desired 
selenide 125 in 25% yield.
12
 Facing some difficulties to repeat this reaction, we decided to 
increase the temperature of the reaction from -78 °C to -10 °C. Using these conditions, 
selenide 125 was obtained in an improved 41% yield (Scheme 2.18). 
 
Scheme 2.18 
 
The blocking group TMS was then removed using tetrabutylammonium 
triphenyldifluorosilicate (TBAT) in 74% yield (Scheme 2.19).  
 
Scheme 2.19 
 
Selenide 124 was oxidised with meta-chloroperbenzoic acid (mCPBA) to afford the 
corresponding bridged alkene 126 in 56% yield (Scheme 2.19). 
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2.5.2 Construction of diketone 198 
With bridgehead enone 126 in hand, we turned our preliminary studies towards an oxidative 
strategy in order to introduce the second ketone functionality. Alkene 126 was converted into 
allylic alcohol 201 using selenium dioxide as the oxidising agent. Treatment of allylic alcohol 
201 with Dess-Martin Periodinane (DMP) afforded the corresponding enone 198. 
Unfortunately, the scale of our experiments did not allow us to carry out full data analyses; 
however from the data collected there was enough evidence for the formation of these two 
intermediates to justify repeating these steps on the real system (Scheme 2.20). 
 
Scheme 2.20 
 
The
 1
H NMR spectrum of alcohol 201 showed the presence of a vinylic proton at 6.68 ppm 
(d, 1H, J 5.9, H12) as well as a characteristic resonance at 4.70 ppm (ddd, 1H, J 5.9, 4.5, 1.5, 
H13) (Figure 2.3).  
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Figure 2.3 
The mass spectrum showed a single peak at [M + Na]
+ 
= 276.0. Finally, the IR spectrum 
displayed a broad band at 3332 cm
-1
 associated with the alcohol, as well as the remaining 
strong carbonyl band at 1699 cm
-1
. The combination of these data led us to propose the 
following structure for intermediate 201 (Figure 2.4). 
 
Figure 2.4 
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In the same fashion, the 
1
H NMR spectrum of diketone 198 showed the presence of a vinylic 
proton at 6.40 ppm (s, 1H, H12) (Figure 2.5). The multiplicity of this signal supported the 
absence of a proton adjacent to H12. 
 
Figure 2.5 
Moreover, a combination of mass spectrometry (showing a single peak at [M + Na]
+
 = 274.1) 
and IR spectroscopy (displaying the presence of two carbonyl bands at 1702 and 1681 cm
-1
) 
confirmed the structure of enone 198 (Figure 2.6). Unfortunately, the amount of enone 198 
synthesised was not enough to obtain a decent 
13
C NMR spectrum. 
 
Figure 2.6 
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2.6 LIMITATIONS OF THIS MODEL SYSTEM 
At first, tetracyclic structure 88 was a particularly attractive target due to its extremely short 
synthesis which made it an easily accessible intermediate. However, this model system 
showed some limitations (issues to insert the gem-dimethyl) as well as difficulties (longer 
synthetic route, lower yields) that led us to consider working on the real system. 
 
2.6.1 Difficulties encountered introducing the gem-dimethyl at the C16 position 
Previous studies carried out by members of our group showed how difficult it was to install 
the gem-dimethyl on tetracyclic cores 88 or 89 (obtained by oxidative treatment of aldehyde 
87 in the presence of pTSA) (Scheme 2.21).
12,14
 
 
Scheme 2.21 
 
Chosen for its easy access, diketone 89 was then subjected to a range of nucleophiles aiming 
to react at the C16 position. However, due to the high reactivity of the bridged ketone at 
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position C10, an acetal protection using ethylene glycol was performed as the first step to 
allow further selective manipulations of the ketone at position C16. Unfortunately, treatment 
of 202 with a range of nucleophiles (such as MeLi, MeMgBr) did not proceed to the desired 
alcohol and the product of C2 addition 203 was obtained (Scheme 2.22). A combination of the 
hindrance of the carbonyl at the C16 position and higher reactivity in the position C2 of the 
indole prevented the formation of the gem-dimethyl.
12
 
 
Scheme 2.22 
The presence of a methyl group on the indole nitrogen was identified as an activating agent 
for the C2 addition. Previous work within the group had investigated the influence of the 
protecting group on the nitrogen for the preparation of the gem-dimethyl from carbonyl 204.
14
 
 
 Scheme 2.23 
Similar experiments as on the N-methyl series were carried out with the N-tosyl-substituted 
indole motif, however the same problem of regioselectivity and the difficulty obtaining the 
desired gem-dimethyl remained (scheme 2.23). 
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2.6.2 Rapid access to the desired regioselectivity at the bridgehead position C11 
Whilst we were working on this model system, the bridgehead chemistry on the scaffold 
possessing the gem-dimethyl in position C16 was also being studied within our group.
14
  
 
 Scheme 2.24 
After exposing skeleton 170 to the bridgehead reaction conditions, our group was pleased to 
discover that the presence of the gem-dimethyl in position C16 would generate a steric clash at 
the position C15 so favouring the regioselective addition in position C11 (Scheme 2.24).
14 
 
 
2.7 SUMMARY  
The bicyclo[4.3.1]decane 88 has been synthesised in four steps from commercially available 
4-bromoindole (71). Functionalisation of the bridged positions was successively achieved by 
metallations and substitutions using strategies developed by previous members of our group. 
After removal of the TMS blocking agent, selenide intermediate 124 was oxidised into the 
corresponding bridgehead alkene 126. Despite the low yields of this synthetic route, 
preliminary studies on this model system provided encouragement that it was conceivable to 
functionalise the cyclohexanone motif of the tetracycle towards welwistatin 7 (Scheme 2.25). 
74 
 
 
Scheme 2.25 
 
Despite the expedient synthesis of tetracycle 88, we started to encounter diverse issues that we 
linked to the absence of the gem-dimethyl on the tetracyclic scaffold. We realised that 
functionalisation of the bridgehead position C11 could be achieved without the introduction of 
a temporary blocking agent on position C15 when carried out on tetracycle 170, avoiding some 
unnecessary protection and deprotection steps (Figure 2.7). In addition, previous studies 
carried out in our group had highlighted the difficulties when trying to introduce the 
gem-dimethyl framework at a late stage of the synthesis. 
 
Figure 2.7 
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At this stage, we decided to turn our attention towards the synthesis of tetracyclic scaffold 170 
(Figure 2.7). We will develop the techniques and strategies that we learned on this model 
system as well as pursuing the synthesis towards the total synthesis of welwistatin 7. 
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CHAPTER THREE 
TOWARDS THE TOTAL SYNTHESIS OF  
N-METHYLWELWITINDOLINONE C ISOTHIOCYANATE 
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3.1 AIMS AND OBJECTIVES  
As discussed in the previous chapter, we carried out a number of experiments to functionalise 
our key intermediate 88 with the aim to complete the total synthesis of 
N--methylwelwitindolinone C isothiocyanate 7. However, converting the C16 ketone of 89 
into the required gem-dimethyl of 170, proved to be a substantial challenge (Figure 3.1). 
 
Figure 3.1 
 
With these difficulties in mind, our group decided to synthesise the core structure with the 
gem-dimethyl fragment already in place and, for this purpose, chose to adopt the early stages 
of Rawal’s synthesis to assemble key intermediate 169 (Figure 3.2).1  
 
Figure 3.2 
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This chapter focuses on the formation of the tetracyclic scaffold 170 including the closure of 
the seven-membered ring system and the functionalisation of the cyclohexanone motif, in the 
northern part of the molecule, using the bridgehead chemistry previously developed.  
 
Scheme 3.1 
 
Previous studies on skeleton 170 have been carried out in the Simpkins group.
2
  Our work 
will consist of improving the proposed sequence (optimisation of the yield of the reactions) as 
well as attempting to install the quaternary centre at the C12 position (Scheme 3.1).  
 
3.2 PREVIOUS WORK IN OUR GROUP 
3.2.1 Synthesis of enone 214 
1,2
 
In 2005, Rawal and co-workers reported an efficient and convergent sequence to the 
welwistatin scaffold based on an intramolecular Pd-catalysed arylation of ketoester 81, 
synthesised in seven steps from commercially available 4-bromoindole (71) (Scheme 3.2).
1
 
80 
 
 
Scheme 3.2 
Taking inspiration from Rawal’s work, our group decided to adopt their strategy to synthesise 
functionalised cyclohexanone 169, possessing the required gem-dimethyl moiety on the C16 
position (Scheme 3.2). 
 
With indole derivative 169 in hand, our group focused on an alternative route towards the 
desired seven-membered ring system. Attempts to form the C4-C11 bond using the direct 
standard enolate arylation conditions developed in our laboratory did not afford the desired 
tetracycle 170. This was also the case when precursor 169 was subjected to Rawal’s 
cyclisation conditions (Scheme 3.3).
2
 
 
81 
 
  
Scheme 3.3 
 
Drawing inspiration from Hartwig’s work on cross-coupling reactions, our group established 
a two-step sequence to construct tetracycle 170, containing the welwitindolinone skeleton, 
from the functionalised cyclohexanone 169.
3
 Exposure to KHMDS followed by addition of 
TMSCl under basic conditions gave enol silane 211. After optimisation, palladium-catalysed 
cyclisation of silyl enol ether 211 in the presence of cesium fluoride and tri-n-butyltin fluoride 
using tri-tert-butylphosphine as the ligand occurred in high yield, to provide tetracycle 170 
(Scheme 3.4).
2
 
 ` 
Scheme 3.4 
 
With tetracycle 170, possessing the gem-dimethyl in the desired C16 position, in hand, we 
turned our attention towards the other features present on welwistatin 7. We envisaged that 
welwistatin 7 could be obtained from key intermediate 212 via functional group 
interconversions (FGI) to install the oxindole, the bridgehead isothiocyanate at the C11 
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position and to convert the ketone at the C13 position into the vinyl chloride. Highly advanced 
intermediate 212 might be accessible from diketone 213 using regioselective aldol chemistry. 
An unusual Michael-type addition on enone 214 was envisaged to insert the bridgehead 
functionality. Bridgehead enone 214 would result from successive oxidations on alkene 171, 
which could in turn be accessed from tetracycle 170 via a regioselective enolate substitution 
(Scheme 3.5).  
 
Scheme 3.5 
 
Inspired by the successful bridgehead substitutions carried out on our model system 88 
(see: Chapter 2), our group decided to employ the same methodology to functionalise 
tetracycle 170 possessing the gem-dimethyl moiety. They were delighted to discover that 
subjecting tetracyclic structure 170 to our standard bridgehead deprotonation conditions, 
using an ISQ, afforded silylated adduct 209 in 60% yield. No trace of either the other 
regioisomer or the bis-silylated adduct was observed. The steric hindrance imparted by the 
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gem-dimethyl in position C16 reduced the possibility of the deprotonation of H15 in 170 also 
encouraging the direct formation of the desired regioselective silyl product 209 
(Scheme 3.6).
2
 
 
Scheme 3.6 
 
In order to access bridgehead alkene 171, our group sought the introduction of a selenide 
group at position C11. Suspecting a lack of reactivity between the enolate formed and the 
selenium electrophile, the reaction was conducted at an elevated temperature (-10 °C instead 
of -78 °C) and this allowed bridgehead selenide 215 to be obtained in moderate yield 
(Scheme 3.7).
2
 
 
Scheme 3.7 
 
The synthesis of bridgehead alkene 171 was completed in good yield by an oxidative 
elimination of the selenium species, using mCPBA at low temperature (Scheme 3.8).
2
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Scheme 3.8 
 
Precursor 171 was oxidised in the presence of selenium dioxide to provide allylic alcohol 216 
in 30% yield, which was then oxidised with Dess-Martin periodinane to give the 
corresponding enone 214 in 45% yield. The configuration of alcohol 216 was determined by 
an nOe experiment (Scheme 3.9).
2
 
 
Scheme 3.9 
Therefore, the functionalisation of the northern portion of tetracyclic structure 170, using a 
regioselective deprotonation of the bridgehead ketone as the key step, successfully afforded 
advanced enone 214. 
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3.2.2 Introduction of a nitrogen-containing group at the bridgehead position C11 
2
 
The presence of an isothiocyanate functionality at the bridgehead position C11 of our target 
led our group to consider introducing a nitrogen motif at this bridgehead position. At this 
stage, an azide functionality was chosen as a suitable candidate and our group investigated the 
addition of azide onto the branching position C11 in order to access intermediate 217 
(Figure 3.3).
2
 
 
Figure 3.3 
 
The highly strained scaffolds of tetracycles 171 and 214 prevented conjugation between the 
bridging ketone C10 and the alkene C11-C12. However, a molecular model of intermediate 214 
suggested a planarity between alkene C11-C12 and ketone C13, and therefore suitable 
conjugation, to allow an eventual Michael addition on C11 (Figure 3.4).
2
 
 
Figure 3.4 
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In 1999, Miller and co-workers published an azide ion addition onto a large range of 
-unsaturated molecules using triethylamine as a catalyst.4 Miller reported numerous 
advantages to this strategy, that could be applied to a great variety of structures, including 
mild reaction conditions, utilisation of commercially available catalyst and substrates and 
high-yielding reactions (Scheme 3.10).
4
 
 
Scheme 3.10 
The combination of the high toxicity and the explosive reactivity of a stock solution of 
hydrazoic acid prompted Miller to pursue its in situ preparation.
4
 Miller chose commercially 
available trimethylsilyl azide as an azide derivative owing to its greater stability. Reaction of 
trimethylsilyl azide with a carboxylic acid, in this case acetic acid (AcOH), would afford 
trimethylsilyl acetate along with the desired hydrazoic acid, in situ (Scheme 3.11).
4
 
 
Scheme 3.11 
To this end, Miller found that employing this system, along with a catalytic amount of amine, 
allowed the conjugate addition of azide ion to occur (Scheme 3.12).
4
 
 
Scheme 3.12 
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A large range of -unsaturated enones was subjected to these conditions and the 
corresponding azides were obtained in good yield.
4
 However, the presence of an alkyl group 
at the reaction centre dramatically decreased the yield of the transformation. This was 
observed for enones 220 and 224, where the yield of the conjugate addition decreased from 
90% to 20% if the hydrogen atom at position C4 in 220 was replaced with a methyl group 
(Scheme 3.13).
4
 
 
Scheme 3.13 
 
In order to obtain azide 217, our group subjected enone 214 to the conditions developed by 
Miller (Scheme 3.14).
2,14
  
 
Scheme 3.14 
Despite the complex architecture of starting enone 214, azide 217 was produced in excellent 
yield.  
 
88 
 
3.2.3 Studies towards a regioselective functionalisation of carbon C12 
With a robust route to synthesise azide 217 in hand, our objective was to functionalise 
position C12 (Scheme 3.15). 
 
Scheme 3.15 
 
Advanced intermediate 226, possessing the desired stereochemistry at position C12 (imposed 
by the geometry of the molecule), could be obtained by deprotonation at C21 position of enone 
227 followed by an external quench with methyl iodide. Enone 227 would be accessed by 
dehydration of aldol 228, which in turn can be disconnected to azide 217 by utilising a 
regioselective aldol reaction with acetaldehyde at the position C12 (Scheme 3.15). 
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3.2.3.1 Rawal’s investigations towards a regioselective functionalisation of carbon C12 
In 2011, Rawal and co-workers published an interesting article regarding the difficulties 
encountered in their approach towards the welwitindolinone family.
5
 This article displayed 
and rationalised the formation of various unexpected products obtained throughout their 
synthetic route. 
Through this publication, we discovered how Rawal envisaged functionalisation at position 
C12 of the tetracyclic structure. Alkene 229 was to be obtained via a Wittig reaction performed 
on aldehyde 230. A regioselective deconjugative methylation on vinyl chloride 233 would 
achieve the desired regiocentre at the C12 position of 230. Aldehyde 233 would be formed 
from ketone 234 using the Vilsmeier-Haack conditions. The regioselectivity of the 
chloro-formylation would be enhanced by the presence of the ester group at the bridgehead 
position that would provide either a favourable electronic inductive effect or chelation for 
increasing the reactivity at position C12 (Scheme 3.16).
5
 
 
Scheme 3.16 
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Surprisingly, despite the presence of the ester group, only the undesired regioisomer 235 was 
formed, in 58% yield, without any traces of addition to the C12 position (Scheme 3.17).
5
 
 
Scheme 3.17 
 
Particularly intrigued by this result, Rawal and co-workers investigated the regioselectivity of 
silyl enol ether formation under various experimental conditions. Whilst treatment of ketone 
234 under soft enolisation conditions afforded principally the undesired silyl enol ether 237a, 
under kinetic control the reaction seemed to favour deprotonation at the C12 position.  Indeed, 
deprotonation of ketone 234 at -100 °C using KHMDS as the base followed by the addition of 
a silyl chloride reagent gave either silyl enol ether 236a or 236b with high regiocontrol 
(Scheme 3.18, Table 3.1). Rawal justified the choice of bulky silyl groups (TBS or TIPS) by 
their higher resistance to the acidic conditions involved in the subsequent Vilsmeier-Haack 
reaction.
5 
 
Scheme 3.18 
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Table 3.1 
Pleased by the high regiocontrol of the formation of silyl enol ethers 236a and 236b, both 
enol silanes were formylated following the Vilsmeier-Haack reaction conditions. 
Unfortunately, undesired aldehyde 235 was the only product of this reaction. The acidic 
conditions were believed to be responsible for the isomerisation of the double bond to 237a or 
237b, the precursor of aldehyde 235 (Scheme 3.19).
5
  
 
Scheme 3.19 
 
This highlighted the regioselectivity issue of this strategy. Despite high regiocontrol for the 
formation of the desired silyl enol ethers 236a and 236b, Rawal demonstrated the limitations 
of this procedure for introducing the desired fragment at position C12. 
Conditions 
Ratio 
236 : 237 
NEt3, TBSOTf, -20 °C 1 : 9 
KHMDS, TBSCl, -78 °C 2 : 1 
KHMDS, TIPSCl/TBSCl, -100 °C >10 : 1 
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3.2.3.2 Studies carried out by our group 
Despite the recent work published by Rawal and co-workers, our group chose to pursue their 
planned synthetic route towards azide 226 (see: Scheme 3.15).
5
 
Preliminary studies have been carried out by our group towards the synthesis of aldol 228 
from azide 217. In order to obtain the correct regioisomer, the protons at positions C12 and C14 
would need to be differentiated. 
The configuration of the molecule will impose the deprotonation of an exo-proton. 
Preliminary computational studies on azide 217 showed that the exo-proton at position C12 
resides in an axial orientation, whilst the exo-proton at position C14 is positioned equatorially 
(Figure 3.5). Thus electronic and steric factors should favour the deprotonation at the 
position C12.
2
 
  
Figure 3.5 
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Preliminary experiments have been carried out by our group to define the regioselectivity of 
the deprotonation. Our group studied the ratio of silyl enol ethers 238 or 240 (corresponding 
to the deprotonation at the C12 position) to silyl enol ethers 239 or 241 (corresponding to the 
deprotonation at the C14 position), respectively, formed under thermodynamic and kinetic 
conditions to define the optimum reaction conditions for affording aldol 228 (Scheme 3.20). 
Due to the instability of these silyl enol ethers to column chromatography, the ratios of 
regioisomers were determined by NMR spectroscopic analyses of the crude material.
2
 
 
Scheme 3.20 
 
Our group reported that under thermodynamic conditions, azide 217 was mainly deprotonated 
at the position C14. Thus, the use of TBDMSOTf in the presence of triethylamine at 0 °C 
afforded a mixture of silyl enol ethers 238 and 239 in a 1:2 ratio (Scheme 3.21).
2
 
 
Scheme 3.21 
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Under kinetic control, silyl enol ether 240 was formed as the major regioisomer and 
gratifyingly, subjecting azide 217 to a solution of LDA and TMSCl in THF pre-cooled to 
-78 °C gave a mixture of enol silanes 240 and 241 in a 4:1 ratio (Scheme 3.22).
2
 
 
Scheme 3.22 
 
Delighted by these results, our group screened various conditions to define the optimal 
conditions to access silyl enol ether 240. Exposure of azide 217 to a solution of LHMDS and 
TMSCl in THF at -78 °C afforded exclusively enol silane 240 without any trace of the 
undesired regioisomer 241. 
With silyl enol ether 240 in hand, an aldol reaction was performed using acetaldehyde in the 
presence of BF3.OEt2 at low temperature. The isolation of aldol product 228 was an issue due 
to its instability to column chromatography (product was performing a retro-aldol reaction on 
column chromatography); however, after further investigation, aldol 228 was formed in 43% 
yield over two steps (Scheme 3.23). 
 
Scheme 3.23 
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Dehydration of aldol 228 was then required to access enone 227. Various methods were 
screened by our group, including treatment with CeCl3.7H2O in the presence of sodium 
iodide,
6
 reaction of acetic anhydride using pyridine/DMAP as bases,
7
 or addition of TFA
8
. 
However, no trace of the desired enone 227 was observed (Scheme 3.24).
2 
 
Scheme 3.24 
 
An alternative method using mesyl chloride in the presence of DBU as base afforded an 
unexpected product that appeared to have lost the azide functionality at the branching 
position, as well as being dehydrated at the position C20-C21.
2,9
 Based on the data collected, 
our group suggested a structure for this unexpected intermediate 242 (Scheme 3.25).
2
 
 
Scheme 3.25 
Finally, subsequent treatment of aldol 228 with triflic anhydride in the presence of pyridine 
yielded enone 227 in 42% yield (Scheme 3.26).
2,10
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Scheme 3.26 
Despite a moderate yield for the preparation of enone 227, our group could now attempt to 
access advanced intermediate 226. At this stage, our aim was to deprotonate at position C21 of 
enone 227 and insert a methyl group at position C12 via an external quench with an excess of 
methyl iodide.  
Our group decided to attempt a two-step strategy following Smith’s conditions.11 Potassium 
tert-butoxide was added to a solution of substrate 227 in the presence of diphenyl sulfoxide, 
followed by the addition of methyl iodide. Unfortunately, no trace of a product possessing a 
methyl group at position C12 was observed (Scheme 3.27).  
 
Scheme 3.27 
Our group reported the formation of a new product, which possessed similar 
1
H NMR 
spectroscopic data in the vinylic region to alkene 242; however, this product was not fully 
characterised. The elimination of the azide functionality had once again impeded the 
synthesis. 
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Despite the promising results obtained by previous members of our group, the challenging 
sequence presented a number of drawbacks, including low yields and a lack of 
reproducibility, which prevented it from becoming a suitable sequence to approach 
welwistatin 7. As a result, our first goal became to improve the proposed synthetic route to 
azide 217 (particularly regarding the preparation of enone 214 from tetracyclic structure 170). 
With azide 217 in hand, we would turn our attention towards the functionalisation of the C12 
position. Diverse approaches were envisaged to insert the required motif at the position C12 
while preventing the elimination of the bridgehead functionality. 
 
3.3 Our work towards the improvement of the sequence developed by our group 
Our work started with the preparation of tetracycle 170 using the route developed by our 
group. Taking inspiration from Rawal’s work, functionalised cyclohexanone 169, possessing 
the desired gem-dimethyl fragment in the required position, was synthesised from 
commercially available 4-bromoindole (71). Tertiary alcohol 245 was obtained via a 
three-step sequence involving acylation of carbon C3, tosyl protection and a Grignard 
addition. Freshly prepared silyl enol ether 246 was then coupled to tertiary alcohol 245, in the 
presence of a Lewis acid, presumably through an SN1 process to form cyclohexanone adduct 
247 in 79% yield. Key intermediate 169 was finally accessed from the tosylated derivative 
247 in 91% yield after a N-deprotection/N-methylation sequence (Scheme 3.28). We 
reproduced this sequence in similar yields compared to the one reported by Rawal and 
co-workers (displayed in brackets).
1 
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Scheme 3.28 
In our hands, silyl enol ether 211 was obtained in 79% yield along with the starting ketone 
169 (96% yield BRSM). Following this procedure, we observed that performing the arylation 
on gramme scale increased the yield of this reaction considerably and tetracycle 170 was 
obtained in a reproducible 92% yield (Scheme 3.29). 
 ` 
Scheme 3.29 
 
At this stage, the preparation of oxindole 248 from tetracyclic 170 was performed following 
the two-step procedure developed by Garg and co-workers.
12 
Bromination of the C2 position 
of bicyclic indole 170 was achieved by addition of NBS, prior to acid-promoted hydrolysis in 
refluxing ethanol (Scheme 3.30).  
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Scheme 3.30 
 
The reaction was carried out on a small scale and was not optimised. Despite the low yield 
obtained (25% over two steps), we were pleased to successfully introduce the oxindole feature 
present on welwistatin 7 onto tetracyclic skeleton 170.  
 
3.3.1 Improvement of the synthesis of enone 214 and preparation of azide 217 
Inspired by the work developed by our group and convinced of the high importance of enone 
214 in our strategy, we decided to undertake the synthetic route to enone 214 using the 
conditions previously described.
2
 Unfortunately, this synthetic strategy exhibited some 
reproducibility issues combined with a very low-yielding process and investigations to 
overcome these difficulties were required. 
 
Our attention turned towards the preparation of bridgehead alkene 171, obtained by a two-step 
sequence involving regioselective selenylation of the bridgehead position, C11, followed by 
oxidation of the selenide adduct. We were particularly concerned that, despite a high 
conversion observed for each step of this process, alkene 171 was isolated in poor yield (up to 
27% yield).  
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Bridgehead selenide 215 was isolated along with starting ketone 170 (up to 35% yield). The 
recovery of tetracycle 170 was attributed to the high sensitivity of bridgehead selenide 215 to 
column chromatography. We assumed that the acidity of the silica could protonate the bridged 
ketone of selenide 215 and therefore decided to perform the oxidative elimination of the 
selenide group on unpurified 215. 
Moreover, oxidation of selenide 215 in the presence of mCPBA seemed to occur rapidly at 
low temperature (-10 °C) towards intermediate 249, as total consumption of starting material 
215 was observed by TLC in less than 30 min. However, at this stage only 65% of alkene 171 
was isolated. As a result, we believed that the slow elimination process of intermediate 249 to 
the desired bridgehead alkene 171 was responsible for this moderate yield. A combination of 
higher temperature (from -10 °C to rt) and longer reaction time (from 30 min to 16 h) was 
required to complete the conversion of selenide 215 to bridging -unsaturated carbonyl 171  
(Scheme 3.31). 
 
Scheme 3.31 
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We were particularly delighted that subjecting tetracyclic skeleton 170 to these combined 
modified procedures gave bridgehead alkene 171 in a reproducible 82% yield over two steps. 
 
With bridged alkene 171 in hand, we turned our attention towards the preparation of enone 
214. Our group proposed that oxidation of alkene 171 by the addition of selenium dioxide in 
dioxane at 70 °C would give access to allylic alcohol 216, which could be turned into the 
corresponding enone 214 using standard Dess-Martin oxidation conditions. Unfortunately, the 
yields of these two steps were too low to obtain sufficient amount of enone 214 and 
optimisation of the oxidation was essential to pursue the synthesis towards welwistatin 7. 
 
Direct oxidations of alkenes into corresponding enones have been extensively studies and 
many methods have been described. Unfortunately, treatment of alkene 171 with either CrO3 
with 3,5-dimethylpyrazole,
13
 or Pd/C in the presence of tert-butyl hydroperoxide (tBuOOH) 
under basic conditions,
14
 did not afford the desired enone 214 (Scheme 3.32). In both cases, 
only degradation was observed. 
 
Scheme 3.32 
Unable to synthesise enone 214 in one step from alkene 171, we changed our focus to 
improving the sequence developed by our group to access enone 214 via allylic alcohol 216.
2
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Despite total consumption of starting allylic methylene 171 during the oxidation process, we 
were particularly concerned by a low yield of isolated alcohol 216. The first step of the 
oxidative mechanism is the formation of the allylic seleninic acid intermediate 250 via an ene 
reaction. The ene reaction proceeds via a pericyclic reaction initiated by activation of the 
C13-H bond. A [2,3]-sigmatropic rearrangement then regenerates the double bond and affords 
allylic alcohol 216 after hydrolysis of the Se(II) ester 251 (Scheme 3.33).
2
 
 
Scheme 3.33 
 
The absence of starting alkene 171 led us to consider that the formation of allylic seleninic 
acid 250 was proceeding smoothly. At this stage, two hypotheses could be envisaged to 
explain the low yield of this oxidative procedure: The particular configuration of intermediate 
250 forced the rearrangement to occur on the exo-face of the molecule that represented a 
spatially challenging transformation, or alternatively, the selenium could adhere to the 
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molecule despite the aqueous work-up. A combination of these two hypotheses led us to 
consider alternative methods for this oxidation. 
 
The formation of allylic alcohols from the corresponding alkenes has been widely reported in 
the literature and taking inspiration from the work of Sharpless,
15
 we subjected alkene 171 to 
a sub-stoichiometric catalytic amount of SeO2 in the presence of tBuOOH as the co-oxidant. 
Unfortunately, no trace of the desired allylic alcohol 216 was observed (Scheme 3.34). 
 
Scheme 3.34 
 
Particularly concerned that alternative methods did not show any trace of the desired enone 
214 or allylic alcohol 216, we decided to optimise the conditions developed by our group by 
varying the physical parameters such as the temperature, length of reaction and work-up 
conditions. 
Initially, we decided to investigate the work-up conditions. Concerned that removing the 
selenium adduct could represent an issue in this procedure, we attempted to avoid any 
aqueous work-up. After removal of the solvent, the residue was purified by column 
chromatography. However, under these conditions, the yield was reduced to 16% yield 
(33% yield BRSM). 
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In 2007, Koert’s group reported the synthesis of tetrasubstituted decalin 252 via an allylic 
oxidation performed with selenium dioxide in dioxane and water at 90 °C (Scheme 3.35).
16 
 
Scheme 3.35 
Even though the yield for the oxidation of olefin 253 to corresponding allylic alcohol 254 was 
moderate, the temperature was considered as an important parameter for our reaction.
16
 
Increasing the temperature of the reaction from 70 °C to 90 °C increased the rate of the 
reaction. TLC indicated that after 3.5 h, the ratio of starting alkene 171 to allylic alcohol 216 
was approximately 1:1. After another 3.5 h, only traces of starting alkene 171 were observed 
and the reaction was stopped. After neutralising the reaction using the usual aqueous work-up 
(see page 197), the product was purified to afford allylic alcohol 216 with an average yield of 
49% (from 42% to 63%) (Scheme 3.36). 
 
Scheme 3.36 
 
Although this yield was not ideal, we decided to turn our attention towards the second 
oxidation, performed by our group via a Dess-Martin oxidation. Even though diverse methods 
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could be envisaged, the Swern and the Dess-Martin oxidations are the most commonly 
employed and often the mildest and most efficient strategies. 
Allylic alcohol 216 was submitted to Swern oxidation conditions. After one hour, two 
products were obtained. The desired enone 214 was isolated in 32% yield along with an 
unidentified compound (Scheme 3.37). 
 
Scheme 3.37 
 
In 1994, Schreiber and Meyer reported an intriguing method to accelerate the Dess-Martin 
oxidation.
17
 Despite the advantages offered by Dess-Martin periodinane (DMP) (including 
milder reaction conditions and tolerance to sensitive functional groups), Schreiber described 
the reagent as ‘capricious’. Following some observations made by the group of Ireland on the 
quality of the DMP batch, Schreiber and co-workers studied the influence of the purity of 
DMP for the oxidation.
17,18 
 
In 1983, Dess and Martin noticed that the addition of an extra equivalent of ethanol 
considerably enhanced the rate of the oxidative reaction.
19
 This could be explained by the 
acceleration of the rate of dissociation of the acetate ligand from 256 in the presence of an 
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alkoxy group due to its higher electron-donating character (compared to the acetate ligand in 
255 that required 2 h, see: Scheme 3.38).
19
 
 
Scheme 3.38
 
 
Intrigued by this observation, Schreiber investigated the influence of water on the rate of 
reaction.
17 
Water could be introduced in various ways, including addition of an equivalent of 
water to intermediate 259 or by pre-hydrolysis of DMP prior to the addition of the alcohol 
(Figure 3.6). However, an alternative strategy based on the dropwise addition of ‘wet 
dichloromethane’ was chosen for its excellent reliability. Wet CH2Cl2 was prepared by the 
addition of 1 µL of water per mL of CH2Cl2 and this was then added dropwise to the 
vigorously stirred solution of substrate and DMP in dry dichloromethane.
17
 
 
Figure 3.6 
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The reaction was carried out on a diverse range of substrates and excellent yields were 
obtained after only 30 min. For example, conversion of alcohol 260 into the corresponding 
ketone 261 was achieved in 14 h. Performing the same reaction in the presence of wet CH2Cl2 
decreased the reaction time to 30 minutes (Scheme 3.39).
17
 
 
Scheme 3.39 
Schreiber also presented the oxidation of cholesterol (262). Using the traditional DMP 
oxidation procedure, 5-cholesten-3-one (263) was obtained in 78% yield after 8.5 h. When 
wet oxidation conditions were employed, 5-cholesten-3-one (263) was accessed in 91% after 
only 30 min (Scheme 3.40).
17
 
 
 
Scheme 3.40 
 
Concerned that the transformation of alcohol 216 to enone 214 could be facing some issues 
related to a dissociation process, we chose to undertake the addition of ‘wet CH2Cl2’ during 
the oxidation. After stirring the substrate and DMP vigorously in CH2Cl2 for 20 min, the ‘wet 
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CH2Cl2’ was added dropwise over 20 min. We were particularly pleased to observe total 
consumption of starting material by TLC and by 
1
H NMR spectroscopic analysis of the crude 
reaction mixture. After purification, enone 214 was isolated in 82% yield (Scheme 3.41). 
 
Scheme 3.41 
With a robust sequence to access enone 214 in hand, we decided to continue the synthesis 
towards our target, N-methylwelwitindolinone C isothiocyanate 7. The next objective of this 
strategy was to introduce a nitrogen atom at the branching position, C11. 
 
In our hands, azide 217 was synthesised using a Michael-type addition on enone 214 as 
developed by previous members of our group (Scheme 3.42).  
 
Scheme 3.42 
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The direct insertion of the nitrogen at the branching position became one of the main 
characteristics of this sequence. Many groups have shown an interest for this natural target 
and many tetracyclic structures have been synthesised, however our group was the first to 
introduce a nitrogen fragment at the bridgehead position without the prior installation of a 
carbon-containing group. 
 
3.3.2 Introduction of the desired fragment at the C12 position 
3.3.2.1 Our first investigations: An alternative solution to a labile azide group at the 
bridgehead position 
Aware of the problem of azide elimination previously encountered by our group, we opted to 
mask the azide functionality as in 172. An analogous strategy, based on a regioselective aldol 
reaction, would then build the desired fragment at the C12 position present on intermediate 
173 (Scheme 3.43). 
 
Scheme 3.43 
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Subsequent reduction of azide 217 into the corresponding amine 268 was achieved via a 
Staudinger reaction using tributylphosphine (PBu3).
20
 Reaction of PBu3 with the azide 
generated the phosphazide intermediate 266 which, after elimination of N2, gave the 
corresponding iminophosphorane 267. Due to the higher affinity of the phosphine with 
oxygen, the presence of water in the reaction allowed the desired amine 268 to be liberated 
(Scheme 3.44).  
 
Scheme 3.44 
 
At this stage, we considered protecting amine 268 as the corresponding amide derivative 269. 
Unfortunately, the reaction of amine 268 with formic acid in toluene heated at reflux led to 
degradation, whilst conducting the reaction at room temperature provided the recovery of 
starting material in 54% yield (Scheme 3.45).
21 
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Scheme 3.45 
 
After failing to protect amine 268 as a formamide, we decided to convert amine 268 into the 
corresponding carbamate derivative 270. Taking inspiration from the work of Baillie and 
Leung, we treated amine 268 with methyl chloroformate in the presence of sodium carbonate 
in toluene at room temperature to access carbamate derivative 270 in 83% yield 
(Scheme 3.46).
22
  
 
Scheme 3.46 
 
Particularly pleased by the formation of carbamate 270, we noticed that treatment of crude 
amine 268 with these conditions afforded carbamate 270 in an excellent 99% yield over the 
two steps (Scheme 3.47).  
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Scheme 3.47 
 
At this stage, we aimed to reproduce the regioselective enolate chemistry developed by 
previous members of our group on carbamate 270 to introduce the desired fragment in the C12 
position without eliminating the nitrogen bridgehead already in place (see: Scheme 3.43). 
The optimised conditions for the preparation of a silyl enol ether developed by our group were 
applied to our carbamate substrate 270. A solution of LHMDS was added to a solution of 
substrate 270 in THF pre-cooled to -78 °C. After 10 min at -78 °C, TMSCl was added 
dropwise. After 30 min at the same temperature, no trace of starting carbamate was observed. 
Triethylamine was added prior to the neutralising agent to avoid any formation of acid 
(Scheme 3.48).  
 
Scheme 3.48 
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Despite total consumption of starting material prior to the quench, the 
1
H NMR spectrum of 
the crude material displayed the presence of two products. The presence of a resonance at 
6.90 ppm (d, 1H, J 4.0) reassured us of the formation of silyl enol ether 271; however, the 
1
H NMR spectroscopic data of the crude material also showed the presence of starting 
material 270. 
A possible interpretation of this phenomenon would be that both silyl enol ethers 271 and 272 
were formed but due to the instability of the undesired enol silane 272, the latter would 
hydrolyse rapidly into starting ketone 270 (Scheme 3.49). 
 
Despite this issue of regioselectivity, we chose to undertake the aldol reaction on the crude 
mixture of ketone 270 and enol silane 271 (Scheme 3.49). 
 
Scheme 3.49 
After 3.5 h, TLC of the reaction showed total consumption of silyl enol ether 271 and a single 
new spot appeared along with that of starting ketone 270. Purification of the crude reaction 
mixture by column chromatography afforded a new product (2.4 mg).  
The 
1
H NMR spectrum of the new compound showed the presence of rotamers in a ratio 2:1 
(due to the introduction of a carbamate group at the bridgehead position). Correlations 
between the multiplets present at 3.97-4.06 ppm and 3.86-3.94 ppm, corresponding to the 
114 
 
characteristic proton H20 for both rotamers, and the protons H21 of the methyl group were 
observed on the 
1
H-
1
H COSY spectrum. Unfortunately, the amount of product isolated did not 
allow us to obtain an useful 
13
C NMR spectrum (Figure 3.7). 
 
Figure 3.7 
 
The mass spectrum showed a single peak at [M + Na]
+ 
= 421.2. Finally, the IR spectrum 
displayed a broad band at 3338 cm
-1
, associated with an alcohol, as well as three strong 
carbonyl bands at 1730, 1703 and 1654 cm
-1
. Combination of these data led us to assume that 
the reaction afforded the desired aldol 273 (Figure 3.8). 
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Figure 3.8 
Despite the successful formation of aldol 273, the problem of regioselectivity encountered 
during the formation of the silyl enol ether 271 led us to reconsider this synthetic pathway.  
 
We decided to investigate an alternative synthetic route consisting of the preparation of aldol 
228 from azide 217 followed by reduction and protection of the azide bridgehead, before 
dehydration of the alcohol at position C20. In this way, elimination issues should be avoided 
(Scheme 3.50). 
 
Scheme 3.50 
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Following the experimental procedure developed by our group, azide 217 was converted into 
enol silane 240 under kinetic control. Enol silane 240 was achieved by ISQ using LHMDS 
and TMSCl. Without further purification, the reaction of silyl enol ether 240 with 
acetaldehyde in the presence of BF3.OEt2 resulted in aldol 228 in up to 80% yield over two 
steps (average yield between 50 and 80%) as a single diastereoisomer (Scheme 3.51). 
 
Scheme 3.51 
 
At this stage, azide 228 was subjected to the Staudinger reaction using tributylphosphine 
(Scheme 3.52). Even though the desired amine 276 was formed, we were unable to separate it 
from the phosphine oxide formed during the reaction. Various treatments (including column 
chromatography, aqueous/acid/basic work-up) were attempted to isolate pure amine 276, 
unfortunately these efforts proved unsuccessful. 
Delighted by the formation of the amine, we considered changing the reducing agent. Despite 
its high toxicity, trimethylphosphine was chosen, as the trimethylphosphine oxide by-product 
could be removed by sublimation. Treatment of azide 228 with an excess of PMe3 in the 
presence of water afforded bridgehead amine 276 (Scheme 3.52). After removing the 
remaining traces of phosphine oxide under reduced pressure, the isolated product was 
obtained in 35% yield (the reaction was not optimised).  
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Scheme 3.52 
 
Dehydration of amino-alcohol 276 was then attempted using pTSA in toluene (Scheme 3.53). 
After stirring the reaction for 3 h at room temperature and then heating at 65 °C for 2 h, only 
starting material was recovered from this reaction, in 70% yield. Increasing the temperature to 
100 °C led to complete degradation of the starting material. 
 
Scheme 3.53 
 
At this point, a combination of lack of material and low-yielding steps led us to investigate 
the synthetic route developed by previous members of our group with the azide at the 
bridgehead position C11, this time taking some extra precautions to avoid the elimination. 
 
118 
 
3.3.2.2 Our studies of functionalisation of carbon C12 carried out on azide 217 
Based on the preliminary studies of our group on aldol 228, we sought to prepare tetracycle 
226 as a key intermediate in our retrosynthetic route (Scheme 3.54). 
 
Scheme 3.54 
 
Despite the low yield reported by previous members of our group, we chose triflic anhydride 
as a dehydrating agent. Enone 227 was obtained in a 9:1 mixture of double bond isomers in 
45% yield (ratio of isomers determined by 
1
H NMR spectroscopy) (Scheme 3.55).
2
 
 
Scheme 3.55 
 
The configuration of enone 227 was determined by nOe experiments. As shown in Figure 3.9, 
the proton H20 of the Z stereoisomer 227a should show an nOe to aromatic proton H5, while 
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no nOe should be observed between protons H21 and H5. For the E stereoisomer 227b, an nOe 
between the proton H5 and the protons H21 would be expected. 
 
Figure 3.9 
In the nOe experiment, irradiation of the doublet present at 2.18 ppm (i.e. major component) 
revealed an nOe between protons H5 and H20, indicating the presence of the Z stereoisomer 
227a (Figure 3.10). 
 
Figure 3.10 
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Moreover, irradiation of the doublet present at 2.50 ppm (i.e. minor component) confirmed an 
nOe between protons H5 and H21, also indicating the presence of the E stereoisomer 227b. 
This allowed us to conclude that enone 227 was predominantly formed as the Z stereoisomer 
(Figure 3.11). 
 
Figure 3.11 
 
With enone 227 in hand, we aimed to insert a methyl group at position C12 in order to access 
intermediate 226. Following the work reported by our group, we aimed to deprotonate enone 
227 at position C21, resulting in a stabilised extended enolate 278, that could intercept a 
methyl group in the-position C12, provided by the presence of an excess of methyl iodide 
(Scheme 3.56). 
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Scheme 3.56 
 
Initially, we were concerned by the regioselectivity of the deprotonation. This could occur at 
position C14 or C21. We postulated that formation of the lithium enolate at position C14 would 
be more challenging due to the spatial orientation of the exo-proton H14. Moreover, the 
stabilisation gained by the formation of an extended enolate should be enhanced by the 
predominance of the Z configuration for enone 227 (transition state stabilised by the obtention 
of a six-membered ring system),which should favour the formation of enolate 278. 
A solution of enone 227 was added to a solution of LDA at low temperature. After 15 min, a 
large excess of iodomethane was added at -78 °C. The reaction mixture was slowly warmed 
up to -20 °C and stirred at this temperature for 20 min. Monitoring the reaction by TLC 
showed no conversion. Warming the reaction mixture to room temperature only led to 
degradation and after purification, starting enone 227 was recovered in 56% yield 
(Scheme 3.57). 
 
Scheme 3.57 
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Unable to insert the desired fragment by direct methylation, we decided to attempt the 
formation of the desired silyl enol ether 279 prior to methylation. Substrate 227 was added 
dropwise to a solution of LHMDS and TMSCl pre-cooled to -78 °C. The reaction mixture was 
stirred for 1 h at -78 °C whilst being monitored by TLC (Scheme 3.58). 
 
Scheme 3.58 
 
Along with the starting material, a new spot was observed by TLC. As the reaction did not 
show any further advancement, it was stopped. A new product was isolated along with the 
starting enone 227 (recovered in 58% yield). The mass spectrum of the new product showed 
the presence of a peak at [M + Na]
+
 = 443.3, corresponding to the formation of a silyl enol 
ether. 
The 
1
H NMR spectrum seemed to show the presence of both Z/E stereoisomers in a 54:46 
ratio. It also displayed the presence of three signals in the vinylic region; H14 was present at 
5.12 ppm (d, 1H, J 3.8, H14), while H20 was divided into two signals at 6.16 ppm (q, 0.55H, 
J 7.4, H20) and 5.96 ppm (q, 0.45H, J 7.8, H20) that respectively coupled with the signals at 
1.89 ppm (d, 1.35H, J 7.4, H21) and 2.30 ppm (d, 1.65H, J 7.8, H21) (Figure 3.12).  
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Figure 3.12 
 
These initial observations led us to assume that the undesired silyl enol ether 280 was 
obtained (Figure 3.13).  
 
Figure 3.13 
 
Since the use of a labile TMS group was unsuccessful, we decided to investigate the addition 
of a bulkier group such as a TBS group. Enone substrate 227 was added dropwise to a 
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solution of LHMDS pre-cooled to -100 °C. The reaction mixture was stirred for 10 min before 
TBSOTf was added dropwise at -100 °C (Scheme 3.59). An instantaneous change of colour 
occurred. The reaction mixture was allowed to warm to -78 °C and at this temperature total 
consumption of starting material was observed by TLC. The reaction was neutralised by 
successive addition of triethylamine and a saturated solution of NaHCO3.  
 
Scheme 3.59 
 
Mass spectrometry of the crude reaction material showed the desired mass for the formation 
of a silyl enol ether by the presence of a peak at [M + Na]
+
 = 485.2; however, the presence of 
similar signals to that of enol silane 280 in the 
1
H NMR spectroscopic data led us to conclude 
the formation of undesired silyl enol ether 282 (Figure 3.14). 
 
Figure 3.14 
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An alternative strategy was envisaged consisting of successive additions of an equivalent of 
potassium tert-butoxide to a mixture of enone 227 and iodomethane in THF at room 
temperature (Scheme 3.60). After the addition of 3 eq. of tBuOK, a new spot appeared by 
TLC. However, addition of further eq. of tBuOK led to degradation, as indicated by TLC, and 
so the reaction was neutralised. A new product was isolated but unfortunately no trace of 
desired azide 226 was observed. 
 
Scheme 3.60 
 
The mass spectrum of the one of the compounds isolated showed a single peak at 
[M + Na]
+ 
= 342.1 corresponding to the loss of azide and the addition of a methyl group. The 
1
H NMR spectrum exhibited three signals in the vinylic region at 6.66 ppm (dd, 1H, J 17.6, 
11.6, H20), 6.27 ppm (dd, 1H, J 17.6, 1.8, H21) and 5.54 ppm (dd, 1H, J 11.6, 1.8, H21) as well 
as three intriguing signals at 3.22 ppm (qd, 1H, J 7.5, 0.8, H14), 2.95 ppm (d, 1H, J 0.8, H15) 
and 1.38 ppm (d, 3H, J 7.5, H22) (Figure 3.15).  
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Figure 3.15 
A combination of these data led us to propose the following structure for intermediate 283 
(Figure 3.16). 
 
Figure 3.16 
 
Facing some difficulties to install the desired motif at the C12 position, we attempted reducing 
and protecting azide 227 prior to methylation of the intermediate enolate. 
 
127 
 
A Staudinger reaction was carried out on enone 227 using an excess of tributylphosphine in 
the presence of water. Reaction of this intermediate with methyl chloroformate in the 
presence of sodium carbonate was performed in toluene. After 16 h at room temperature, the 
reaction showed only starting material by TLC. Increasing the temperature to 110 °C led to 
the completion of the reaction in 3 h (Scheme 3.61).  
 
Scheme 3.61 
 
To our surprise, the 
1
H NMR spectrum of the isolated product 285 did not show the presence 
of aliphatic protons between 2.5 ppm and 3.5 ppm and four protons appeared in the vinylic 
region at the position 6.65 ppm (dd, 1H, J 17.8, 12.2, H20), 6.07 ppm (s, 1H, H14), 5.73 ppm 
(dd, 1H, J 12.2, 1.6, H21) and 5.71 ppm (dd, 1H, J 17.8, 1.6, H21). A variable temperature 
1
H NMR experiment had been carried out at 0 °C and -20 °C to sharpen the two methyl 
signals present at 1.80 ppm and 1.30 ppm and characterise of the protons H17 and H18 
(Figure 3.17). 
Unconvinced by the presence of two doublets at 6.92 ppm (d, 1H, J 8.8) and 7.03 ppm (d, 
1H, J 8.8) and a singlet at 1.26 ppm (s, 2H), we considered these as an impurity. 
The 
1
H-
1
H COSY NMR spectrum did not show any coupling with any other signals present 
on the system and this was confirmed by the mass spectrometry. This would require 
additional purification and analyses to confirm that these signals belonged to an impurity.  
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Figure 3.17 
 
Careful studies of our data led us to consider cyclophane 285 as the potential product of the 
reaction (Figure 3.18). Meta-cyclophane 285 would present a remarkable structure as 
positions C11 and C15 are connected by only four carbons belonging to an indole.
23 
 
Figure 3.18 
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At first, the formation of this unusual structure 285 was rationalised by the formation of 
intermediate 242 by elimination of the azide functionality followed by tautomerisation at high 
temperature (refluxing toluene was required to overcome the energy barrier).  
 
Particularly surprised by the highly provocative structure we attributed to compound 285, we 
tried to replicate this phenomenon by heating enone 214 in refluxing toluene. After 30 min at 
reflux, the reaction did not show any advancement by TLC. At this stage, sodium carbonate 
was added at room temperature and the reaction was heated again at reflux for another hour, 
however, only starting material was recovered (Scheme 3.62).  
 
Scheme 3.62 
 
Enone 214 was then heated in refluxing toluene for 1 h prior to the addition of few drops of 
TFA at room temperature. The reaction was once again heated at reflux and after only 10 min, 
total consumption of starting material was observed (Scheme 3.63). 
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Scheme 3.63 
After purification, a new product was isolated. The 
1
H NMR spectrum displayed two new 
protons at 7.00 ppm (d, 1H, J 8.5) and 6.68 ppm (dd, 1H, J 8.5, 3.0). However, the coupling 
constants obtained for these two protons clearly represented an ortho coupling, thus 
discrediting the formation of cyclophane 286 (Figure 3.19). 
 
Figure 3.19 
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The following alternative structure, resulting from a retro-Mannich reaction, was proposed as 
product of this reaction. However, the data remained inconclusive for this bis-phenol 287 
(Figure 3.20) 
 
Figure 3.20 
 
Computational studies carried out by Prof. Chris Hayes (at the University of Nottingham) on 
enone 214 have shown that the formation of cyclophane 287 was particularly unlikely as it 
would require 36 kcal.mol
-1
 more energy than the starting enone 214 (Figure 3.21).  
On the other hand, bis-phenol 287 was found to require 23 kcal.mol
-1
 less energy than the 
starting enone 214 making this rearrangement more plausible (calculations were made using 
B3LYP/6-31G* energies on B3LYP/6-31G* optimised structures). 
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Figure 3.21 
 
The formation of bis-phenol 287 could be rationalised by an acid-promoted retro-Mannich 
mechanism. An initial protonation of the bridgehead ketone in the presence of a catalytic 
amount of TFA would afford intermediate 288. A retro-Mannich reaction would then occur to 
give indole 289 (Scheme 3.64).   
 
Scheme 3.64 
Cyclophane 286
36.4 kcal/mol
Bis-phenol 287
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Starting enone 214
0 kcal/mol
Energies relative to dione starting material
(B3LYP/6-31G*//B3LYP/6-31G*)
133 
 
Cyclisation could then be envisaged to afford, after tautomerisation, bis-phenol tetracyclic 
structure 287 (Scheme 3.65). However, this mechanism could not apply to the reaction of 
enone 227 due to the presence of the vinyl group at the C12 position. 
 
Scheme 3.65  
 
A combination of the data confirmed the bis-phenol 287 as product of the reaction; the mass 
spectrum showed two peaks at [M + H]
+
=280.2 and [M + Na]
+
=302.2 and the IR spectrum 
displayed a broad stretch at 3355 cm
-1
.  
However, the 
1
H NMR spectrum showed the presence of a signal at 7.26 ppm (d, 1H, J 1.5) 
coupling with the proton at 6.68 ppm (dd, 1H, J 8.5, 1.5) present on the phenyl ring. This 
observation led us to reconsider the possible structure of the product, as bis-phenyl 287 did 
not match the requirements. 
 
An alternative product could be envisaged by an external quench of the iminium salt in the 
presence of water to afford alcohol 291. The open-structure 291 was found to be compatible 
with the 
1
H NMR spectroscopic data. The mass spectrum of indole 291 confirmed this 
hypothesis by the presence of a single peak at 302.1, corresponding to the mass of 291 after 
losing a molecule of water (Scheme 3.66). 
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Scheme 3.66 
 
Moreover, additional NMR spectroscopic analyses carried out on the product, obtained by 
reaction of enone 227 in refluxing toluene, demonstrated that the proton at 6.07 ppm was an 
alcohol (observed by HSQC, confirmed by D2O exchange; see: Figure 3.17 with H14 being an 
alcohol). The combination of the NMR spectroscopic data and the energy calculations 
discarded the cyclophane 285 as a potential product for this reaction. 
The bis-phenol 292 could be considered as a possible product for the reaction of enone 227 in 
refluxing toluene. The 
1
H NMR spectroscopic data matched the open-structure 292; 
moreover, the mass spectrum showed the presence of a single peak, that corresponded to the 
mass of 292 after losing a molecule of water (formation of the iminium) (Figure 3.22).  
 
Figure 3.22 
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Unfortunately, at this stage, the combination of the data gathered did not allow us to identify 
these two new products and therefore additional studies would be required. 
 
3.4 SUMMARY  
The bicyclo[4.3.1]decane 170 has been successfully synthesised in eight steps from 
commercially available 4-bromoindole (71).
1,2
 Selenation of the bridged position was 
achieved by direct metallation and substitution of the position C11 using strategies developed 
by previous members of our group (Scheme 3.67).
2
 
 
Scheme 3.67 
 
At this stage, we chose to follow the synthetic route to enone 214 previously developed by 
our group, however the low yields of this oxidative sequence were unsatisfactory and required 
optimisation.
2
 A longer reaction time and a higher temperature were served to increase the 
yield of the oxidation of selenide 215. Increasing the temperature of the allylic oxidation 
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reaction allowed access to alcohol 216 in a reproducible 49% yield. Finally, the Dess-Martin 
oxidation was enhanced by addition of ‘wet dichloromethane’ to liberate the key late-stage 
diketone intermediate.  
 
Introduction of the nitrogen fragment at the bridgehead position C11 was achieved in high 
yield following the conditions developed by previous members of our group (Scheme 3.68).
2
 
 
Scheme 3.68 
With a robust synthetic route to azide 217, we attempted to introduce the desired fragment at 
position C12 using enolate chemistry. Some regioselectivity issues as well as the risk of 
elimination of the bridgehead azide required considerations to avoid side reactions. Formation 
of enol silane 240 was achieved via an ISQ under kinetic control using LHMDS. A 
regioselective aldol reaction provided alcohol 228 as a single diastereoisomer in 80% yield 
over two steps. Dehydration was carried out using triflic anhydride in the presence of 
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pyridine. However, insertion of a methyl group at the C12 position remained unsuccessful 
(Scheme 3.69). 
 
Scheme 3.69 
 
Unable to design the required fragment at the C12 position, we envisaged reducing the azide 
functionality at the bridgehead position C11 present on enone 227 and protecting the 
corresponding amine to avoid elimination issues. The two-step process resulted in an 
unexpected product that was identified as bis-phenol 292 (Figure 3.23).  
 
Figure 3.23 
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CHAPTER FOUR 
EPILOGUE: TOTAL SYNTHESES OF  
N-METHYLWELWITINDOLINONE C ISOTHIOCYANATE 
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Despite the numerous syntheses of the welwitindolinone scaffold possessing the 
bicyclo[4.3.1]decane structure, no total synthesis of the compact tetracyclic had been reported  
when we started this project in 2010. However, the challenging architecture and the 
particularly attractive biological properties of welwistatin 7 continued to interest many 
research groups worldwide and since the start of our work, two research groups have reported 
a total synthesis of welwistatin 7 and other members of the welwitindolinone family 
(Figure 4.1).
1-4 
 
Figure 4.1 
 
4.1 TOTAL SYNTHESES OF WELWITINDOLINONES 
In 2011, Rawal and co-workers were the first to disclose a total synthesis of a compact 
member of the welwitindolinone family, N-methylwelwitindolinone D isonitrile 18.
1
 The 
tetracyclic skeleton of the oxidised welwitindolinone 18 was rapidly assembled. Taking 
inspiration from their previous work, precursor 297 was achieved by an alkylative coupling 
between tertiary alcohol 296 and highly functionalised enone 295 in the presence of TMSOTf, 
in good yield. Precursor 297, possessing the required quaternary centre at position C12, was 
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subjected to a Pd-catalysed enolate arylation to afford aldehyde 298 in 73% yield 
(Scheme 4.1). 
 
Scheme 4.1 

-Bromoketone 299 was prepared in a three-step sequence involving desilylation and 
oxidation of protected alcohol 298 followed by bromination of the position C14 using enolate 
chemistry. Surprisingly, oxidation of -bromoketone 299 using DMDO yielded the 
spiro-fused pentacycle 300 after spontaneous intramolecular nucleophilic substitution of 
3-hydroxyoxindole at the position C14 (Scheme 4.2). 
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Scheme 4.2 
 
The synthesis of welwitindolinone 18 was completed by the transformation of the aldehyde 
functionality into an isonitrile. Treatment with hydroxylamine afforded the corresponding 
oxime 301, which was then converted into isothiocyanate bridgehead 302. Desulfurisation 
afforded the desired N-methylwelwitindolinone D isonitrile 18 (Scheme 4.3). 
 
Scheme 4.3 
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A few months later, Rawal described the influence of a chlorine atom at the C2 position of the 
indole on the regioselectivity of the intramolecular oxidative cyclisation, in the presence of 
manganese(III) acetate (Scheme 4.4).
5
 
 
Scheme 4.4 
The chlorine at the C2 position seemed to have a double function: acting as a blocking agent 
for the cyclisation as well as being a masked oxindole for the purpose of the synthesis.
5
 
Preparation of advanced intermediate 303a and its chlorinated analogue 303b was achieved 
using a previously reported strategy. Attempts to form the bicyclo[4.3.1]ring system proved 
unsuccessful in the presence of a proton in the C2 position of the indolic ring. However, a 
combination of steric clash and an electronic deactivation induced by the presence of a 
chlorine atom in the C2 position of the indole, gave access to the desired scaffold 305. Finally, 
acid hydrolysis of chlorinated tetracycle 234 produced oxindole 306, which could be further 
manipulated towards total syntheses of the welwitindolinones (Scheme 4.5).  
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Scheme 4.5 
 
In a separate communication, Rawal described the synthesis of an analogue of 
N-methylwelwitindolinone B isothiocyanate 3.
6
 Key chlorine intermediate 309 was obtained 
via a three-step sequence from silyl ether 298, built following the route previously described. 
After desilylation, hydrogenation of alkene C20-C21 was required to avoid side reactions 
during the chlorination of the C13 position. Preparation of the oxindole and introduction of the 
isothiocyanate functionality at the bridgehead position completed the synthesis of 
20,21-dihydro-N-methylwelwitindolinone B isothiocyanate 311 (Scheme 4.6). 
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Scheme 4.6 
 
In 2011, Garg and co-workers published the first total synthesis of 
(-)-N-methylwelwitindolinone C isothiocyanate 7.
2
 The sequence began with the 
iodine-mediated addition of 5-bromo-N-methylindole (133) to highly substituted enone 312 
(obtained in 5 steps from commercially available (S)-carvone). After silylation of alcohol 313, 
an indolyne cyclisation was carried out in the presence of sodium amide and tert-butanol 
using the procedure previously established by Garg’s group.7 The tetracyclic framework 314 
was obtained along with the product of O-arylation 315 in a 2.5:1 ratio (Scheme 4.7). 
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Scheme 4.7 
 
Silyl alcohol 314 was converted into the corresponding ketone 316 in high yield. The vinyl 
chloride functionality at the C13 position was introduced via a three-step sequence consisting 
of the preparation of an enol triflate followed by a Pd-catalysed stannylation to afford 
stannane 317 which was chlorinated using CuCl2 in refluxing dioxane. Treatment of indole 
318 with NBS followed by acid hydrolysis afforded oxindole 319 in high yield (Scheme 4.8). 
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Scheme 4.8 
 
After reduction of the ketone at the C10 position, the corresponding bridged alcohol was 
protected as a carbamate. Formation of oxazolidinone 321a was achieved by cyclisation of the 
nitrene intermediate obtained by treatment with bathophenanthroline and 
diacetoxyiodobenzene in the presence of a silver catalyst. A two-step sequence involving a 
barium-promoted hydrolysis and an IBX oxidation gave bridgehead amine 322 that was 
converted into welwistatin 7 by addition of di-(2-pyridyl)thionocarbonate in the presence of 
DMAP (Scheme 4.9). Garg completed the total synthesis of welwistatin 7 in 17 linear steps 
from the starting carvone in 0.8% overall yield. 
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Scheme 4.9 
 
In early 2012, Rawal disclosed the total syntheses of welwistatin 7, 
N-methylwelwitindolinone C isonitrile 6 and 3-hydroxy-N-methylwelwitindolinone C 
isothiocyanate 17.
3
 His strategy took inspiration from his previous work towards 
N-methylwelwitindolinone D isonitrile 18, as he presented a synthesis starting from advanced 
aldehyde 323.
1
 After reduction of the bridgehead aldehyde, diketone 324 was regioselectively 
converted to hydrazone 325. Subsequent treatment with NCS in the presence of pyridine 
afforded vinyl chloride 326 in 61% yield over two steps. The oxidation of indole 326 into the 
corresponding oxindole 327 was achieved using the mild oxidant MMPP in the presence of 
acid. At this stage, preparation of the isothiocyanate bridgehead functionality was completed 
via a three-step sequence. After oxidation of alcohol 327, treatment with hydroxylamine 
afforded the corresponding oxime and this was converted into welwistatin 7 (Scheme 4.10). 
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Scheme 4.10 
 
With welwistatin 7 in hand, Rawal turned his attention towards the total synthesis of its 
isonitrile analogue 6 and its oxidised form 17. Isonitrile 6 was obtained by desulfurisation of 
welwistatin 7 under the action of Mukaiyama’s oxazaphospholidine 328. The reaction of 
welwistatin 7 with LHDMS in the presence of Davis’ oxaziridine 329 resulted in 
welwitindolinone 17 in 67% yield (Scheme 4.11). 
 
Scheme 4.11 
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Soon after, Garg and colleagues published an improved synthesis of welwistatin 7 as well as 
the total syntheses of welwitindolinones 6, 16 and 17.
4
 Garg showed that the deuterium at the 
position C10 on 320b, introduced during the reduction of the bridged ketone by a deuterated 
borane, had a dramatic effect on the sequence. Avoiding some side reactions such as the 
addition of the nitrene at the position C10 instead of C11, 319 was converted in the 
corresponding bridgehead amine 322 in 40% yield over 5 steps (compared to 13% yield for its 
analogue 320a) (Scheme 4.12).
2,4
 
 
Scheme 4.12 
 
Garg also reported the first total synthesis of N-methylwelwitindolinone C isonitrile 6 from 
amine 322 via a two-step sequence consisting of a formylation reaction followed by 
dehydration (Scheme 4.13).
4
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Scheme 4.13 
 
Finally, Garg reported access to two of the oxidised welwitindolinones. Natural products 6 
and 7 were subjected to a direct oxidation to yield oxidised welwitindolinones 16 and 17, 
respectively. While 16 was achieved by exposure of 6 to sodium hydride in air, treatment of 7 
with LHMDS in THF in air was required to access welwitindolinone 17 (Scheme 4.14).
4
 
 
Scheme 4.14 
 
In 2012, Martin and co-workers reported a formal synthesis of the welwitindolinones 6, 7 and 
the oxidised members of the family 16, 17 and 18, based on a late-stage Pd-catalysed allylic 
alkylation to access the tetracyclic framework.
8
 A Lewis acid-mediated coupling between 
tertiary alcohol 296 and silyl enol ether 329 was achieved in the presence of TMSOTf. A 
Pd-catalysed enolate arylation was then performed on ketoester 330 to install the 
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seven-membered ring system. The furan ring of tricycle 331 was converted to the 
substituted-unsaturated enone in 332, which is a precursor for the formation of the last 
ring (Scheme 4.15).  
 
Scheme 4.15 
 
The last ring of the welwitindolinone skeleton was obtained by treatment of precursor 332 
with Pd2dba3, P(2-furyl)3 and Bu3SnOMe in toluene at 100 °C, in 84% yield. A regioselective 
enolate reaction on ketone 333 was realised by reaction with NaHMDS at -40 °C prior to 
methylation at the C12 position. Ester 334 was then converted into the corresponding aldehyde 
323, a formal intermediate in Rawal’s syntheses of three members of the welwitindolinone 
family (welwitindolinones 6, 7 and 17) (Scheme 4.16). 
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Scheme 4.16 
 
More than 17 years after its isolation, N-methylwelwitindolinone C isothiocyanate 7 has been 
successfully synthesised by the research groups of Garg and Rawal and a formal synthesis 
was reported by the group of Martin. The total syntheses of other members of the family have 
also been published.  
 
 
4.2 FUTURE SYNTHETIC STUDIES 
At this stage, the methylation at position C12 seemed compromised. However, an alternative 
approach based on the conditions developed by Martin for the formal syntheses of some 
welwitindolinone members could be envisaged. In the first instance, we would perform this 
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reaction on enones 227 or 335 to study the influence of a nitrogen motif at the bridgehead 
position (Scheme 4.17) 
 
Scheme 4.17 
 
We could also consider the insertion of a carbon fragment at the bridgehead position, which 
could be introduced via a Michael addition on unusual enone 214. A cyanide partner could be 
taken into consideration. The regioselective aldol reaction could afford aldol 339, which after 
dehydration would give access to 341, the precursor of the methylation reaction. Enone 341 
could be treated under Martin’s conditions to give the desired quaternary carbon at the C12 
position. A reduction of the nitrile into the corresponding ester could also be envisaged at any 
stage of this synthetic route to give access to a formal synthesis of welwitindolinone with 
regards to Martin’s work (Scheme 4.18). 
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Scheme 4.18 
 
Finally, we would examine how the biological properties (particularly the MDR-reversing 
activity) could be attributed to the features present in welwistatin 7. Investigations could be 
carried out on analogues obtained at different stages of our synthetic route. The influence of 
some functionalities, such as the isothiocyanate, the oxindole, the vinyl chloride, the 
gem-dimethyl at the C16 position or the quaternary centre at position C12, could all be 
evaluated. In this way, a structure-activity relationship of the welwitindolinone family will be 
developed. 
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CHAPTER FIVE 
EXPERIMENTAL PROCEDURES 
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5.1 GENERAL METHODS 
All reactions were carried out under an atmosphere of nitrogen in dry glassware unless 
otherwise stated. All solvents were dried prior to use. Tetrahydrofuran was either distilled 
from sodium/benzophenone or used from a solvent purification system (alumina columns), 
Pure Solv-MD Solvent, from Innovative Technology. Dichloromethane, diethyl ether, 
methanol and toluene were used from a solvent purification system, Pure Solv-MD Solvent 
(alumina columns), from Innovative Technology, unless otherwise stated. All other reagents 
were used as received from commercial suppliers unless otherwise indicated. All aqueous 
solutions of NH4Cl, NaHCO3 and NaCl were saturated unless otherwise indicated. Reaction 
temperatures refer to the temperature measured in an external bath unless otherwise indicated. 
All 
1
H NMR and 
13
C NMR experiments were recorded on a Bruker AC300, AVIII300, 
AVIII400, AV400 or DRX500 spectrometer at 300 K. 
13
C NMR spectra were recorded using 
the PENDANT pulse sequence and using UDEFT pulse sequence from the Bruker standard 
pulse program library. For NMR experiments recorded in deuterated chloroform, the 
resonances of the residual solvent peaks at 7.27 ppm for the 
1
H spectra and 77.0 ppm for the 
13
C spectra were used as internal references. For NMR experiments recorded in deuterated 
methanol, the resonances of the residual solvent peaks at 3.34 ppm for the 
1
H spectra and 
49.9 ppm for the 
13
C spectra were used as internal references. Chemical shifts () are 
measured in ppm and coupling constants (J) are quoted in Hz to one decimal place. Spectral 
data for 
1
H NMR spectra are reported as follows: chemical shift (multiplicity, number of 
protons, coupling constants, assignment); for 
13
C NMR spectra: chemical shift (assignment). 
In reporting spectral data, the following abbreviations are used for multiplicity in 
1
H NMR 
spectra: s (singlet), d (doublet), dd (doublet of doublets), dt (doublet of triplets), ddd (doublet 
of doublet of doublets), t (triplet), m (multiplet), br (broad), app (apparent). In the case of 
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ambiguous assignments, 2-dimensional homonuclear (
1
H-
1
H) and heteronuclear (
1
H-
13
C) 
NMR experiments were recorded. 
Reactions were monitored by thin layer chromatography (TLC) using aluminium-backed 
plates coated with keiselgel F254 with 0.2 mm thickness. Visualisation was achieved first by 
UV light followed by either p-anisaldehyde or potassium permanganate unless otherwise 
stated. Column chromatography was carried out using Davisil 60 Å silica gel in the eluent 
systems indicated. Melting points were recorded using a Gallenkamp melting point apparatus 
and are uncorrected. Infrared spectra were recorded neat on a PerkinElmer Spectrum 100 
FTIR spectrometer. Wavelengths () are reported in cm-1. In reporting spectral data, the 
following abbreviations are used: s (strong), m (medium), w (weak), br (broad). EI mass 
spectra were recorded on a VG ZabSpec magnetic sector mass spectrometer. ESI mass spectra 
were recorded on a Micromass LCT time of flight mass spectrometer. GC mass spectra were 
recorded on a Micromass GCT Premier using a ZB5MS column from Phenomenix. 
 
5.2 NOMENCLATURE 
The numbering of the isolation paper of welwistatin published by Moore and co-workers in 
1994 was used for our spectral data assignments (Figure 5.1). 
 
Figure 5.1 
161 
 
5.3 EXPERIMENTAL PROCEDURES 
4-Bromoindole (71)
1
 
 
To a solution of 2-methyl-3-amino-nitrobenzene (344) (38.87 g, 225 mmol) in H2O (325 mL) 
heated at reflux was added dropwise via a dropping funnel over 15 min HBr (48% in H2O, 
130 mL, 239 mmol). The solution was heated at reflux for 20 min, then cooled to 0 °C before 
slow addition over 45 min of a solution of NaNO2 (17.56 g, 225 mmol) in H2O (90 mL), so as 
to maintain the temperature below 5 °C. After complete addition, the solution of the 
diazo-intermediate was stirred for 15 min at 0 °C and quickly transferred to a solution of 
CuBr (42.03 g, 293 mmol) in H2O (225 mL) at room temperature. The generated red foamy 
solution was heated to 100 °C for 20 min. The resulting red suspension was allowed to cool to 
room temperature before pouring onto water (350 mL). Et2O (300 mL) was added to the 
suspension and the phases were separated. The aqueous phase was extracted with Et2O 
(2 × 300 mL). The combined green-coloured organic layers were washed with NH4OH (3 M 
in H2O, 500 mL), dried over MgSO4 and concentrated under reduced pressure. The resulting 
crude orange solid (52.81 g) was carried on to the next step without further purification.  
To a solution of bromo-nitrobenzene 345 (52.81 g, 245 mmol) in DMA (300 mL) was added 
N,N-dimethylformamide dimethyl acetal (102.57 mL, 733 mmol) followed by pyrrolidine 
(20.4 mL, 245 mmol). The resulting black solution was heated at 110 °C for 5 h. The solution 
was allowed to cool to room temperature, poured onto water (300 mL) and the phases were 
separated. The aqueous phase was extracted with Et2O (5 × 300 mL). The combined organic 
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layers were washed with water (500 mL), dried over MgSO4 and concentrated under reduced 
pressure. The resulting thick red solution (70.45 g) was used without further purification. 
Zn granules (153 g, 2.34 mol) were added to the solution of crude enamine 346 (70.45 g, 
260 mmol) in AcOH (80% aq, 1.17 L) preheated to 75 °C. The suspension was then heated at 
85 °C for 3 h. After cooling to room temperature, the resulting orange suspension was poured 
onto water (500 mL). Et2O (300 mL) was added to the suspension and the phases were 
separated. The aqueous phase was extracted with Et2O (2 × 300 mL). The combined organic 
layers were carefully washed with a solution of NaHCO3 (5 × 200 mL), dried over MgSO4 
and concentrated under reduced pressure. The crude product was purified by flash column 
chromatography (using a gradient of petroleum ether/CH2Cl2 (8/2 to 5/5) as eluent) to afford 
indole 71 (32.85 g, 75%) as a light blue oil; 
1
H NMR (300 MHz, CDCl3) 8.26 (br s, 1H, 
HN-H), 7.33 (d, 1H, J 7.8, H5), 7.29 (d, 1H, J 7.8, H7), 7.23-7.25 (m, 1H, H2), 7.05 (app t, 1H, 
J 7.8, H6), 6.61-6.65 (m, 1H, H3); 
13
C NMR (100 MHz, CDCl3)  135.9 (C, C8), 128.5 (C, C4), 
124.8 (CHAr, C2), 122.9 (CHAr, C6), 122.7 (CHAr, C5), 114.6 (C, C9), 110.3 (CHAr, C7), 102.8 
(CHAr, C3); IR max (film)/cm
-1
: 3419 (s, br), 1564 (m), 1429 (m), 1413 (m), 1333 (s), 1178 
(s), 890 (m), 745 (s); HRMS (EI) m/z 194.9682 [M]
+
, [C8H6N
79
Br]
+
 requires 194.9684. Data 
were in agreement with those reported in the literature.  
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4-Bromo-N-methylindole (85)
2
 
 
A solution of 4-bromoindole (71) (0.65 mL, 5.15 mmol) in THF (4 mL) was added dropwise 
over 15 min via cannula to a solution of sodium hydride (308 mg of a 60% dispersion in 
mineral oil, 7.7 mmol) in THF (5 mL) pre-cooled to 0 °C. After 30 min of vigorous agitation, 
iodomethane (0.64 mL, 10.3 mmol) was added at 0 °C. After removal of the ice-bath, the 
reaction mixture was allowed to warm to room temperature and stirred for 13 h. After total 
consumption of the starting material, a 1:1 mixture of MeOH/H2O (10 mL) was added and the 
layers were separated. The aqueous phase was extracted with Et2O (3 × 10 mL). The 
combined organic layers were washed with brine (30 mL) then dried over Na2SO4 and 
concentrated under reduced pressure. The crude product was purified by flash column 
chromatography (petroleum ether/EtOAc, 9/1) to afford methylated indole 85 (1.045 g, 97%) 
as a yellow oil; 
1
H NMR (400 MHz, CDCl3)  7.34 (dd, 1H, J 7.6, 0.6, H5), 7.28 (ddd, 1H, 
J 8.0, 0.8, 0.6, H7), 7.12 (dd, 1H, J 8.0, 7.6, H6), 7.10 (d, 1H, J 3.2, H2), 6.58 (dd, 1H, J 3.2, 
0.8, H3), 3.89 (s, 3H, HNCH3); 
13
C NMR (100 MHz, CDCl3)  136.9 (C, C8), 129.3 (CHAr, C2), 
129.1 (C, C4), 122.3 (CHAr, C5), 122.1 (CHAr, C6), 114.7 (C, C9), 108.4 (CHAr, C7), 101.2 
(CHAr, C3), 33.1 (CH3, CNMe); IR max (film)/cm
-1
: 2941 (w), 1558 (m), 1512 (m), 1480 (m), 
1445 (m), 1414 (m), 1333 (s), 1287 (s), 1192 (m), 1109 (s), 889 (s), 824 (w), 740 (s), 710 (m); 
HRMS (EI) m/z 208.9850 [M+Na]
+
, [C9H8N
79
BrNa]
+
 requires 208.9840. Data were in 
agreement with those reported in the literature. 
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3-Acetyl-4-bromoindole (243)
3
 
 
Acetyl chloride (1.45 mL, 20.5 mmol) was added to a solution of 4-bromoindole (71) (2.0 g, 
10.3 mmol) in toluene (100 mL) pre-cooled to 0 °C. After stirring the pale yellow solution for 
15 min at 0 °C, a solution of tin(IV) chloride (2.4 mL, 20.5 mmol) in toluene (45 mL) was 
added via cannula. A pink precipitate formed and the suspension was stirred for 2 h at 0 °C. 
The reaction mixture was quenched with a solution of NaHCO3 (150 mL). The resultant slurry 
was extracted with EtOAc (3 × 100 mL). The combined organic layers were dried over 
MgSO4 and filtered. The solvent was removed under reduced pressure, and the crude residue 
was recrystallised from acetone to afford ketone 243 (2.21 g, 90%) as a pale pink powder; 
mp 165-166 °C, [lit.,
3
 mp 167-168 °C]; 
1
H NMR (300 MHz, CD3OD)  8.19 (s, 1H, H2), 
7.43-7.47 (m, 2H, H5 and 7), 7.11 (app t, 1H, J 9.0, H6), 2.57 (s, 3H, H11), HNH was not 
observed; 
13
C NMR (75 MHz, CD3OD)  195.6 (C, C10), 140.4 (C, C8), 136.0 (CHAr, C2), 
128.4 (CHAr, C5), 125.9 (C, C4), 125.2 (CHAr, C6), 119.5 (C, C3), 115.4 (C, C9), 112.4  (CHAr, 
C7), 29.5 (CH3, C11); IR max (film)/cm
-1
: 3236 (m, br), 1642 (s), 1561 (w), 1509 (w), 1400 (s), 
1365 (m), 1334 (m), 1303 (m), 1017 (w), 939 (m), 911 (m), 784 (s), 746 (s); HRMS (ESI) m/z 
259.9692 [M + Na]
+
, [C10H8NO
79
BrNa]
+
 requires 259.9687. Data were in agreement with 
those reported in the literature. 
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3-Acetyl-4-bromo-N-methylindole (347)
4
 
 
A solution of indole 243 (500 mg, 2.1 mmol) in THF (4 mL) was added dropwise over 5 min 
via cannula to a solution of sodium hydride (126 mg of a 60% dispersion in mineral oil, 
3.2 mmol) in THF (3 mL) pre-cooled to 0 °C. After 30 min of vigorous agitation, 
iodomethane (260 µL, 4.2 mmol) was added at 0 °C. After removal of the ice-bath, the 
reaction mixture was allowed to warm to room temperature. After total consumption of the 
starting material, a 1:1 mixture of MeOH/H2O (10 mL) was added dropwise over 10 min and 
the layers were separated. The aqueous phase was extracted with Et2O (3 × 10 mL). The 
combined organic layers were washed with brine (30 mL), dried over MgSO4 and 
concentrated under reduced pressure. The crude product was purified by flash column 
chromatography (using a gradient of petroleum ether/EtOAc (85/15 to 50/50) as eluent) to 
afford methylated indole 347 (280 mg, 53%) as a colourless powder; 
1
H NMR (400 MHz, 
CDCl3) 7.57 (s, 1H, H2), 7.42 (dd, 1H, J 7.6, 0.7, H5), 7.18 (dd, 1H, J 8.0, 0.7, H7), 7.06 (dd, 
1H, J 8.0, 7.6, H6), 3.72 (s, 3H, HNCH3), 2.48 (s, 3H, H11); 
13
C NMR (100 MHz, CDCl3) 
191.8 (C, C10), 138.9 (C, C8), 136.3 (CHAr, C2), 127.3 (CHAr, C5), 124.9 (C, C4), 123.8 
(CHAr, C6), 117.7 (C, C3), 114.6 (C, C9), 108.8 (CHAr, C7), 33.5 (CH3, C NMe), 29.7 (CH3, C11); 
IR max (film)/cm
-1
: 3108 (w), 2969 (w, br), 2923 (w, br), 1655 (s), 1556 (m), 1525 (m), 1425 
(m), 1365 (m), 1325 (m), 1227 (m), 1109 (s), 1001 (m), 923 (m), 774 (m), 733 (s), 639 (m);
 
HRMS (ESI) m/z 273.9844 [M + Na]
+
, [C11H10
79
BrNNaO]
+
 requires 273.9843. Data were in 
agreement with those reported in the literature. 
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2-(1’-Methyl-1H-indol-4’-yl)cyclohexanone (86)5 
 
An oven-dried flask was charged with Pd2(dba)3.CHCl3 (58.4 mg, 0.06 mmol), 
(S)-Tol-BINAP (189) (91.9 mg, 0.14 mmol) and sodium tert-butoxide (470 mg, 4.89 mmol), 
and finally purged with nitrogen to remove any trace of oxygen. Dry THF (11 mL) was added 
and the reaction mixture turned a reddish brown colour. Cyclohexanone (1.56 mL, 15 mmol) 
was added and the solution turned dark red. A solution of 4-bromo-N-methylindole (85) 
(700 mg, 3.33 mmol) in THF (5 mL) was added. The reaction mixture was heated at 70 °C for 
3 h, by which time it turned black in colour and total consumption of the starting material was 
observed by TLC. The reaction was allowed to cool to room temperature, diluted with Et2O 
(20 mL) and the phases were separated. The aqueous phase was extracted with Et2O 
(2 × 20 mL). The combined organic layers were washed with water (2 × 20 mL), dried over 
MgSO4 and concentrated under reduced pressure. The crude product was purified by flash 
column chromatography (using a gradient of petroleum ether/ethyl acetate (80/20 to 70/30) as 
eluent) to afford cyclohexanone 86 as a yellow solid (681 mg, 90%); mp 122-123 °C [lit.,
5
 
mp 124-125 °C]; 
1
H NMR (400 MHz, CDCl3) δ 7.22-7.29 (m, 2H, H6 and 7), 7.05 (d, 1H, J 3.1, 
H2), 6.97 (dd, 1H, J 6.2, 1.7, H5), 6.34 (dd, 1H, J 3.1, 0.4, H3), 4.00 (dd, 1H, J 11.6, 6.3, H11), 
3.78 (s, 3H, HNMe), 2.50-2.66 (m, 2H, H15), 2.28-2.40 (m, 2H, H12), 2.15-2.25 (m, 1H, H14), 
2.04-2.11 (m, 1H, H14), 1.86-1.99 (m, 2H, H13); 
13
C NMR (100 MHz, CDCl3) δ 209.9 (C, 
C10), 136.6 (C, C8), 131.3 (C, C4), 128.4 (CHAr, C2), 127.6 (C, C9), 121.5 (CHAr, C6), 118.3 
(CHAr, C5), 108.2 (CHAr, C7), 99.3 (CHAr, C3), 55.2 (CH, C11), 42.3 (CH2, C15), 34.1 (CH2, 
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C12), 30.8 (CH3, CNMe), 27.7 (CH2, C14), 25.5 (CH2, C13); IR max (film)/cm
-1
: 3670 (w, br), 
2923 (m, br), 2870 (m), 1711 (s), 1497 (m), 1438 (m), 1299 (m), 1129 (m), 1065 (s), 751 (s), 
710 (s); HRMS (EI) m/z 227.1316 [M]
+
, [C15H17NO]
+
 requires 227.1310. Data were in 
agreement with those reported in the literature. 
 
 
1-Methyl-4-(2’-oxycyclohexyl)-1H-indol-3-carbaldehyde (87)5 
 
The reaction was carried out in 7 identical reaction tubes using a carousel. To each vessel, 
phosphorus oxychloride (180 µL, 1.94 mmol) was added dropwise over 1 min to DMF 
(3.2 mL) pre-cooled to 0 °C. The mixture was stirred at this temperature for 30 min and a 
solution of cyclohexanone 86 (400 mg, 1.76 mmol) in DMF (3.2 mL) was added at 0 °C. The 
ice bath was removed and the resulting pale orange solution was stirred for 1 h at room 
temperature. Ice (2.0 g) was added to the reaction mixture to give a yellowish colour to the 
mixture. A solution of potassium hydroxide (990 mg, 17.6 mmol) in water (8 mL) was 
carrefully added. A yellow precipitate was formed. After 3 h, the reaction mixture showed 
total consumption of starting material by TLC. The 7 carousel fractions were collected 
together and the solvent was evaporated under reduced pressure. The excess of DMF was 
removed overnight using a high-vacuum pump and a trap cooled with liquid nitrogen. The 
residue was diluted with Et2O (200 mL) and water (200 mL) and the phases were separated. 
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The aqueous phase was extracted with Et2O (3 × 200 mL). The combined organic layers were 
washed with a solution of NaHCO3 (200 mL), brine (200 mL), dried over MgSO4 and 
concentrated under reduced pressure. The crude material was purified by flash column 
chromatography (using a gradient of petroleum ether/ethyl acetate (40/60 to 20/80) as eluent) 
to afford aldehyde 87 (1.35 g, 43%) as a pale yellow solid; mp 139-141 °C [lit.,
5
 mp 
139-140 °C]; 
1
H NMR (400 MHz, CDCl3) δ 9.67 (s, 1H, H16), 7.67 (s, 1H, H2), 7.42 (app t, 
1H, J 7.7, H6), 7.27-7.30 (m, 1H, H7), 7.20 (d, 1H, J 7.7, H5), 5.41 (br d, 1H, J 7.7, H11), 3.81 
(s, 3H, HNMe), 2.92-3.08 (m, 1H), 2.56 (m, 1H), 2.37-2.50 (m, 1H), 2.24-2.35 (m, 1H), 
2.13-2.23 (m, 1H), 1.97-2.08 (m, 2H), 1.80-1.95 (m, 1H); 
13
C NMR (100 MHz, CDCl3) 
δ 207.7 (C, C10), 183.1 (CH, C16), 143.9 (CHAr, C2), 139.0 (C, C8), 134.6 (C, C4), 125.0 
(C, C9), 124.2 (CHAr, C5), 121.5 (CHAr, C6), 119.2 (C, C3), 108.6 (CHAr, C7), 57.9 (CH, C11), 
42.2 (CH2, C15), 33.8 (CH2, C12), 33.7 (CH3, CNMe), 28.1 (CH2, C14), 25.8 (CH2, C13); IR max 
(film)/cm
-1
: 2935 (w, br), 2723 (w), 1703 (s), 1652 (s), 1579 (w), 1534 (m), 1468 (m), 1449 
(m), 1406 (m), 1373 (m), 1353 (m), 1198 (m), 1077 (m), 879 (m), 776 (m), 742 (s); HRMS 
(ESI) m/z 278.1154 [M+Na]
+
, [C16H17NO2Na]
+
 requires 278.1157. Data were in agreement 
with those reported in the literature. 
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Preparation of bridging ketone 88
5
 
 
A solution of 0.53 M of pTsOH was prepared by adding pTsOH (5.01 g, 26.34 mmol) to THF 
(50 mL). The solution was dried for 2 h over 3 Å molecular sieves. To a solution of aldehyde 
87 (1.15 g, 4.50 mmol) in THF (69 mL) was added the freshly prepared solution of pTsOH 
(9.00 mL, 4.73 mmol) and triethylsilane (0.90 mL, 5.40 mmol). The resulting solution was 
heated at 50 °C for 22 h. The reaction mixture was cooled to room temperature. Further 
portions of freshly prepared solution of pTsOH (9.00 mL, 4.73 mmol) and triethylsilane 
(0.90 mL, 5.40 mmol) were added at room temperature and the reaction mixture was again 
heated at 50 °C. This process was repeated every 24 h until the starting material was fully 
consumed. After 50 h, the reaction was allowed to cool to room temperature. The reaction 
was quenched using a solution of NaHCO3 (70 mL) and diluted with Et2O (100 mL). The 
phases were separated and the aqueous layer was extracted with Et2O (5 × 100 mL). The 
combined organic layers were washed with brine (2 × 100 mL), dried over MgSO4 and 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography (using a gradient of petroleum ether/ethyl acetate (80/20 to 70/30) as eluent) 
to afford tetracyclic  88 (890 mg, 83%) as a colourless solid; mp 113-114 °C, [lit.,
5
 
mp 114-115 °C]; 
1
H NMR (300 MHz, CDCl3) δ 7.17-7.27 (m, 2H, H6 and 7), 6.92 (s, 1H, H2), 
6.89 (dd, 1H, J 6.1, 1.5, H5), 4.11-4.13 (m, 1H, H11), 3.73 (s, 3H, HNMe), 3.01-3.17 (m, 3H, 
H15, 2 × H16), 2.09-2.26 (m, 2H, 1 × H12, 1 × H14), 1.96-2.08 (m, 2H, 1 × H12, 1 × H14), 
1.42-1.58 (m, 1H, H13), 1.27-1.39 (m, 1H, H13); 
13
C NMR (100 MHz, CDCl3) δ 215.3 (C, 
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C10), 136.8 (C, C8), 132.6 (C, C4), 127.1 (C, C9), 126.6 (CHAr, C2), 121.8 (CHAr, C6), 118.1 
(CHAr, C5), 111.9 (C, C3), 107.3 (CHAr, C7), 58.1 (CH, C11), 47.8 (CH, C15), 37.3 (CH2, C12), 
32.8 (CH2, C14), 32.6 (CH3, CNMe), 30.2 (CH2, C16), 18.3 (CH2, C13); IR max (film)/cm
-1
: 2917 
(m), 2912 (m), 2867 (w), 1694 (s), 1607 (w), 1544 (w), 1446 (m), 1323 (m), 1302 (w), 1246 
(w), 1105 (w), 779 (m), 739 (s); HRMS (ESI) m/z 262.1210 [M+Na]
+
, [C16H17NONa]
+
 
requires 262.1208. Data were in agreement with those reported in the literature. 
 
 
Preparation of bridged alcohol 199 
 
The material was divided in 2 equal parts that were combined for the work-up. 
Preparation of the solution of LTMP (0.48 M): 
A solution of nBuLi (1.6 M in hexanes, 5.8 mL, 3.63 mmol) was added to a solution of 
2,2,6,6-tetramethylpiperidine (782 µL, 655 mg, 2.38 mmol) in THF (5 mL) pre-cooled to 
-78 °C. The solution was left for 5 min at -78 °C, then warmed up to room temperature for 
20 min and cooled to -78 °C prior to its transfer to the solution of the substrate. The LTMP 
solution was charged with an excess of nBuLi. 
To each round bottom flask: To a solution of the tetracyclic core 88 (466 mg, 1.95 mmol) in 
THF (52 mL), pre-cooled to -10 °C, was added the freshly prepared solution of LTMP, 
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pre-cooled to -78 °C. The resulting orange mixture was stirred for 10 min at -10 °C and a 
solution of freshly distilled TMSCl (2.48 mL, 19.5 mmol) was added to the mixture. The light 
orange solution was stirred for an additional 40 min until the TLC showed full consumption 
of starting material. The mixture was then quenched with a solution of NH4Cl (30 mL) and 
the reaction mixtures were allowed to warm to room temperature. 
The two flasks were combined and Et2O (20 mL) was added. The phases were separated and 
the aqueous layer was extracted with Et2O (2 × 20 mL). The combined organic layers were 
dried over MgSO4 and concentrated under reduced pressure. The yellow oil crude product 
was purified by flash column chromatography (petroleum ether/ethyl acetate, 8/2) to afford 
silylated bridged ketone 114 (480 mg, 37%, data page 173) along with alcohol 199 (438.9 mg, 
38%) as a white foam; Data for alcohol 199: 
1
H NMR (400 MHz, CDCl3) δ 7.22 (dd, 1H, 
J 8.2, 6.4, H6), 7.20 (dd, 1H, J 8.2, 1.7, H7), 6.96 (dd, 1H, J 6.4, 1.7, H5), 6.89 (s, 1H, H2), 
3.76 (s, 3H, HNMe), 3.43-3.49 (m, 2H, H11, 1 × H16), 2.95 (dd, 1H, J 16.8, 2.3, 1 × H16), 2.35 
(app t, 1H, J 5.4, H15), 1.98-2.07 (m, 3H, 1 × H14, 1 × H17, 1 × H18), 1.81-1.95 (m, 2H, 
1 × H14, 1 × H18), 1.55-1.66 (m, 3H, H12, 1 × H17), 1.41-1.50 (m, 2H, H19), 1.17-1.29 (m, 2H, 
H13), 1.04 (t, 3H, J 7.2, H20), HOH was not observed; 
13
C NMR (100 MHz, CDCl3) δ 136.8 (C, 
C8), 135.6 (C, C4), 127.8 (C, C9), 126.0 (CHAr, C2), 121.9 (CHAr, C6), 120.5 (CHAr, C5), 114.1 
(C, C3), 106.9 (CHAr, C7), 75.4 (C, C10), 51.6 (CH, C11), 40.5 (CH, C15), 40.3 (CH2, C14), 34.4 
(CH2, C17), 32.5 (CH3, CNMe), 31.6 (CH2, C18), 28.7 (CH2, C16), 25.6 (CH2, C12), 23.4 (CH2, 
C19), 18.7 (CH2, C13), 14.2 (CH3, C20); IR max (film)/cm
-1
: 3578 (w, br), 2924 (s, br), 2864 (s, 
br), 1457 (s), 1418 (m), 1311 (s), 1265 (m), 1149 (m), 1079 (m), 1043 (m), 903 (m), 771 (s), 
739 (s); HRMS (ESI) m/z 320.1987 [M+Na]
+
, [C20H27NONa]
+
 requires 320.1990. 
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Preparation of bridgehead alcohol 200 
 
The material was divided in 2 equal parts that were combined for the work-up. 
Preparation of the solution of LTMP (0.48 M): 
A solution of nBuLi (1.6 M in hexanes, 4.34 mL, 6.94 mmol) was added to a solution of 
2,2,6,6-tetramethylpiperidine (586 µL, 490 mg, 3.47 mmol) in THF (3.75 mL) pre-cooled to 
-78 °C. The solution was left for 5 min at -78 °C, then warmed up to room temperature for 
20 min and cooled to -78 °C prior to its transfer to the solution of the substrate. The LTMP 
solution was charged with an excess of nBuLi. 
To each round bottom flask: To a solution of the silylated bridged ketone 114 (240 mg, 
0.77 mmol) in THF (17 mL), pre-cooled to -10 °C, was added the freshly prepared solution of 
LTMP, pre-cooled to -78 °C. The resulting orange mixture was stirred for 10 min at -10 °C 
and a solution of PhSeSePh (1.08 g, 4.5 mmol) in THF (5 mL) was added to the mixture. The 
dark orange solution was stirred for an additional 40 min until the TLC showed full 
consumption of starting material. The mixture was then quenched with a solution of NH4Cl 
(30 mL) and the reaction mixtures were allowed to warm to room temperature. 
The two flasks were combined and Et2O (20 mL) was added. The phases were separated and 
the aqueous layer was extracted with Et2O (2 × 20 mL). The combined organic layers were 
dried over MgSO4 and concentrated under reduced pressure. The yellow oil crude product 
was purified by flash column chromatography (petroleum ether/ethyl acetate, 8/2) to afford 
173 
 
selenide 125 (150 mg, 20%, data page 175) along with bridgehead alcohol 200 (340 mg, 60%) 
as a white foam; Data for alcohol 200: 
1
H NMR (400 MHz, CDCl3) δ 7.21 (dd, 1H, J 8.2, 6.6, 
H6), 7.17 (dd, 1H, J 8.2, 1.3, H7), 6.93 (dd, 1H, J 6.6, 1.3, H5), 6.89 (s, 1H, H2), 3.76 (s, 3H, 
HNMe), 3.60 (dd, 1H, J 4.2, 3.0, H11), 3.43 (d, 1H, J 16.6, 1 × H16), 2.93 (d, 1H, J 16.6, 
1 × H16), 2.19-2.28 (m, 1H, 1 × H19), 1.90-2.01 (m, 2H, 1 × H12, 1 × H14), 1.61-1.82 (m, 4H, 
1 × H12, 1 × H14, 1 × H18, 1 × H19), 1.41-1.57 (m, 3H, 1 × H18, H20), 1.31-1.40 (m, 1H, 
1 × H13), 1.18-1.23 (m, 1H, 1 × H13), 1.04 (t, 3H, J 7.2, H21), -0.23 (s, 9H, H17), HOH was not 
observed; 
13
C NMR (100 MHz, CDCl3) δ 136.6 (C, C8), 135.9 (C, C4), 127.8 (C, C9), 126.0 
(CHAr, C2), 122.0 (CHAr, C6), 120.3 (CHAr, C5), 115.8 (C, C3), 106.7 (CHAr, C7), 78.6 (C, C10), 
49.2 (CH, C11), 40.2 (CH2, C19), 35.7 (C, C15), 34.7 (CH2, C14), 32.7 (CH2, C12), 32.5 (CH3, 
CNMe), 30.3 (CH2, C16), 26.1 (CH2, C18), 23.6 (CH2, C20), 19.1 (CH2, C13), 14.2 (CH3, C21), 
-0.05 (CH3, C17); IR max (film)/cm
-1
: 3522 (w, br), 2924 (m, br), 1459 (m), 1416 (m), 1319 
(m), 1249 (s), 838 (s), 759 (m), 735 (s); HRMS (ESI) m/z 392.2389 [M+Na]
+
, 
[C23H35NOSiNa]
+
 requires 392.2386. 
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Preparation of silyl ketone 114
6
 
 
Preparation of the solution of LTMP (0.46 M): 
To a solution of freshly distilled TMP (1.51 mL, 8.95 mmol) in THF (10 mL), pre-cooled to 
-78 °C, was added a solution of nBuLi (1.14 M in hexanes, 7.85 mL, 8.95 mmol). The 
solution was stirred for 5 min at -78 °C, then allowed to warm to room temperature for 
15 min, the solution becoming yellow in colour. The lithium amide base solution was then 
cooled to -78 °C prior to the transfer to the substrate.  
A solution of bridged ketone 88 (900 mg, 3.76 mmol) and freshly distilled TMSCl (4.77 mL, 
37.6 mmol) in THF (90 mL), pre-cooled to -78 °C, was slowly added via cannula into a 
LTMP solution at -78 °C over 20 min. The resulting solution was stirred at this temperature 
for 2.5 h. The reaction was quenched using a solution of NH4Cl (50 mL) at -78 °C. The 
reaction was allowed to warm to room temperature, the mixture was diluted with Et2O 
(75 mL) and the phases were separated. The aqueous layer was extracted with Et2O 
(3 × 100 mL). The combined organic layers were washed with brine (2 × 100 mL), dried over 
MgSO4 and concentrated under reduced pressure. The crude product was purified by flash 
column chromatography (using a gradient of petroleum ether/ethyl acetate (90/10 to 70/30) as 
eluent) to afford silyl 114 (668 mg, 57%, 70% BRSM) as a colourless solid; mp 110-111 °C, 
[lit.,
6
 mp 111-114 °C]; 
1
H NMR (400 MHz, CDCl3) δ 7.11-7.22 (m, 2H, H6 and 7), 6.86 (dd, 
1H, J 7.3, 0.8, H5), 6.85 (s, 1H, H2), 4.01 (t, 1H, J 3.3, H11), 3.67 (s, 3H, HNMe), 3.13 (d, 1H, 
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J 15.6, H16), 2.91 (d, 1H, J 15.6, H16), 2.04-2.13 (m, 1H, 1 × H12), 1.91-1.99 (m, 2H, 1 × H12, 
1 × H14), 1.81-1.87 (m, 1H, 1 × H14), 1.41-1.53 (m, 1H, 1 × H13), 1.28-1.36 (m, 1H, 1 × H13), 
0.16 (s, 9H, H17); 
13
C NMR (100 MHz, CDCl3) δ 217.9 (C, C10), 136.9 (C, C8), 133.3 (C, C4), 
127.3 (C, C9), 126.4 (CHAr, C2), 121.6 (CHAr, C6), 118.0 (CHAr, C5), 113.2 (C, C3), 107.2 
(CHAr, C7), 58.3 (CH, C11), 42.3 (C, C15), 35.7 (CH2, C12), 33.1 (CH2, C14), 32.9 (CH2, C16), 
32.5 (CH3, CNMe), 18.6 (CH2, C13), -2.8 (CH3, C17); IR max (film)/cm
-1
: 2917 (w, br), 2852 
(w), 1678 (m), 1455 (w), 1418 (w), 1320 (w), 1244 (m), 1224 (w), 968 (w), 915 (w), 832 (s), 
739 (s); HRMS (ESI) m/z 334.1605 [M+Na]
+
, [C19H25NOSiNa]
+
 requires 334.1603. Data 
were in agreement with those reported in the literature. 
 
 
Preparation of selenide 125
6
  
 
Method a: 
Preparation of the solution of LTMP (0.5 M): 
To a solution of freshly distilled TMP (1.27 mL, 7.5 mmol) in THF (8.1 mL), pre-cooled to 
-78 °C, was added a solution of nBuLi (1.14 M in hexanes, 5.98 mL, 6.8 mmol). The solution 
was stirred for 5 min at -78 °C, and then allowed to warm to room temperature for 15 min, the 
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solution became yellow in colour. The lithium amide base solution was then cooled to -78 °C 
prior to the transfer to the substrate. 
To a solution of silylated ketone 114 (150 mg, 0.48 mmol) in THF (6 mL), pre-cooled to 
-78 °C, was added the solution of freshly prepared LTMP (0.5 M in THF, 1.9 mL). The 
resultant mixture turned brown in colour and was stirred for 1 h at -78 °C before addition of a 
solution of diphenyldiselenide (451 mg, 1.44 mmol) in THF (3 mL) at -78 °C. The bright 
yellow mixture was stirred for 1 h at -78 °C and then for 1 h at 0 °C. The yellow solution was 
allowed to slowly warm to room temperature. After 2 h the reaction was quenched using a 
solution of NH4Cl (10 mL) at 0 °C. After returning to room temperature, the mixture was 
diluted with Et2O (10 mL) and the phases were separated. The aqueous layer was extracted 
with Et2O (3 × 10 mL). The combined organic layers were washed with brine (2 × 10 mL), 
dried over MgSO4 and concentrated under reduced pressure. The crude product was purified 
by flash column chromatography (petroleum ether/ethyl acetate, 9/1) to afford selenide 125 
(56.2 mg, 25%, 54% BRSM) as a pale yellow oil.  
 
Method b: 
Preparation of the solution of LTMP (0.4 M): 
To a solution of freshly distilled TMP (461 µL, 2.73 mmol) in THF (4.36 mL), pre-cooled to 
-78 °C, was added a solution of nBuLi (1.37 M in hexanes, 2.00 mL, 2.73 mmol). The 
solution was stirred for 5 min at -78 °C, then allowed to warm to room temperature for 
15 min, the solution became yellow in colour. The lithium amide base solution was then 
cooled to -78 °C prior to the transfer to the substrate. 
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To a solution of silylated ketone 114 (189.3 mg, 0.61 mmol) in THF (10 mL), pre-cooled to 
-10 °C, was added the solution of freshly prepared lithium amide base (0.4 M in THF, 
6.81 mL), pre-cooled to -10 °C. A solution of diphenyldiselenide (854 mg, 2.74 mmol) in 
THF (7 mL) was added to the resultant mixture turned brown in colour. The reaction turned 
bright yellow in colour, it was stirred for 1 h at -10 °C, and 1 h at 0 °C. The yellow solution 
was allowed slowly to warm to room temperature. The reaction mixture was quenched using a 
solution of NH4Cl (10 mL) at 0 °C. After returning to room temperature, the mixture was 
diluted with Et2O (10 mL) and the phases were separated. The aqueous layer was extracted 
with Et2O (3 × 10 mL). The combined organic layers were washed with brine (2 × 10 mL), 
dried over MgSO4 and concentrated under reduced pressure. The crude product was purified 
by flash column chromatography (using a gradient of petroleum ether/ethyl acetate/toluene 
(80/5/15 to 80/20/0) as eluent) to afford selenide 125 (118 mg, 41%) as a pale yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 7.78 (dd, 2H, J 9.7, 2.0, H20), 7.73 (dd, 1H, J 7.0, 4.3, H5), 
7.23-7.32 (m, 3H, H19 and 21), 7.16-7.20 (m, 2H, H6 and 7), 6.89 (s, 1H, H2), 3.72 (s, 3H, HNMe), 
3.26 (d, 1H, J 20.4, 1 × H16), 2.82 (d, 1H, J 20.4, 1 × H16), 2.28-2.45 (m, 2H, H12), 1.86 (ddd, 
1H, J 13.2, 7.2, 5.9, 1 × H14), 1.65-1.71 (dm, 1H, J 13.2, 1 × H14), 1.25-1.53 (m, 2H, H13), 
0.02 (s, 9H, H17); 
13
C NMR (100 MHz, CDCl3) δ 213.3 (C, C10), 138.0 (CHAr, C21), 136.9 (C, 
C8), 134.3 (C, C4), 129.7 (C, C9), 128.4 (CHAr, C20), 128.1 (CHAr, C22), 126.9 (CHAr, C2), 
126.6 (C, C19), 121.7 (CHAr, C6), 118.1 (CHAr, C5), 113.2 (C, C3), 108.4 (CHAr, C7), 70.9 (C, 
C11), 43.7 (C, C15), 43.4 (CH2, C12), 34.7 (CH2, C16), 32.7 (CH3, CNMe), 32.4 (CH2, C14), 21.5 
(CH2, C13), -2.7 (CH3, C17); IR max (film)/cm
-1
: 3058 (w, br), 2954 (w, br), 2903 (w, br), 2849 
(w), 1680 (m), 1446 (m, br), 1414 (m), 1320 (m), 1246 (m), 1087 (m), 1019 (m), 833 (s), 736 
(s), 693 (s); HRMS (ESI) m/z 490.1085 [M+Na]
+
, [C25H29NOSi
80
SeNa]
+
 requires 490.1081. 
Data were in agreement with those reported in the literature. 
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Preparation of selenide 124
6
  
 
To a solution of substituted bridged ketone 125 (25.1 mg, 0.054 mmol) in THF (1.5 mL) was 
added dropwise over 1 min a solution of TBAT (32.0 mg, 0.059 mmol) in THF (1.5 mL). The 
resulting pale yellow solution was stirred at room temperature and the reaction was monitored 
by TLC. After 2.5 h, the starting material was fully consumed and the reaction was quenched 
with a solution of NH4Cl (10 mL) and diluted with Et2O (10 mL). The phases were separated. 
The aqueous layer was extracted with Et2O (3 × 10 mL). The combined organic layers were 
washed with brine (2 × 10 mL), dried over MgSO4 and concentrated under reduced pressure. 
The crude product was purified by flash column chromatography (petroleum ether/ethyl 
acetate, 85/15) to afford selenide 124 (15.7 mg, 74%) as a pale green oil; 
1
H NMR (400 MHz, 
CDCl3) δ 7.85 (dd, 1H, J 5.6, 2.8, H5), 7.74-7.76 (m, 2H, H19), 7.29-7.32  (m, 3H, H18 and 20), 
7.20-7.25 (m, 2H, H6 and 7), 6.95 (s, 1H, H2), 3.77 (s, 3H, HNMe), 3.23-3.32 (m, 2H, H15, 
1 × H16), 2.99 (dd, 1H, J 14.9, 2.0, 1 × H16), 2.44-2.50 (m, 1H, 1 × H12), 2.40 (ddd, 1H, J 12.2, 
8.4, 3.8, 1 × H12), 1.97-2.07 (m, 1H, 1 × H14), 1.88-1.92 (m, 1H, 1 × H14), 1.43-1.56 (m, 1H, 
1 × H13), 1.34-1.40 (m, 1H, 1 × H13); 
13
C NMR (100 MHz, CDCl3) δ 210.5 (C, C10), 137.9 (C, 
C8), 136.9 (CHAr, C19), 133.4 (C, C4), 130.1 (C, C9), 128.5 (CHAr, C18), 127.9 (CHAr, C20), 
127.1 (CHAr, C2), 126.3 (C, C17), 121.8 (CHAr, C6), 118.6 (CHAr, C5), 111.6 (C, C3), 108.5 
(CHAr, C7), 70.9 (C, C11), 47.7 (CH, C15), 44.5 (CH2, C12), 32.8 (CH3, CNMe), 31.6 (CH2, C16), 
31.3 (CH2, C14), 20.8 (CH2, C13); IR max (film)/cm
-1
: 2920 (m, br), 2851 (m), 1699 (s), 1475 
(m), 1446 (s), 1313 (s), 739 (s), 691 (s); HRMS (ESI) m/z 418.0678 [M+Na]
+
, 
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[C22H21NO
80
SeNa]
+
 requires 418.0686. Data were in agreement with those reported in the 
literature. 
 
 
Preparation of bridging enone 126
6
 
 
To a solution of bridging ketone 124 (25.8 mg, 0.065 mmol) in CH2Cl2 (2.5 mL), pre-cooled 
to -10 °C, was added mCPBA (16.3 mg, 0.065 mmol) in one portion. After 15 min, starting 
material remained unconsumed. mCPBA (16.3 mg, 0.065 mmol) was added to the reaction 
mixture at -10 °C. The reaction was monitored by TLC and after another 30 min, total 
consumption of starting material was observed. The reaction was quenched with water (5 mL) 
and diluted with Et2O (10 mL). The phases were separated and the aqueous layer was 
extracted with Et2O (3 × 10 mL). The combined organic layers were washed with a saturated 
solution of NaS2O3 (10 mL), then brine (2 × 10 mL), dried over MgSO4 and concentrated 
under reduced pressure. The crude product was purified by flash column chromatography 
(petroleum ether/ethyl acetate, 9/1) to afford bridged enone 126 (8.6 mg, 56%) as a colourless 
oil; 
1
H NMR (400 MHz, CDCl3) δ 7.26 (dd, 1H, J 8.4, 6.9, H5), 7.15-7.21 (m, 2H, H6 and 7), 
7.07-7.10 (m, 1H, H2), 6.38 (dd, 1H, J 6.8, 3.2, H12), 3.71 (s, 3H, HNMe), 3.63 (dd, 1H, J 15.0, 
8.9, 1 × H16), 3.16-3.21 (m, 1H, H15), 2.70 (dd, 1H, J 15.0, 7.2, 1 × H16), 2.43-2.51 (m, 1H, 
H13), 2.28-2.39 (m, 2H, 1 × H13, 1 × H14), 1.96-2.06 (m, 1H, 1 × H14); 
13
C NMR (100 MHz, 
CDCl3) δ 207.3 (C, C10), 142.3 (C, C11), 129.5 (CHC=C, C12), 126.3 (CHAr, C2), 123.9 (CHAr, 
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C6), 114.9 (CHAr, C5), 109.1 (CHAr, C7), 48.6 (CH, C15), 31.5 (CH3, CNMe), 29.7 (CH2, C16), 
26.8 (CH2, C14), 20.2 (CHAr, C13) (C3,4,8,9 were not observed due to the small amount of 
sample used for this NMR experiment); IR max (film)/cm
-1
: 2923 (m, br), 2851 (m), 1699 (s), 
1476 (m), 1448 (s), 1315 (s), 744 (s), 698 (s); HRMS (ESI) m/z 260.1059 [M+Na]
+
, 
[C16H15NONa]
+
 requires 260.1051. Data were in agreement with those reported in the 
literature. 
 
 
Preparation of allylic alcohol 201 
 
To a solution of bridghead enone 126 (5.5 mg, 0.023 mmol) in dioxane (0.5 mL) was added 
SeO2 (2.9 mg, 0.025 mmol) in one portion followed by 2 drops of water. The suspension was 
stirred at reflux overnight. The precipitated mixture showed total consumption of starting 
material by TLC and was allowed to cool to room temperature. The reaction was quenched 
with water (5 mL) and the mixture was diluted with CH2Cl2 (10 mL). The phases were 
separated and the aqueous layer was extracted with CH2Cl2 (2 × 10 mL). The combined 
organic layers were washed with brine (2 × 10 mL), dried over MgSO4 and concentrated 
under reduced pressure. The crude product was purified by flash column chromatography 
(using a gradient of petroleum ether/ethyl acetate (9/1 to 5/5) as eluent) to afford alcohol 201 
(1.3 mg, 22%) as a single diastereoisomer as a colourless oil; 
1
H NMR (300 MHz, CDCl3) 
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δ 6.99-7.28 (m, 4H, HAr), 6.68 (d, 1H, J 5.9, H12), 4.70 (ddd, 1H, J 5.9, 4.5, 1.5, H13), 3.82 
(dd, 1H, J 14.5, 9.8, 1 × H14), 3.72 (s, 3H, HNMe), 3.35 (dddd, 1H, J 14.9, 9.8, 6.9, 1.2, H15), 
2.56-2.66 (m, 2H, 2 × H16), 2.10 (ddd, 1H, J 14.5, 4.5, 1.2, 1 × H14), HOH not observed; No 
13
C NMR spectroscopic data was recorded considering the limit amount of product obtained; 
IR max (film)/cm
-1
: 3332 (m, br), 2953 (m), 2927 (w), 2894 (w), 1699 (s), 1377 (m), 1088 
(w), 1046 (w), 880 (m), 747 (m), 737 (m); HRMS (ESI) m/z 276.0008 [M+Na]
+
, 
[C16H15NO2Na]
+
 requires 276.0000. 
 
Preparation of enone 198 
 
Dess-Martin periodinane (3.3 mg, 7.7 µmol) was added in one portion to a solution of alcohol 
201 (1.3 mg, 5.13 µmol) in CH2Cl2 (1.0 mL). The resulting yellow solution was stirred at 
room temperature for 1 h. The reaction mixture was quenched with water (2 mL) and diluted 
with CH2Cl2 (5 mL) and the phases were separated. The aqueous layer was extracted with 
CH2Cl2 (2 × 3 mL). The combined organic layers were dried over MgSO4 and concentrated 
under reduced pressure. The crude product was purified by flash column chromatography 
(using a gradient of petroleum ether/ethyl acetate (8/2 to 6/4) as eluent) to afford diketone 198 
(0.6 mg, 33%) as pale pink solid;  
1
H NMR (300 MHz, CDCl3) δ 7.06-7.32 (m, 4H, HAr), 6.40 
(s, 1H, H12), 3.80 (dd, 1H, J 15.2, 8.6, 1 × H14), 3.75 (s, 3H, HNMe), 3.48-3.56 (m, 1H, H15), 
3.00 (dd, 1H, J 15.2, 7.8, 1 × H14), 2.97 (m, 2H, H16); IR max (film)/cm
-1
: 2957 (w), 2934 (w), 
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2921 (w, br), 2866 (w, br), 1702 (s), 1681 (m, br), 1423 (m), 1375 (m), 1368 (m), 1254 (m), 
1158 (m), 791 (s), 755 (s), 743 (m); HRMS (ESI) m/z 274.0860 [M+Na]
+
, [C16H13NO2Na]
+
 
requires 274.0844.  
 
 
3-Acetyl-4-bromo-N-tosylindole (244)
3
 
 
DMAP (122 mg, 1.0 mmol), pTsCl (4.20 g, 22.0 mmol) and DIPEA (5.23 mL, 30.0 mmol) 
were added to a solution of 3-acetyl-4-bromoindole (243) (4.76 g, 20.0 mmol) in dry CH2Cl2 
(105 mL). The resulting solution was stirred at room temperature for 15 h and the reaction 
was quenched by addition of 10% HCl (100 mL). The reaction mixture was diluted with 
CH2Cl2 (80 mL) and the layers were separated. The aqueous phase was extracted with CH2Cl2 
(100 mL). The organic layers were combined, dried over MgSO4 and concentrated under 
reduced pressure. The crude product was purified by flash column chromatography 
(hexanes/EtOAc, 7/3) to afford tosylated indole 244 (7.64 g, 98%) as an off-white foam; 
mp 141-142 °C, [lit.,
3
 mp 142.5-143.0 °C];
 1
H NMR (300 MHz, CDCl3) 8.04 (s, 1H, H2), 
7.95 (dd, 1H, J  8.2, 0.9, H5), 7.78 (d, 2H, J 8.6, H13), 7.50 (dd, 1H, J 7.9, 0.9, H7), 7.28 (d, 
2H, J 8.6, H14), 7.21 (dd, 1H, J 8.2, 7.9, H6), 2.63 (s, 3H, H11), 2.38 (s, 3H, H16); 
13
C NMR 
(75 MHz, CDCl3) 194.6 (C, C10), 146.2 (C, C12), 136.1 (C, C8), 134.2 (C, C4), 130.3 (CHAr, 
C14), 130.2 (CHAr, C2), 129.5 (CHAr, C5 or 7), 127.8 (CHAr, C13), 127.1 (C, C9), 126.5 (CHAr, 
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C6), 124.2 (C, C15), 115.0 (C, C3), 112.4 (CHAr, C5 or 7), 31.2 (CH3, C11), 21.6 (CH3, C16); 
IR max (film)/cm
-1
: 3116 (w), 1678 (m), 1595 (m), 1529 (m), 1416 (m), 1376 (s), 1305 (w), 
1176 (s), 1170 (s), 1157 (s), 1092 (s), 979 (s), 928 (s), 809 (s), 776 (s), 716 (s), 666 (s);  
HRMS (ESI) m/z 413.9778 [M+Na]
+
, [C17H14NO3S
79
BrNa]
+
 requires 413.9775. Data were in 
agreement with those reported in the literature. 
 
 
2-[4’-Bromo-1’-(tosyl)-1H-indol-3’-yl]-propan-2-ol (245)3 
 
A solution of 3-acetyl-4-bromo-N-tosylindole (244) (5.99 mg, 15.3 mmol) in dry THF 
(110 mL) was added dropwise over 15 min via cannula to a solution of methylmagnesium 
bromide (3.00 M in Et2O, 12.0 mL, 35.2 mmol) in dry THF (20 mL) pre-cooled to 0 °C. After 
stirring the reaction for 30 min, the starting material was fully consumed and the reaction was 
quenched with a 1:1 mixture of water and a solution of NH4Cl (75 mL). The mixture was 
diluted with Et2O (75 mL) and the phases were separated. The aqueous phase was extracted 
with Et2O (2 × 75 mL). The combined organic layers were dried over MgSO4 and 
concentrated under reduced pressure. The crude product was purified by flash column 
chromatography (petroleum ether/EtOAc, 8/2) to afford tertiary alcohol 245 (6.07 g, 97%) as 
a white foam; mp 99.0-100.7 °C, [lit.,
3
 mp 100-101 °C]; 
1
H NMR (400 MHz, CDCl3)  8.02 
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(dd, 1H, J 8.2, 1.0, H5 or 7), 7.75 (d, 2H, J 8.6, H14), 7.67 (s, 1H, H2), 7.49 (dd, 1H, J 7.9, 1.0, 
H5 or 7), 7.25 (d, 2H, J 8.6, H15), 7.15 (dd, 1H, J 8.2, 7.9, H6), 3.06 (br s, 1H, HOH), 2.36 (s, 3H, 
H17), 1.81 (s, 6H, H11, H12); 
13
C NMR (100 MHz, CDCl3) 145.4 (C, C13), 137.5 (C, C8), 
134.7 (C, C4), 130.0 (CHAr, C15), 129.2 (C, C9 or 16), 128.9 (CHAr, C5 or 7), 128.3 (C, C9 or 16), 
126.9 (CHAr, C14), 125.3 (CHAr, C6), 124.2 (CHAr, C2), 117.8 (C, C3), 113.1 (CHAr, C5 or 7), 
68.9 (C, C10), 31.7 (2 × CH3, C11 and 12), 21.6 (CH3, C17); IR max(film)/cm
-1
: 3555 (w, br), 
3427 (w, br), 2972 (w), 2931 (w), 1596 (m), 1456 (m), 1407 (m), 1366 (s, br), 1294 (m, br), 
1169 (s), 1149 (s), 1090 (s), 1042 (m), 968 (m), 941 (m), 745 (m), 713 (s), 663 (s); HRMS 
(ESI) m/z 430.0085 [M+Na]
+
, [C18H18NO3S
79
BrNa]
+
 requires 430.0088. Data were in 
agreement with those reported in the literature. 
 
 
2-[2’-(4’’-Bromo-1’’-(tosyl)-1H-indol-3’’-yl]-propan-2’-yl)]cyclohexanone (247)3 
 
A solution of silyl enol ether 246 (6.84 mL, 35.68 mmol) followed by a solution of TiCl4 
(1.00 M in toluene, 34.2 mL, 34.19 mmol) were added to a solution of tertiary alcohol 245 
(6.07 mL, 14.87 mmol) in toluene (500 mL), pre-cooled to -78 °C. After stirring the reaction 
mixture for 1 h at -78 °C, the reaction was quenched by dropwise addition over 15 min of a 
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solution of NaHCO3 (250 mL) at -78 °C. After warming to room temperature, water (200 mL) 
and CH2Cl2 (300 mL) were added to the reaction mixture and the phases were separated. The 
aqueous layer was extracted with CH2Cl2 (2 × 150 mL). The combined organic layers were 
washed successively with NaHCO3 (150 mL) then HCl (10% aqueous solution, 150 mL), 
dried over MgSO4 and concentrated under reduced pressure. The crude product was purified 
by flash column chromatography (using a gradient of petroleum ether/EtOAc (9/1 to 7/3) as 
eluent) to afford Mukaiyama product 247 (5.62 g, 79%) as a white solid; mp 73-74 °C [lit.,
3
 
mp 74-75 °C]; 
1
H NMR (300 MHz, CDCl3) 8.01 (d, 1H, J 8.2, H5 or 7), 7.72 (d, 2H, J 8.4, 
H20), 7.56 (br s, 1H, H2), 7.51 (d, 1H, J 7.8, H5 or 7), 7.24 (d, 2H, J 8.4, H21), 7.09 (dd, 1H, 
J 8.2, 7.8, H6), 4.06 (dd, 1H, J 11.2, 4.6, H15), 2.35 (s, 3H, H23), 2.28 (br s, 2H, H11), 
1.99-2.03 (m, 1H), 1.57-1.91 (m, 3H), 1.72 (s, 3H, H17 or 18), 1.56 (s, 3H, H17 or 18), 1.42-1.55 
(m, 2H); 
13
C NMR (75 MHz, CDCl3) 211.8 (C, C10), 145.1 (C, C19), 138.1 (C, C8), 134.7 
(C, C4), 130.6 (C, C22), 130.0 (CHAr, C21), 129.9 (CHAr, C5 or 7), 129.0 (C, C9), 126.9, 
(CHAr, C20), 125.7 (CHAr, C2), 124.8 (CHAr, C6), 113.8 (C, C3), 113.3 (CHAr, C5 or 7), 56.0 (CH, 
C15), 44.3 (CH2, C11), 36.2 (C, C16), 30.2 (CH2), 28.3 (CH2), 26.0 (CH3, C17 or 18), 25.9 (CH2), 
21.6 (CH3, C23), one CH3 signal not observed; IR max (film)/cm
-1
: 2934 (w, br), 2862 (w), 
1707 (m), 1596 (w), 1448 (w), 1359 (m, br), 1167 (s), 1090 (m), 966 (m), 721 (m), 668 (s); 
HRMS (ESI) m/z 510.0720 [M+Na]
+
, [C24H26NO3S
79
BrNa]
+
 requires 510.0714. Data were in 
agreement with those reported in the literature. 
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2-[2’-(4’’-Bromo-1H-indol-3-yl)propan-2-yl]cyclohexanone (348)3 
 
Crushed KOH (19.1 g, 340.3 mmol) was added to a solution of functionalised cyclohexanone 
247 (8.3 g, 17.0 mmol) in degassed EtOH (720 mL) and the reaction mixture was stirred for 
1 h at 40 °C. The pale yellow solution was cooled to room temperature and quenched with a 
solution of NH4Cl (350 mL) to form a white precipitate. The mixture was extracted with Et2O 
(2 × 250 mL) and the combined organic layers were washed with brine (350 mL), dried over 
MgSO4 and concentrated under reduced pressure. The crude product was purified by flash 
column chromatography (petroleum ether/EtOAc, 8/2) to afford indole 348 (5.3 g, 93%) as a 
yellow foam; mp 163-164 °C [lit.,
3
 167-168 °C]; 
1
H NMR (300 MHz, CDCl3)  8.31 (br s, 
1H, HNH), 7.41 (dd, 1H, J 7.8, 1.0, H5 or 7), 7.32 (dd, 1H, J 7.8, 1.0, H5 or 7), 7.13 (d, 1H, J 2.5, 
H2), 6.99 (app t, 1H, J 7.8, H6), 4.24 (dd, 1H, J 11.9, 4.7, H15), 2.26-2.45 (m, 2H), 2.01-2.09 
(m, 1H), 1.76 (s, 3H, H17 or 18), 1.70-1.87 (m, 2H), 1.57 (s, 3H, H17 or 18), 1.44-1.70 (m, 3H); 
1
H NMR (400 MHz, CD3OD)  7.36 (dd, 1H, J 8.0, 0.7, H5 or 7), 7.30 (dd, 1H, J 7.7, 0.7, 
H5 or 7), 7.17 (s, 1H, H2), 6.93 (app t, 1H, J 8.0, 7.7, H6), 4.26 (dd, 1H, J 9.1, 3.4, H15), 
2.35-2.43 (m, 1H, 1 × H11), 2.20-2.24 (m, 1H, 1 × H11), 2.03-2.07 (m, 1H, H12), 1.74 (s, 3H, 
H17 or 18), 1.70-1.87 (m, 2H, 1 × H13, 1 × H14), 1.53 (s, 3H, H17 or 18), 1.43-1.70 (m, 3H, 1 × H12, 
1 × H13, 1 × H14); 
13
C NMR (100 MHz, CD3OD) 216.5 (C, C10), 142.3 (C, C8), 130.3 (C, 
C4), 127.1 (CHAr, C5 or 7), 126.6 (C, C9), 126.2 (CHAr, C5 or 7), 123.6 (CHAr, C2), 114.9 (C, C3), 
113.2 (CHAr, C6), 59.7 (CH, C15), 46.3 (CH2, C11), 38.2 (C, C16), 32.9 (CH2, C13 or 14), 30.8 
(CH2, C12), 28.0 (CH2, C13 or 14), 29.7 (CH3, C17 or 18), 26.6 (CH3, C17 or 18); IR max (film)/cm
-1
: 
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3274 (m, br), 2940 (m, br), 1683 (s), 1452 (m), 1326 (m), 1311 (m), 1175 (m), 806 (m), 723 
(s);  HRMS (ESI) m/z 356.0623 [M+Na]
+
, [C17H20NO
79
BrNa]
+
 requires 356.0626. Data were 
in agreement with those reported in the literature. 
 
 
2-[2’-(4’’-Bromo-1’’-methyl-1H-indol-3’’-yl)propan-2’-yl]cyclohexanone (169)3 
 
A solution of indole 348 (8.55 g, 25.6 mmol) in THF (50 mL) was added dropwise over 
15 min to a suspension of NaH (1.53 g of a 60% dispersion in mineral oil, 38.4 mmol) in THF 
(20 mL), pre-cooled to 0 °C. After complete addition, the reaction mixture was allowed to 
warm to room temperature for 45 min. The reaction mixture was cooled to 0 °C before 
addition of a solution of iodomethane (3.18 mL, 51.2 mmol). The ice-bath was removed and 
the reaction mixture was stirred overnight at room temperature. After 14 h, the reaction was 
quenched with a 1:1 mixture of water and methanol (70 mL). The mixture was extracted with 
Et2O (2 × 80 mL) and the phases were separated. The combined organic layers were washed 
with brine (80 mL), dried over MgSO4 and concentrated under reduced pressure. The crude 
product was purified by flash column chromatography (petroleum ether/EtOAc, 8/2) to afford 
methylated indole 169 (8.62 g, 97%) as a white foam; mp 77-78 °C [lit.,3 80-81 °C]; 1H NMR 
(400 MHz, CDCl3) 7.41 (dd, 1H, J 7.6, 1.0, H5), 7.26 (d, 1H, J 8.1, 1.0, H7), 7.03 (dd, 1H, 
J 8.1, 7.6, H6), 7.01 (s, 1H, H2), 4.23 (dd, 1H, J 12.6, 4.6, H15), 3.74 (s, 3H, HNMe), 2.33-2.42 
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(m, 1H, 1 × H11), 2.24-2.31 (m, 1H, 1 × H11), 2.02-2.07 (m, 1H, 1 × H12), 1.70-1.95 (m, 2H, 
1 × H13, 1 × H14), 1.77 (s, 3H, H17 or 18), 1.55-1.70 (m, 2H, 1 × H12, 1 × H13), 1.56 (s, 3H, 
H17 or 18), 1.40-1.55 (m, 1H, 1 × H14); 
13
C NMR (100 MHz, CDCl3) 212.9 (C, C10), 139.8 (C, 
C8), 128.6 (CHAr, C2), 125.3 (CHAr, C5), 125.2 (C, C4), 123.9 (C, C9), 121.7 (CHAr, C6), 113.7 
(C, C3), 108.9 (CHAr, C7), 57.3 (CH3, C15), 44.5 (CH2, C11), 36.1 (C, C16), 33.0 (CH3, CNMe), 
30.8 (CH2, C14), 28.6 (CH2, C12), 27.7 (CH3, C17 or 18), 26.1 (CH2, C13), 26.1 (CH3, C17 or 18); 
IR max (film)/cm
-1
: 2932 (w, br), 2862 (w), 1703 (s), 1546 (w), 1447 (m), 1416 (m), 1381 
(w), 1359 (w), 1317 (w), 1113 (s), 1059 (w), 984 (w), 839 (w), 774 (m), 732 (s); HRMS (ESI) 
m/z 370.0783 [M+Na]
+
, [C18H22NO
79
BrNa]
+
 requires 370.0782. Data were in agreement with 
those reported in the literature. 
 
4-Bromo-1-(methyl)-3-(2’-(2’’-((trimethylsilyloxy)cyclohex-2’’-en-1’’-yl)propan-2’-yl)-
1H-indole (211)
7
 
 
A solution of KHMDS (0.5 M in toluene, 11.02 mL, 5.51 mmol) was added dropwise over 
8 min to the solution of cyclohexanone 169 (1.75 g, 5.01 mmol) in THF (43 mL), pre-cooled 
to -78 °C. The resulting solution turned yellow in colour. The reaction mixture was stirred for 
30 min at this temperature before addition of freshly distilled TMSCl (3.18 mL, 25.1 mmol). 
The reaction mixture was stirred for a further 10 min at -78 °C then freshly distilled Et3N 
(7.02 mL, 50.1 mmol) was added to the yellow solution. After 5 min at -78 °C, the reaction 
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was quenched with a solution of NaHCO3 (20 mL of an aqueous saturated solution). The 
reaction mixture was allowed to warm to room temperature, then was diluted with Et2O 
(25 mL) and the phases were separated. The aqueous phase was extracted with Et2O 
(2 × 15 mL). The combined organic phases were dried over MgSO4 and concentrated under 
reduced pressure. The crude product was purified by flash column chromatography 
(petroleum ether/EtOAc, 9/1 + 1% Et3N) to afford silyl enol ether 211 (1.67 g, 79%, 
91% BRSM) as a colourless sticky foam; 
1
H NMR (300 MHz, CDCl3) 7.41 (dd, 1H, J 7.6, 
1.0, H5), 7.25 (dd, 1H, J 8.1, 1.0, H7), 7.01 (app t, 1H, J 8.1, 7.6, H6), 6.92 (s, 1H, H2), 4.92 (t, 
1H, J 3.6, H11), 3.71-3.78 (m, 1H, H15), 3.72 (s, 3H, HNMe), 1.97 (br s, 2H, H12), 1.62 (br s, 
4H, 1 × H13, H17 or 18), 1.50 (s, 3H, H17 or 18), 1.36 (br s, 3H, 1 × H13, H14), -0.05 (br s, 9H, 
H19);
13
C NMR (100 MHz, CDCl3) 153.7 (C, C10), 139.6 (C, C8), 127.5 (CHAr, C2), 125.8 
(C, C4), 125.0 (CHAr, C5), 125.0 (C, C9), 121.5 (CHAr, C6), 114.1 (C, C3), 108.6 (CHAr, C7), 
106.6 (CH, C11), 45.8 (CH3, C15), 37.1 (C, C16), 32.9 (CH3, CNMe), 27.6 (CH3, C17 or 18), 27.5 
(CH2, C14), 24.5 (CH2, C12), 22.7 (CH2, C13), 22.7  (CH3, C17 or 18), 0.45 (CH3, C19); 
IR max (film)/cm
-1
: 2930 (m, br), 2861 (w), 1596 (w), 1547 (w), 1448 (m), 1405 (m), 1364 
(s), 1311 (w), 1172(s), 1152 (s), 1091 (m), 966 (m), 668 (s); HRMS (ESI) m/z 442.1175 
[M+Na]
+
, [C21H30NO
79
BrSiNa]
+
 requires 442.1178. Data were in agreement with those 
reported in the literature. 
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Preparation of bridged ketone 170
7
 
 
A solution of PtBu3 (1.00 M intoluene, 333 µL, 0.333 mmol) followed by a solution of silyl 
enol ether 211 (2.80 g, 6.66 mmol) in toluene (12 mL) were added to a solution of palladium 
acetate (50.8 mg, 0.226 mmol), Bu3SnF (2.47 g, 7.99 mmol) and CsF (1.21 g, 7.99 mmol) in 
toluene (50 mL). The reaction mixture was heated at 85 °C for 48 h. The resulting solution 
was cooled to room temperature and diluted with Et2O (25 mL). The reaction mixture was 
filtered through a pad of silica (using Et2O as eluent) and concentrated under reduced 
pressure. The crude product was purified by flash column chromatography (petroleum 
ether/EtOAc, 85/15) to afford bicyclo[4.3.1]core structure 170 (1.63 g, 92%) as a colourless 
foam; 
1
H NMR (300 MHz, CDCl3) 7.15-7.24 (m, 2H, H5 or 7, H6), 6.95 (s, 1H, H2), 6.84 (dd, 
1H, J 6.7, 1.1, H5 or 7), 4.05-4.09 (m, 1H, H11), 3.76 (s, 3H, HNMe), 2.60 (dt, 1H, J 7.1, 1.9, 
H15), 2.18-2.32 (m, 2H, 1 × H12, 1 × H14), 1.82-1.98 (m, 2H, 1 × H12, 1 × H14), 1.55 (s, 3H, 
H17 or 18), 1.19-1.26 (m, 1H, 1 × H13), 1.33-1.48 (m, 1H, 1 × H13), 1.15 (s, 3H, H17 or 18); 
13
C NMR (100 MHz, CDCl3) 214.5 (C, C10), 136.9 (C, C8), 132.0 (C, C4), 126.0 (CHAr, C2), 
125.3 (C, C9), 122.7 (C, C3), 122.3 (CHAr, C6), 118.3 (CHAr, C5 or 7), 107.2 (CHAr, C5 or 7), 61.3 
(CH, C15), 58.2 (CH, C11), 39.6 (CH2, C12), 36.3 (CH3, C17 or 18), 34.9 (C, C16), 32.8 (CH3, 
CNMe), 28.7 (CH2, C14), 28.1 (CH3, C17 or 18), 18.1 (CH2, C13); IR max (film)/cm
-1
: 2924 (m, br), 
1694 (s), 1454 (m), 1419 (m), 1366 (m), 1248 (m), 1227 (m), 1064 (m, br), 789 (m), 743 (s); 
HRMS (ESI) m/z 290.1510 [M+Na]
+
, [C18H21NONa]
+
 requires 290.1521. Data were in 
agreement with those reported in the literature. 
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Preparation of oxindole 248 
 
To a colourless solution of indole 170 (29.5 mg, 0.11 mmol) in CH2Cl2 (0.6 mL) was added 
NBS (21.6 mg, 0.121 mmol) in one portion. The reaction turned orange instantaneously. After 
15 min of stirring at room temperature, NaHCO3 (12 mg) was added in one portion to the 
reaction mixture and the suspension was stirred for another 5 min. The resulting suspension 
was filtered through a pad of silica (petroleum ether/ethyl acetate, 8/2) to afford brominated 
compound 349 (41.7 mg) as a red solution; HRMS (ESI) m/z 368.0630 [M+Na]
+
, 
[C18H20NO
79
BrNa]
+
 requires 368.0626. Bromide 349 was carried on to the next step without 
further purification.  
Bromide 349 (41.7 mg) was solubilised in absolute EtOH (2.5 mL) and concentrated HCl 
(2.5 mL) was added dropwise over 1 min. After heating the suspension at 80 °C for 14 h, the 
reaction mixture was cooled to room temperature. EtOAc (5 mL) and H2O (5 mL) were added 
to the black solution followed by addition of solid NaHCO3. The solution was stirred until no 
more gas evolution was observed. The phases were separated and the aqueous layer was 
extracted with EtOAc (3 × 5 mL). The combined organic layers were dried over MgSO4 and 
concentrated under reduced pressure. The crude material was purified by flash column 
chromatography (petroleum ether/ethyl acetate, 8/2) to afford oxindole 248 (7.9 mg, 25%) as 
yellow solid; 
1
H NMR (400 MHz, CDCl3) δ 7.25 (app t, 1H, J 7.7, H6), 6.82 (d, 1H, J 7.7, 
H5), 6.72 (d, 1H, J 7.7, H7), 3.92 (s, 1H, H3), 3.62-3.66 (m, 1H, H11), 3.20 (s, 3H, HNMe), 
2.42-2.49 (m, 2H, H15, 1 × H14), 2.18-2.26 (m, 2H, H12), 1.99-2.13 (m, 1H, 1 × H14), 1.80-1.96 
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(m, 1H, 1 × H13), 1.57-1.64 (m, 1H, 1 × H13), 1.62 (s, 3H, H17 or 18), 0.70 (s, 3H, H17 or 18); 
13
C NMR (100 MHz, CDCl3) δ 211.3 (C, C10 ), 175.3 (C, C2), 144.5 (C, C8), 135.0 (C, C4), 
128.8 (CHAr, C6), 124.8 (C, C9), 124.0 (CHAr, C5), 106.6 (CHAr, C7), 62.3 (CH, C15), 58.3 
(CH, C11), 53.0 (CH, C3), 39.8 (C, C16), 35.9 (CH2, C12), 27.6 (CH2, C14), 26.2 (CH3, CNMe), 
26.0 (CH3, C17 or 18), 23.0 (CH3, C17 or 18), 20.1 (CH2, C13); IR max (film)/cm
-1
: 2967 (w), 2940 
(w), 1855 (w), 1698 (s), 1607 (m), 1594 (m), 1463 (m, br), 1343 (w), 1298 (w), 1252 (w), 
1038 (w), 985 (w), 775 (m), 727 (m); HRMS (ESI) m/z 306.1477 [M+Na]
+
, [C18H21NO2Na]
+
 
requires 306.1470. 
 
 
Preparation of selenide 215
7
 
 
Preparation of the solution of LTMP (0.4 M): 
A solution of nBuLi (1.6 M in hexanes, 10.2 mL, 17.7 mmol) was added to a solution of 
freshly distilled 2,2,6,6-tetramethylpiperidine (2.75 mL, 2.50 g, 17.7 mmol) in THF 
(27.8 mL), pre-cooled to -78 °C, was added. The solution was stirred for 5 min at -78 °C, then 
was allowed to warm to room temperature for 20 min and cooled to -78 °C prior to its transfer 
to the solution of the substrate. 
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The solution of LTMP at -78 °C and immediately afterwards a solution of PhSeSePh (5.08 g, 
16.3 mmol) in THF (8 mL) were added to a solution of the tetracyclic core 170 (435.4 mg, 
1.63 mmol) in THF (24 mL), pre-cooled to -10 °C. The resulting orange mixture was stirred 
for 1 h at -10 °C, time by which the starting material was fully consumed. The reaction was 
quenched with a solution of NH4Cl (30 mL) and extracted with Et2O (2 × 20 mL). The 
combined organic layers were washed with brine (30 mL), dried over MgSO4 and 
concentrated under reduced pressure. The crude product was purified by flash column 
chromatography (using a gradient of petroleum ether/EtOAc/toluene (9/0.5/0.5 to 8/2/0) as 
eluent) to afford selenylated product 215 (287.7 mg, 42%) as a pale yellow oil; 1H NMR 
(300 MHz, CDCl3) 7.93 (dd, 1H, J 7.1, 1.4, H22), 7.65-7.68 (m, 2H, H20 or 21), 7.15-7.26 (m, 
5H, H20 or 21, H5, H6, H7), 6.96 (s, 1H, H2), 3.74 (s, 3H, HNMe), 2.77 (dd, 1H, J 7.5, 3.4, H15), 
2.50 (dtd, 1H, J 12.8, 2.0, 1.9, 1 × H12), 2.40 (ddd, 1H, J 12.8, 10.4, 4.8, 1 × H12), 2.10-2.21 
(dm, 1H, J 14.3, 1 × H14), 1.70-1.83 (m, 1H, 1 × H14), 1.50 (s, 3H, H17 or 18), 1.38-1.48 (m, 1H, 
1 × H13), 1.28 (s, 3H, H17 or 18), 1.22-1.27 (m, 1H, 1 × H13);
 13
C NMR (75 MHz, CDCl3) 
207.9 (C, C10), 136.7 (C, C8), 136.3 (CHAr, C20 or 21), 133.0 (C, C4 or 11), 130.8 (C, C4 or 11), 
128.4 (CHAr, C20 or 21), 127.6 (CHAr, C5), 126.5 (CHAr, C2), 124.4 (C, C9), 122.3 (C, C3), 122.1 
(CHAr, C6), 119.7 (CHAr, C22), 108.3 (CHAr, C7), 60.6 (CH, C15), 46.0 (CH2, C12), 36.2 (CH3, 
C17 or 18), 34.9 (C, C16), 32.9 (CH3, CNMe), 29.3 (CH3, C17 or 18), 27.4 (CH2, C14), 20.5 (CH2, C13), 
C11 was not observed; IR max (film)/cm
-1
: 2928 (m, br), 2862 (m), 1697 (m), 1437 (m), 1416 
(m), 739 (s), 692 (m); HRMS (ESI) m/z 446.1001 [M+Na]
+
, [C24H25NOSeNa]
+
 requires 
446.0999. Data were in agreement with those reported in the literature. 
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Preparation of bridehead alkene 171
7
 
 
mCPBA (70%, 513 mg, 2.08 mmol) was added in one portion to a solution of keto-selenide 
215 (877 mg, 2.08 mmol) in CH2Cl2 (80 mL), pre-cooled to -10 °C. The reaction was 
monitored by TLC and after 15-20 min, total consumption of the starting material was 
observed. The reaction mixture was quenched with water (60 mL) and allowed to warm to 
room temperature. The phases were separated and the organic phase was washed with a 
saturated solution of Na2SO3 (30 mL). The aqueous layer was extracted with CH2Cl2 
(3 × 30 mL). The combined organic layers were washed with a solution of NH4Cl (30 mL), 
then brine (2 × 25 mL). The aqueous layers were extracted with CH2Cl2 (2 × 30 mL). The 
combined organic layers were dried over MgSO4 and concentrated under reduced pressure. 
The crude material was purified by flash column chromatography (petroleum ether/ethyl 
acetate, 8/2) to afford bridgehead alkene 171 (343.1 mg, 62%) as a yellow solid. 
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Bridgehead alkene 171 
Alternative procedure: 
  
Preparation of the solution of LTMP (0.4 M): 
A solution of nBuLi (1.6 M in hexanes, 4.8 mL, 7.7 mmol) was added to a solution of freshly 
distilled 2,2,6,6-tetramethylpiperidine (1.3 mL, 1.09 g, 7.7 mmol) in THF (11.4 mL) 
pre-cooled to -78 °C. The solution was stirred for 5 min at -78 °C, then allowed to warm to 
room temperature for 20 min and cooled to -78 °C prior to its transfer to the solution of the 
substrate. 
The solution of LTMP, pre-cooled to -78 °C, was added to a solution of the tetracyclic core 
170 (411.7 mg, 1.54 mmol) in THF (15 mL), pre-cooled to -10 °C. The resulting orange 
mixture was stirred for 10 min at -10 °C and a solution of PhSeSePh (2.4 g, 7.7 mmol) in THF 
(6 mL) was added. The dark orange solution was stirred for an additional 40 min until the 
TLC showed full consumption of starting material. The mixture was then quenched with a 
solution of NH4Cl (30 mL) and extracted with Et2O (2 × 20 mL). The combined organic 
layers were dried over MgSO4 and concentrated under reduced pressure. The yellow oil crude 
product was used into the next step without any further purification. 
mCPBA (70%, 2.28 g, 9.24 mmol) was added in one portion to a solution of the ketoselenide 
crude 215 in CH2Cl2 (65 mL), pre-cooled to -10 °C. The reaction mixture was allowed to 
warm to 0 °C and was stirred for 1 h at 0 °C. The ice-bath was then removed and the reaction 
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was allowed to stir at room temperature for another 18 h. The reaction mixture was quenched 
with water (30 mL) then Na2S2O3 (30 mL). The phases were separated and the aqueous phase 
was extracted with CH2Cl2 (2 × 40 mL). The combined organic layers were washed with a 
solution of NH4Cl (30 mL) then brine (40 mL). A final wash using a solution of Na2CO3 
(2 × 40 mL) was performed to remove any mCPBA adducts. The combined organic layers 
were dried over MgSO4 and concentrated under reduced pressure. The crude material was 
purified by flash column chromatography (petroleum ether/ethyl acetate, 8/2) to afford 
bridgehead alkene 171  (336.4 mg, 82%) as a yellow solid; 
1
H NMR (400 MHz, CDCl3) δ 
7.21 (dd, 1H, J 8.3, 6.6, H6), 7.16 (dd, 1H, J 8.3, 1.2, H5), 7.05 (dd, 1H, J 6.6, 1.2, H7), 6.92 
(s, 1H, H2), 6.33 (dd, 1H, J 7.2, 4.3, H12), 3.73 (s, 3H, HNMe), 2.84 (dd, 1H, J 7.6, 4.9, H15), 
2.28-2.40 (m, 1H, 1 × H13), 2.14-2.21 (m, 2H, 1 × H13, 1 × H14), 1.97-2.06 (m, 1H, 1 × H14), 
1.45 (s, 3H, H17 or 18), 1.36 (s, 3H, H17 or 18); 
13
C NMR (100 MHz, CDCl3) δ 208.6 (C, C10), 
142.0 (C, C11), 135.9 (C, C8), 132.9 (CH, C12), 130.8 (C, C4), 126.9 (CH, C2), 124.8 (C, C9), 
123.5 (C, C3), 122.4 (CH, C6), 113.7 (CH, C7), 108.4 (CH, C5), 59.5 (CH, C15), 36.9 (C, C16), 
34.3 (CH3, C17 or 18), 32.8 (CH3, CNMe), 29.3 (CH3, C17 or 18), 24.6 (CH2, C14), 22.9 (CH2, C13); 
IR max (film)/cm
-1
: 2969 (w), 2940 (w), 2921 (w), 2858 (w), 1704 (s), 1520 (w), 1415 (m), 
1254 (m), 1212 (m), 1150 (m), 869 (m), 788 (m), 751 (s); HRMS (ESI) m/z 288.1369 
[M+Na]
+
, [C18H19NONa]
+
 requires 288.1364. Data were in agreement with those reported in 
the literature.  
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Preparation of allylic alcohol 216
7
 
 
Selenium dioxide (23 mg, 0.207 mol) was added in one portion to a solution of bridged alkene 
171 (50 mg, 0.188 mmol) in dioxane (1.2 mL) and H2O (70 µL). The reaction mixture was 
stirred at 90 °C overnight. After cooling to room temperature, the mixture was quenched with 
water (5 mL) and diluted with CH2Cl2 (10 mL). The phases were separated and the aqueous 
layer was extracted with CH2Cl2 (2 × 10 mL). The combined organic layers were dried over 
MgSO4 and concentrated under reduced pressure. The crude product was purified by flash 
column chromatography (using a gradient of petroleum ether/ethyl acetate (8/2 to 4/6) as 
eluent) to afford alcohol 216 (25.7 mg, 49%) as a yellow solid; 
1
H NMR (300 MHz, CDCl3) 
δ 7.18-7.23 (m, 2H, H6 and 7), 7.05 (dd, 1H, J 5.9, 2.0, H5), 6.95 (s, 1H, H2), 6.45 (d, 1H, J 5.8, 
H12), 4.66 (ddd, 1H, J 5.8, 3.0, 2.8, H13), 3.73 (s, 3H, HNMe), 2.96 (dd, 1H, J 7.5, 4.9, H15), 
2.43 (ddd, 1H, J 14.2, 7.5, 2.8, 1 × H14), 2.13 (ddd, 1H, J 14.2, 4.9, 3.0, 1 × H14), 1.82 (br s, 
1H, HOH), 1.47 (s, 3H, H17 or 18), 1.40 (s, 3H, H17 or 18); 
13
C NMR (100 MHz, CDCl3) δ 207.0 
(C, C10), 145.9 (C, C11), 135.7 (C, C8), 134.2 (CH, C12), 130.2 (C, C4), 127.7 (CHAr, C2), 
123.9 (C, C9), 122.9 (C, C3), 122.3 (CHAr, C6), 113.6 (CHAr, C5), 108.9 (CHAr, C7), 64.8 (CH, 
C13), 55.6 (CH, C15), 37.2 (C, C16), 35.8 (CH3, C17 or 18), 35.2 (CH2, C14), 32.8 (CH3, CNMe), 
29.2 (CH3, C17 or 18); IR max (film)/cm
-1
: 3336 (m, br), 2973 (m), 2927 (w), 2891 (w), 1696 
(m), 1377 (m), 1088 (m), 1046 (s), 880 (m), 747 (m), 737 (m); HRMS (ESI) m/z 304.1320 
[M+Na]
+
, [C18H19NONa]
+
 requires 304.1313. Data were in agreement with those reported in 
the literature. 
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Preparation of bridgehead enone 214
7
 
 
Method a: 
Dess-Martin periodinane (121.1 mg, 0.29 mmol) was added in one portion to a solution of 
functionalised alcohol 216 (53.5 mg, 0.19 mmol) in CH2Cl2 (2.5 mL). The resulting yellow 
solution was stirred at room temperature for 1 h. The reaction mixture was quenched with 
water (5 mL) and diluted with CH2Cl2 (10 mL) and the phases were separated. The aqueous 
layer was extracted with CH2Cl2 (2 × 10 mL). The combined organic layers were dried over 
MgSO4 and concentrated under reduced pressure. The crude was purified by flash column 
chromatography (using a gradient of petroleum ether/ethyl acetate (8/2 to 6/4) as eluent) to 
afford enone 214 (17.3 mg, 33%) as dark pink solid. 
 
Method b: 
An oven-dried round-bottom flask, purged with nitrogen, was charged with the allylic alcohol 
216 (127 mg, 0.45 mmol) in dry CH2Cl2 (3 mL). A solution of Dess-Martin periodinane 
(287 mg, 0.68 mmol) in dry CH2Cl2 (3 mL) was added to the yellow solution. The resulting 
orange solution was stirred vigorously for 20 min. H2O (9 µL, 0.5 mmol) was solvated in dry 
CH2Cl2 (9 mL) by drawing the solvent mixture into and expelling it from a disposable pipette 
several times. The “wet CH2Cl2” was then added to the orange solution dropwise over 20 min. 
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The mixture was diluted with Et2O (10 mL) then concentrated into a few mL of solvent under 
reduced pressure. The residue was dissolved in Et2O (25 mL) and washed with a 1:1 mixture 
of 10% Na2S2O3:NaHCO3. The phases were separated and the aqueous layer was extracted 
with Et2O (2 × 20 mL). The combined organic layers were washed successively with H2O 
(20 mL) and brine (20 mL), dried over MgSO4 and concentrated under reduced pressure. The 
crude material was purified by flash column chromatography (petroleum ether/ethyl acetate, 
6/4) to afford enone 214 (102.9 mg, 82%) as dark pink solid; 
1
H NMR (300 MHz, CDCl3) 
δ 7.25-7.27 (m, 2H, H6 and 7), 7.15 (dd, 1H, J 4.0, 4.0, H5), 6.94 (s, 1H, H2), 6.41 (d, 1H, J 1.0, 
H12), 3.75 (s, 3H, HNMe), 3.28 (dd, 1H, J 5.5, 0.7, H15), 3.18 (ddd, 1H, J 19.1, 1.8, 0.7, 
1 × H14), 2.86 (ddd, 1H, J 19.1, 5.5, 1.0, 1 × H14), 1.59 (s, 3H, H17 or 18), 1.27 (s, 3H, H17 or 18); 
13
C NMR (100 MHz, CDCl3) δ 204.5 (C, C10), 195.3 (C, C13), 159.6 (C, C11), 136.6 (C, C8), 
128.7 (C, C4), 128.0 (CH, C12), 126.5 (CHAr, C2), 125.3 (C, C9), 124.2 (C, C3), 122.5 (CHAr, 
C6), 113.6 (CHAr, C5), 110.5 (CHAr, C7), 60.3 (CH, C15), 39.7 (CH2, C14), 35.5 (C, C16), 32.9 
(CH3, CNMe), 30.7 (CH3, C17 or 18), 30.2 (CH3, C17 or 18); IR max (film)/cm
-1
: 2969 (w), 2940 
(w), 2921 (w, br), 2866 (w, br), 1705 (s), 1677 (m, br), 1520 (w), 1415 (m), 1372 (m), 1363 
(m), 1251 (m), 1212 (m), 1150 (m), 868 (w), 788 (s), 751 (s), 741 (s); HRMS (ESI) 
m/z 302.1148 [M+Na]
+
, [C18H17NO2Na]
+
 requires 302.1157. Data were in agreement with 
those reported in the literature. 
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Preparation of azide 217
7
 
 
An oven-dried round-bottom flask, purged with nitrogen, was charged with TMSN3 (318 µL, 
2.39 mmol) in dry CH2Cl2 (3 mL). AcOH (140 µL, 2.39 mmol) was added to the colourless 
solution and the resulting solution was stirred vigorously for 20 min. A solution of enone 214 
(133.4 mg, 0.478 mmol) in dry CH2Cl2 (3 mL) and freshly distilled Et3N (13 µL, 0.10 mmol) 
were added to the colourless solution which turned dark orange. The mixture was stirred for 
1 h at room temperature and the solvent was evaporated under reduced pressure. The crude 
material was purified by flash column chromatography (petroleum ether/ethyl acetate, 6/4) to 
afford azide 217 (137.5 mg, 89%) as pink needles; 
1
H NMR (300 MHz, CDCl3) δ 7.44 (dd, 
1H, J 7.4, 1.2, H5), 7.38 (dd, 1H, J 8.0, 7.4, H6), 7.32 (dd, 1H, J 8.0, 1.2, H7), 7.04 (s, 1H, H2), 
3.79 (s, 3H, HNMe), 3.10 (d, 1H, J 17.1, H12), 3.04 (dd, 1H, J 8.9, 6.9, H15), 2.98 (d, 1H, 
J 17.1, H12), 2.86 (d, 1H, J 6.9, 1 × H14), 2.83 (d, 1H, J 8.9, 1 × H14), 1.49 (s, 3H, H17 or 18), 
1.33 (s, 3H, H17 or 18); 
13
C NMR (100 MHz, CDCl3) δ 205.2 (C, C10), 204.0 (C, C13), 137.3 (C, 
C8), 128.1 (CHAr, C2), 127.5 (C, C4), 122.8 (CHAr, C6), 122.6 (C, C9), 119.2 (C, C3), 118.6 
(CHAr, C5), 110.2 (CHAr, C7), 74.9 (C, C11), 55.4 (CH, C15), 55.4 (CH2, C12), 42.7 (CH2, C14), 
36.9 (C, C16), 33.0 (CH3, CNMe), 32.9 (CH3, C17 or 18), 29.0 (CH3, C17 or 18); IR max (film)/cm
-1
: 
2970 (w, br), 2921 (w, br), 2117 (s), 1715 (s), 1449 (w), 1418 (w), 1248 (m, br), 995 (w), 733 
(s); HRMS (ESI) m/z 345.1341 [M+Na]
+
, [C18H18N4O2Na]
+
 requires 345.1327. Data were in 
agreement with those reported in the literature. 
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Preparation of amine 268 
 
To a solution of azide 217 (60 mg, 0.19 mmol) in THF (8.5 mL) and H2O (343 µL) pre-cooled 
to 0 °C, was added dropwise over 1 min PBu3 (93 µL, 0.37 mmol). The resulting solution was 
stirred for 15 min at 0 °C and was then allowed to warm up to room temperature. After 1 h at 
room temperature, the reaction showed total consumption of starting material. The solvent 
was evaporated under reduced pressure. The residue was diluted in CH2Cl2 (5 mL) and H2O 
(5 mL). The phases were separated and the aqueous phase was extracted with CH2Cl2 
(2 × 5 mL). The combined organic layers were washed with 1 M NaOH (10 mL), dried over 
MgSO4 and concentrated under reduced pressure. The red crude solution was purified by flash 
column chromatography (using a gradient of petroleum ether/ethyl acetate (5/5 to 3/7) as 
eluent) to afford amine 268 (30.8 mg, 56%) as a red oil; 
1
H NMR (400 MHz, CDCl3) δ 7.64 
(dd, 1H, J 7.4, 1.1, H5), 7.32 (dd, 1H, J 8.1, 7.4, H6), 7.26 (dd, 1H, J 8.1, 1.1, H7), 7.00 (s, 1H, 
H2), 4.01 (br s, 2H, HNH2), 3.77 (s, 3H, HNMe), 3.26 (d, 1H, J 17.0, 1 × H12), 3.01 (dd, 1H, 
J 9.4, 6.8, H15), 2.90 (d, 1H, J 17.0, 1 × H12), 2.75-2.82 (m, 1H, 1 × H14), 2.79 (d, 1H, J 17.0, 
1 × H12), 1.47 (s, 3H, H17 or 18), 1.30 (s, 3H, H17 or 18); 
13
C NMR (100 MHz, CDCl3) δ 212.0 (C, 
C10), 206.0 (C, C13), 137.1 (C, C8), 132.1 (C, C4), 127.6 (CHAr, C2), 122.7 (CHAr, C6), 122.6 
(C, C9), 119.6 (C, C3), 118.6 (CHAr, C5), 109.4 (CHAr, C7), 66.6 (C, C11), 58.5 (CH2, C12), 
55.9 (CH, C15), 43.4 (CH2, C14), 36.7 (C, C16), 33.0 (2 × CH3, CNMe, C17 or 18), 29.7 (CH3, 
C17 or 18); HRMS (ESI) m/z 319.1427 [M+Na]
+
, [C18H20N2O2Na]
+
 requires 319.1422. 
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Preparation of carbamate 270 
 
To a solution of azide 217 (47.2 mg, 0.15 mmol) in THF (6.8 mL) and H2O (271 µL) 
pre-cooled to 0 °C, was added dropwise over 1 min PBu3 (74 µL, 0.29 mmol). The resulting 
solution was stirred for 15 min at 0 °C and was then allowed to warm up to room temperature. 
After 1 h at room temperature, the reaction showed total consumption of starting material. 
The solvent was evaporated under reduced pressure. The residue was diluted in CH2Cl2 
(5 mL) and H2O (5 mL). The phases were separated and the aqueous phase was extracted with 
CH2Cl2 (2 × 5 mL). The combined organic layers were washed with 1 M NaOH (10 mL), 
dried over MgSO4 and concentrated under reduced pressure. The red crude solution 
(135.2 mg) was carried on to the next step without further purification. 
To a suspension of crude amine 268 and Na2CO3 (145 mg, 1.37 mmol) in anhydrous toluene 
(25 mL) was added methyl chloroformate (106 µL, 1.37 mmol). The resulting orange solution 
was stirred for 14 h at room temperature. The reaction mixture was quenched with water 
(20 mL) and the phases were separated. The aqueous layer was extracted with Et2O 
(2 × 15 mL). The combined organic layers were washed with Na2CO3 (10% in H2O, 30 mL) 
then water (30 mL), dried over MgSO4 and concentrated under reduced pressure. The crude 
material was purified by flash column chromatography (using a gradient of petroleum 
ether/ethyl acetate (5/5 to 4/6)) to afford carbamate 270 (52.5 mg, 99%) as red liquid; 
1
H NMR (400 MHz, CDCl3) δ 7.38 (dd, 1H, J 7.0, 1.4, H5), 7.29 (dd, 1H, J 8.1, 7.0, H6), 7.26 
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(dd, 1H, J 8.1, 1.4, H7), 6.99 (s, 1H, H2), 5.45 (br s, 1H, HNHR), 3.76 (s, 3H, HNMe), 3.72 (d, 
1H, J 16.0, 1 × H12), 3.70 (br s, 3H, H20), 3.14 (d, 1H, J 16.0, 1 × H12), 3.07 (dd, 1H, J 9.4, 
6.8, H15), 2.83-2.87 (m, 2H, H14), 1.49 (s, 3H, H17 or 18), 1.31 (s, 3H, H17 or 18); 
13
C NMR 
(100 MHz, CDCl3) δ 212.0 (C, C10), 205.2 (C, C13), 176.3 (C, C19), 137.3 (C, C8), 130.8 (C, 
C4), 127.6 (CHAr, C2), 122.6 (CHAr, C6), 122.3 (C, C9), 119.7 (C, C3), 117.0 (CHAr, C5), 109.7 
(CHAr, C7), 68.9 (C, C11), 55.7 (CH, C15), 55.3 (CH2, C12), 52.2 (CH3, C20), 42.6 (CH2, C14), 
36.6 (C, C16), 33.0 (2 × CH3, CNMe, C17 or 18), 28.7 (CH3, C17 or 18); IR max (film)/cm
-1
: 3354 
(m, br), 2961 (w, br), 2920 (w, br), 2851 (w), 1734 (m), 1707 (s), 1523 (m), 1453 (w), 1421 
(w), 1248 (s), 1238 (s), 1038 (s), 791 (w), 745 (s); HRMS (ESI) m/z 377.1470 [M+Na]
+
, 
[C20H22N2O4Na]
+
 requires 377.1477. 
 
 
Preparation of aldol 273 
 
To a solution of carbamate 270 (20 mg, 0.056 mmol) in THF (2 mL), pre-cooled to -78 °C, 
was added dropwise over 1 min a solution of LHMDS (1.00 M in THF, 565 µL, 0.56 mmol). 
The resulting yellow solution was stirred for 10 min at -78 °C and a solution of freshly 
distilled TMSCl (72 µL, 0.56 mmol) was added to the mixture. After 30 min at -78 °C, Et3N 
(0.5 mL) was added followed by addition of a solution of NaHCO3 (3 mL). The reaction was 
allowed to warm up to room temperature. Et2O (5 mL) was added and the phases were 
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separated. The aqueous phase was extracted with Et2O (3 × 5 mL). The combined organic 
layers were dried over MgSO4 and concentrated under reduced pressure. The crude material 
was carried on to the next step without further purification. 
To a solution of crude silyl enol ether 271 in CH2Cl2 (1 mL) was added acetaldehyde (16 µL, 
0.028 mmol). The reaction mixture was cooled to -60 °C and a solution of BF3.OEt2 (7 µL, 
0.056 mmol) in CH2Cl2 (0.2 mL) was added dropwise over 1 min to the reaction. After 3 h of 
stirring at -60 °C, the starting silyl enol ether 271 was fully consumed, however starting 
ketone 270 appeared along with the desired Mukuyaima product 273 by TLC. The reaction 
was quenched with a solution of NaHCO3 (20 mL) and the reaction was allowed to warm to 
room temperature. The phases were separated and the aqueous layer was extracted with Et2O 
(2 × 15 mL). The combined organic layers were washed with brine (30 mL), dried over 
MgSO4 and concentrated under reduced pressure. The crude material was purified by flash 
column chromatography (using a gradient of petroleum ether/ethyl acetate (8/2 to 4/6) as 
eluent) to afford aldol 273 as a mixture of two rotamers as an orange oil (2.4 mg, 12%); Major 
rotamer*/Minor rotamer: 
1
H NMR (400 MHz, CDCl3) δ 7.22-7.40 (m, 6H, H5*, 6* and 7*, 
H5, 6 and 7), 6.99 (s, 1H, H2*), 6.94 (s, 1H, H2), 5.50 (br s, 1H, HNH*), 5.43 (br s, 1H, HNH), 
3.98-4.06 (m, 1H, H20*), 3.87-3.94 (m, 1H, H20), 3.77 (s, 3H, HNMe), 3.75 (s, 3H, HNMe*), 3.72 
(br s, 3H, HOMe*), 3.70 (br s, 3H, HOMe), 3.12-3.17 (m, 2H, H12*, H12), 3.05-3.12 (m, 2H, H15*, 
H15), 2.67-2.93 (m, 4H, H14*, H14), 1.44 (s, 6H, H17* or 18*, H17 or 18), 1.23-1.25 (m, 12H, 
H17* or 18*, and 21*, H17 or 18, and 21), HOH were not observed; IR max(film)/cm
-1
: 3425 (w, br), 3338 
(w, br), 2922 (w, br), 2921 (w, br), 1730 (m), 1703 (s), 1654 (s), 1528 (m), 1450 (m), 1251 
(s), 1075 (m), 1047 (s), 916 (m), 735 (s); HRMS (ESI) m/z 421.1741 [M+Na]
+
, 
[C22H26N2O5Na]
+
 requires 421.1739. 
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Preparation of aldol 228
7
 
 
To a solution of LHMDS (1.00 M in THF, 2.13 mL, 2.13 mmol) and a solution of freshly 
distilled TMSCl (271 µL, 2.13 mmol) in THF (1 mL), pre-cooled to -78 °C, was added 
dropwise over 3 min a solution of azide 217 (137.5 mg, 0.427 mmol) in THF (3.5 mL), pre-
cooled to -78 °C. After 1 h of stirring at -78 °C, the reaction showed total consumption of 
starting material. The reaction was quenched with a solution of NaHCO3 (3 mL) and was 
allowed to warm to room temperature. Et2O (5 mL) was added and the phases were separated. 
The aqueous phase was extracted with Et2O (3 × 5 mL). The combined organic layers were 
dried over MgSO4 and concentrated under reduced pressure. Half of the crude material was 
carried on to the next step without further purification. 
To a solution of crude silyl enol ether 240 in CH2Cl2 (4.5 mL) was added a solution of 
acetaldehyde (60 µL, 1.07 mmol) in CH2Cl2 (0.69 mL). The reaction mixture was cooled to 
-60 °C and a solution of BF3.OEt2 (30 µL, 0.214 mmol) was added dropwise over 1 min to the 
reaction at remaining temperature. After 3 h of stirring at -60 °C, another equivalent of 
BF3.OEt2 (30 µL, 0.214 mmol) was added dropwise over 1 min to the reaction at remaining 
temperature. After an additional 2 h of stirring at -60 °C, another equivalent of BF3.OEt2 
(30 µL, 0.214 mmol) was added dropwise over 1 min to the reaction at remaining 
temperature. After a total of 6 h of stirring at -60 °C, the reaction showed total consumption 
of starting material and was quenched with a solution of NaHCO3 (5 mL) and was allowed to 
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warm to room temperature. CH2Cl2 (5 mL) was added and the phases were separated. The 
aqueous phase was extracted with CH2Cl2 (3 × 5 mL). The combined organic layers were 
washed with brine (10 mL), dried over MgSO4 and concentrated under reduced pressure. The 
crude material was purified by flash column chromatography (using a gradient of petroleum 
ether/ethyl acetate (6/4 to 4/6) as eluent) to afford aldol 228 (62.7 mg, 80%) as a single 
diastereoisomer as a yellow liquid; 
1
H NMR (400 MHz, CDCl3) δ 7.44 (dd, 1H, J 7.4, 1.2, 
H5), 7.38 (dd, 1H, J 8.0, 7.4, H6), 7.32 (dd, 1H, J 8.0, 1.2, H7), 7.01 (s, 1H, H2), 4.07-4.14 (m, 
1H, H20), 3.85 (d, 1H, J 3.0, HOH), 3.78 (s, 3H, HNMe), 3.08 (dd, 1H, J 9.4, 4.1, H15), 2.92 (dd, 
1H, J 7.2, 1.3, H12), 2.76 (d, 1H, J 9.4, 1 × H14), 2.74 (dd, 1H, J 4.1, 1.3, 1 × H14), 1.52 (s, 3H, 
H17 or 18), 1.27 (s, 3H, H17 or 18), 1.14 (d, 3H, J 6.3, H21); 
13
C NMR (100 MHz, CDCl3) δ 204.9 
(C, C10), 204.7 (C, C13), 137.4 (C, C8), 127.5 (CHAr, C2), 126.9 (C, C4), 123.0 (CHAr, C6), 
122.1 (C, C9), 119.0 (C, C3), 118.8 (CHAr, C5), 110.5 (CHAr, C7), 78.7 (C, C11), 71.8 (CH, 
C12), 67.2 (C, C20), 55.5 (CH, C15), 41.0 (CH2, C14), 36.6 (C, C16), 33.1 (2 ×  CH3, CNMe, 
C17 or 18), 28.6 (CH3, C17 or 18), 21.0 (CH3, C21); IR max (film)/cm
-1
: 3506 (w, br), 2921 (w), 
2117 (w), 1713 (m), 1705 (s), 1451 (w), 1249 (m), 791 (m), 746 (s); HRMS (ESI) 
m/z 389.1599 [M+Na]
+
, [C20H22N4O3Na]
+
 requires 389.1590. Data were in agreement with 
those reported in the literature. 
 
 
  
207 
 
Preparation of amine 276 
 
To a solution of azide 228 (28.8 mg, 0.079 mmol) in THF (3.7 mL) and H2O (147 µL), 
pre-cooled to 0 °C, was added dropwise over 1 min a solution of PMe3 (1.00 M in THF, 
157 µL, 0.157 mmol). After 25 min of stirring at 0 °C, the reaction was allowed to stir at 
room temperature for another 45 min. The solvent was removed under reduced pressure. The 
residue was dissolved in CH2Cl2 (5 mL) and H2O (5 mL) and the phases were separated. The 
aqueous phase was extracted with CH2Cl2 (3 × 5 mL). The combined organic layers were 
washed with 1 M NaOH (10 mL), dried over MgSO4 and concentrated under reduced 
pressure. The residue was concentrated under reduced pressure overnight to remove any 
phosphine oxide generated during the reaction. The crude material was purified by flash 
column chromatography (using a gradient of petroleum ether/ethyl acetate (6/4 to 4/6) as 
eluent) to afford amine 276 (9.3 mg, 35%) as a red oil; 
1
H NMR (400 MHz, CDCl3) δ 7.34 
(dd, 1H, J 8.1, 7.6, H6), 7.26 (dd, 1H, J 8.1, 0.7, H7), 7.17 (dd, 1H, J 7.6, 0.7, H5), 6.98 (s, 1H, 
H2), 3.99-4.06 (m, 1H, H19), 3.76 (s, 3H, HNMe), 3.15 (dd, 1H, J 8.4, 5.0, H15), 2.93 (d, 1H, 
J 9.5, H12), 2.66-2.69 (m, 2H, H14), 1.51 (s, 3H, H17 or 18), 1.25 (s, 3H, H17 or 18), 1.06 (d, 3H, 
J 6.1, H20), none of the exchangeable protons were observed; 
13
C NMR (100 MHz, CDCl3) 
δ 207.9 (C, C10 ), 205.3 (C, C13), 137.2 (C, C8), 133.1 (C, C4), 127.4 (CHAr, C2), 123.0 (CHAr, 
C6), 121.2 (C, C9), 119.4 (C, C3), 116.8 (CHAr, C5), 109.5 (CHAr, C7), 74.1 (CH, C12), 70.1 (C, 
C11), 67.1 (C, C19), 55.8 (CH, C15), 40.8 (CH2, C14), 36.5 (C, C16), 33.4 (CH3, C17 or 18), 33.1 
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(CH3, CNMe), 28.7 (CH3, C17 or 18), 21.3 (CH3, C20); HRMS (ESI) m/z 341.1869 [M+H]
+
, 
[C20H25N2O3]
+
 requires 341.1865. 
 
 
 
Preparation of enone 227 
 
To a solution of azide 228 (79.7 mg, 0.218 mmol) in CH2Cl2 (4 mL), pre-cooled to 0 °C, was 
added dropwise over 1 min Tf2O (183 µL, 307 mg, 1.09 mmol) followed by pyridine (88 µL, 
86 mg, 1.09 mmol). The reaction mixture turned from yellow in colour to brown in colour. 
After 30 min of stirring at 0 °C, the reaction mixture was allowed to stir at room temperature 
for another hour. The reaction was quenched with a solution of NaHCO3 (6 mL) and the 
phases were separated. The aqueous phase was extracted with CH2Cl2 (3 × 5 mL). The 
combined organic layers were washed with brine (10 mL), dried over MgSO4 and 
concentrated under reduced pressure. The crude material was purified by flash column 
chromatography (petroleum ether/ethyl acetate, 8/2) to afford enone 227 (33.8 mg, 45%, 48% 
BRSM) as yellow solid; Mixture Z*/E in a 9/1 ratio: 
1
H NMR (500 MHz, CDCl3) δ 7.46 (d, 
1H, J 7.4, H5 or 7), 7.42 (d, 1H, J 7.5, H5 or 7), 7.34-7.37 (m, 1H, H6), 7.26-7.36 (m, 3H, 
H5*, 6* and 7*), 7.11 (q, 1H, J 7.9, H20), 7.07 (s, 1H, H2), 7.05 (s, 1H, H2*), 6.94 (q, 1H, J 7.5, 
H20*), 3.79 (s, 6H, HNMe*, HNMe), 2.74-2.78 (m, 6H, H14*, 15*, H14, 15), 2.50 (d, 3H, J 7.9, H21), 
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2.18 (d, 3H, J 7.5, H21*),  1.52 (s, 3H, H17 or 18), 1.48 (s, 3H, H17 or 18), 1.46 (s, 3H, H17* or 18*), 
1.43 (s, 3H, H17* or 18*); 
13
C NMR (100 MHz, CDCl3) δ 203.8 (C, C10), 203.3 (C, C10*), 197.0 
(C, C13*, C13), 140.6 (CH, C20*, C20), 137.1 (C, C8*, C8), 136.3 (C, C4*, C4), 128.4 (C, C2*), 
128.1 (C, C2), 127.6 (C, C9*, C9), 123.2 (C, C12*, C12), 122.8 (CHAr, C5 or 6 or 7), 122.4 (CHAr, 
C5* or 6* or 7*), 120.3 (CHAr, C5 or 6 or 7), 120.0 (CHAr, C5* or 6* or 7*), 119.4 (C, C3*, C3), 110.3 
(CHAr, C5 or 6 or 7), 109.8 (CHAr, C5* or 6* or 7*), 54.2 (CH, C15*, C15), 42.7 (C, C11*, C11), 42.4 
(CH2, C14*, C14), 37.4 (C, C16*, C16), 33.1 (CH3, CNMe*, CNMe), 32.4 (CH3, C17* or 18*, C17 or 18), 
30.0 (CH3, C17* or 18*, C17 or 18), 16.3 (CH3, C21*, C21); IR max (film)/cm
-1
: 2918 (w, br), 2109 
(s), 1719 (m), 1687 (m), 1608 (w), 1421 (w), 1369 (w), 1202 (s, br), 1149 (s, br), 1093 (m), 
1056 (m), 1016 (m), 949 (m), 786 (m), 743 (s); HRMS (ESI) m/z 371.1483 [M+Na]
+
, 
[C20H20N4O2Na]
+
 requires 371.1484. 
 
 
Preparation of silyl enol ether 280 
 
To a solution of LHMDS (1.00 M in THF, 320 µL, 0.32 mmol) and a solution of freshly 
distilled TMSCl (40 µL, 0.32 mmol) in THF (0.5 mL), pre-cooled to -78 °C, was added 
dropwise over 1 min a solution of azide 227 (22 mg, 0.063 mmol) in THF (1 mL). The 
resulting yellow solution was stirred for 1 h at -78 °C while monitored by TLC. Along with 
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the starting material, a new spot appeared by TLC. As the reaction did not show any further 
advancement, Et3N (0.5 mL) was added followed by addition of a solution of NaHCO3 
(3 mL). The reaction was allowed to warm up to room temperature. Et2O (5 mL) was added 
and the phases were separated. The aqueous phase was extracted with Et2O (3 × 5 mL). The 
combined organic layers were dried over MgSO4 and concentrated under reduced pressure. 
The crude material was purified by flash column chromatography (petroleum ether/ethyl 
acetate, 8/2) to afford silyl enol ether 280 (2.2 mg, 8%) as colourless oil as a mixture of Z/E 
isomers in a ratio of 54/46 along with starting enone 271 (12.8 mg, 58%); Mixture Z*/E: 
1
H NMR (400 MHz, CDCl3) δ 7.46 (dd, 1H, J 7.3, 1.2, H5* or 7*), 7.20-7.30 (m, 2H, H6* and 
(5* or 7*)), 7.20-7.30 (m, 3H, H5, 6 and 7), 6.94 (s, 1H, H2*), 6.93 (s, 1H, H2), 6.17 (q, 1H, J 7.5, 
H20), 5.95 (q, 1H, J 7.5, H20*), 5.13 (d, 1H, J 4.0, H14), 5.12 (d, 1H, J 3.4, H14*), 3.76 (s, 3H, 
HNMe*), 3.75 (s, 3H, HNMe), 3.24 (d, 1H, J 4.0, H15), 3.20 (d, 1H, J 3.4, H15*), 2.30 (d, 3H, 
J 7.5, H21), 1.89 (d, 3H, J 7.5, H21*), 1.59 (s, 6H, H17 and 18), 1.26 (s, 6H, H17* and 18*), -0.25 (s, 
9H, H19),
 
 -0.44 (s, 9H, H19*);
 13
C NMR (100 MHz, CDCl3) δ 209.7 (C, C10, C10*), 184.0 (C, 
C13, C13*), 126.4 (CHAr, C2, C2*), 123.2 (C=CH, C20, C20*), 122.1 (CHAr, C5 or 6 or 7, 
C5* or 6* or 7*), 118.9 (CHAr, C5 or 6 or 7, C5* or 6* or 7*), 109.2 (CHAr, C5 or 6 or 7, C5* or 6* or 7*), 108.9 
(CHAr, C14), 108.0 (CHAr, C14*), 89.4 (C, C11, C11*), 58.5 (C, C16, C16* ), 32.9 (CH3, CNMe*), 
31.2 (CH3, CNMe), 29.7 (CH3, C17* or 18*), 29.2 (CH3, C17 or 18), 15.1 (CH3, C21), 14.2 (CH3, 
C21*), -0.95 (CH3, C19), -0.57 (CH3, C19*), quaternary carbons C3,4,8,9,12 were missing due to 
the scale of our reaction; IR max (film)/cm
-1
: 3433 (w, br), 3361 (w, br), 3023 (m), 2968 (s, 
br), 2920 (s, br), 2851 (m), 2117 (s), 1721 (s), 1453 (m), 1422 (m), 1253 (s), 1218 (s), 326 
(m), 857 (m), 746 (s, br), 671(m); HRMS (ESI) m/z 443.1877 [M+Na]
+
, [C23H28N4O2SiNa]
+
 
requires 443.1879.
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Preparation of methylated cyclohexanone 283 
 
To a solution of enone 227 (10.7 mg, 0.0307 mmol) and MeI (0.5 mL, 0.008 mmol) in THF 
(0.5 mL) was added tBuOK (3.6 mg, 0.0307 mmol) in one portion. The reaction mixture was 
stirred for 15 min and monitored by TLC. The process was repeated and a new spot was 
observed along with the starting material. Another eq. of tBuOK was added, but the TLC 
started to show degradation so the reaction was quenched using H2O (3 mL). The phases were 
separated and the aqueous phase was extracted with Et2O (3 × 5 mL). The combined organic 
layers were dried over MgSO4 and concentrated under reduced pressure. The crude material 
was purified by flash column chromatography (petroleum ether/ethyl acetate, 8/2) to afford 
methylated cyclohexanone 283 (1.2 mg, 12%) as a single stereoisomer a yellow oil; 
1
H NMR 
(400 MHz, CDCl3) δ 7.27-7.31 (m, 2H, H6 and 7), 7.17 (dd, 1H, J 6.0, 2.0, H5), 6.91 (s, 1H, H2), 
6.66 (dd, 1H, J 17.6, 11.6, H20), 6.27 (dd, 1H, J 17.6, 1.8, H21), 5.54 (dd, 1H, J 11.6, 1.8, H21), 
3.76 (s, 3H, HNMe), 3.22  (qd, 1H, J 7.5, 0.8, H14), 2.95 (d, 1H, J 0.8, H15), 1.57 (s, 3H, 
H17 or 18), 1.38 (d, 3H, J 7.5, H22), 1.20 (s, 3H, H17 or 18);
 13
C NMR (100 MHz, CDCl3) δ 127.1 
(CH=CH2, C20), 126.0 (CHAr, C2), 124.2 (C=CH2, C21), 122.2 (CHAr, C6), 116.7 (CHAr, C5), 
110.2 (CHAr, C7), 77.2 (CHAr, C11), 68.1 (CH, C15), 45.0 (CH, C14), 32.9 (CH3, CNMe), 30.5 
(CH3, C17 or 18), 30.3 (CH3, C17 or 18), 19.0 (CH3, C19), none of the quaternary carbons were 
observed due to the scale of our reaction; IR max (CHCl3)/cm
-1
: 2966 (m), 2919 (m, br), 2116 
(m), 1715 (s), 1682 (s), 1461 (w), 1440 (w), 1419 (w), 1373 (w), 1218 (w), 749 (s); HRMS 
(ESI) m/z 342.1469 [M+Na]
+
, [C21H21NO2Na]
+
 requires 342.1470. 
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Preparation of bis-phenol 292  
 
To a solution of azide 227 (20 mg, 0.057 mmol) in THF (2.6 mL) and H2O (104 µL), 
pre-cooled to 0 °C, was added dropwise over 2 min a solution of PBu3 (1.00 M in THF, 
115 µL, 0.115 mmol). After 15 min of stirring at 0 °C, the reaction was allowed to stir at 
room temperature for another 2 h. The solvent was removed under reduced pressure. The 
residue was dissolved in CH2Cl2 (5 mL) and H2O (5 mL) and the phases were separated. The 
aqueous phase was extracted with CH2Cl2 (3 × 5 mL). The combined organic layers were 
washed with 1 M NaOH (10 mL), dried over MgSO4 and concentrated under reduced 
pressure. The residue was used for the next reaction without further purification. 
To a suspension of crude amine and Na2CO3 (55.5 mg, 0.524 mmol) in anhydrous toluene 
(10 mL) was added methyl chloroformate (41 µL, 0.524 mmol). The resulting yellow solution 
was stirred for 14 h at room temperature. The TLC did not show any advancement. The 
reaction mixture was heated at reflux for 3 h, after which time, the reaction was completed. 
The reaction mixture was quenched with water (20 mL) and the phases were separated. The 
aqueous layer was extracted with Et2O (2 × 15 mL). The combined organic layers were 
washed with Na2CO3 solution (10% in H2O, 30 mL) then water (30 mL), dried over MgSO4 
and concentrated under reduced pressure. The crude material was purified by flash column 
chromatography (petroleum ether/ethyl acetate, 8/2) to afford bis-phenol 292 (5.5 mg, 32%) 
as a yellow oil; λmax (EtOH)/nm 334 (ε/dm3mol-1cm-1 11 300); 1H NMR (500 MHz, CDCl3) 
213 
 
δ 7.55 (dd, 1H, J 6.3, 2.2, H5), 7.25-7.27 (m, 2H, H6 and 7), 7.03 (d, 1H, J 8.8, H14 or 15), 6.92 (d, 
1H, J 8.8, H14 or 15), 6.90 (s, 1H, H2), 6.65 (dd, 1H, J 17.9, 12.2, H20), 6.07 (s, 1H, HOH), 5.74 
(dd, 1H, J 12.2, 1.6, H21), 5.72 (dd, 1H, J 17.9, 1.6, H21), 3.80 (s, 1H, HNMe), 1.80 (s, 1H, 
H17 or 18), 1.31 (s, 1H, H17 or 18); 
13
C NMR (100 MHz, CDCl3) δ 149.4 (C, C10), 149.0 (C, C13), 
137.4 (C=CH, C20), 136.7 (C, C8), 131.5 (C, C4), 127.9 (C, C11), 125.7 (CHAr, C14 or 15), 124.8 
(C, C9), 124.1 (CHAr, C5), 122.9 (C, C3), 122.6 (CHAr, C2), 120.9 (CHAr, C6), 118.9 (C, C12), 
117.7 (C=CH2, C21), 114.9 (CHAr, C14 or 15), 108.8 (CHAr, C7), 79.8 (C, C16), 32.9 (CH3, CNMe), 
30.6 (CH3, C17 or 18), 29.7 (CH3, C17 or 18); IR max (CHCl3)/cm
-1
: 3368 (s, br), 2975 (s), 2927 
(s), 2900 (s, br), 1451 (m), 1417 (m), 1381 (m), 1218 (m), 1090 (s), 1050 (s), 881 (m), 758 
(s); HRMS (ESI) m/z 328.1315 [M-H2O+Na]
+
, [C20H17NONa]
+
 requires 328.1313. 
 
 
Preparation of bis-phenol 291 
 
To a solution of bridgehead enone 214 (21.5 mg, 0.077 mmol) in toluene (13 mL) was added 
a drop of TFA. The reaction turned from yellow in colour to orange in colour. The reaction 
mixture was heated to reflux for 30 min and was quenched by addition of H2O (10 mL). The 
phases were separated and the aqueous phase was extracted with Et2O (3 × 5 mL). The 
combined organic layers were dried over MgSO4 and concentrated under reduced pressure. 
The crude material was purified by flash column chromatography (petroleum ether/ethyl 
214 
 
acetate, 8/2) to afford starting enone 214 (4 mg, 19%) along with bis-phenol 291 (11.7 mg, 
55%, 68% BRSM); 
1
H NMR (400 MHz, CDCl3) δ 7.46 (d, 1H, J 7.2, H5), 7.31-7.35 (m, 2H, 
H6 and 7), 7.29 (d, 1H, J 1.5, H12), 7.03 (d, 1H, J 8.5, H15), 6.90 (s, 1H, H2), 6.71 (dd, 1H, J 8.5, 
1.5, H14), 4.98 (br s, 1H, HOH), 3.76 (s, 3H, HNMe), 1.57 (s, 6H, H17 and 18); 
13
C NMR 
(100 MHz, CDCl3) δ 151.8 (C, C10), 148.8 (C, C13), 137.3 (C, C8), 132.4 (C, C4), 129.3 (C, 
C11), 126.4 (CHAr, C15), 124.7 (C, C9), 124.1 (C, C3), 122.5 (CHAr, C2), 122.3 (CHAr, C6), 
117.4 (CHAr, C5), 114.9 (CHAr, C14), 114.2 (CHAr, C12), 108.6 (CHAr, C7), 78.8 (C, C16), 32.4 
(CH3, CNMe), 29.9 (CH3, C17 and 18); IR max (CHCl3)/cm
-1
: 3355 (m, br), 3016 (m), 2980 (m), 
2928 (m, br), 1608 (w), 1568 (w), 1485 (m), 1466 (m), 1416 (m), 1215 (s), 1130 (m), 909 (w), 
869 (w), 812 (m), 756 (s, br); HRMS (ESI) m/z 302.1158 [M-H2O+Na]
+
, [C18H17NO2Na]
+
 
requires 302.1157. 
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